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Abstract  
This thesis seeks to demonstrate technologies capable of improving the purity of 
pluripotent-derived cells. Such cells offer an enormous opportunity for medical science. 
However, it is anticipated that a higher proportion of undifferentiated pluripotent cells will 
remain when manufacturing at scale. As indicated in the literature, the in vivo 
transplantation of undifferentiated cells is a threat to patient safety and is considered a 
limiting factor for large-scale manufacture.  
Pluripotent undifferentiated cells can be identified and removed based on an affinity 
interaction with the SSEA-4 antigen, which is down-regulated on differentiated cells. Using 
CD20+ and CD20- (HLA-A2+) lymphocyte cells as a cost-effective alternative, where the 
CD20+ cells are target impurities and the HLA-A2+ cells are product-designated cells, this 
thesis presents two technologies to minimise the proportion of undifferentiated cells during 
manufacture. These technologies rely upon shear stress-induced affinity separation to 
differentiate between cells with and without target antigens.  A small-scale model is used to 
identify a range of shear stresses (0 – 25 dynes/cm2) with which these differences can be 
elucidated. These technologies are: 
(1) a quartz crystal microbalance (QCM) biosensor to detect pluripotent cell differentiation 
over a multi-day period, particularly during process development. The limit of quantitation 
(LoQ) was estimated to be 5,000 cells, which would enable the measurement of target cell 
purities in excess of 4 %. Findings provide the basis for such a system, but also highlight the 
technical challenges of development, in particular variability.  
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 (2) two affinity membranes (hollow fibre and flat sheet) were used to deplete cells positive 
for the target antigen, demonstrating a possible downstream-purification tool in instances 
where clinical purity does not suffice. The shear stress-induced detachment of adsorbed 
cells incubated for 30 minutes was investigated over 1 – 25 dynes/cm2 and 1 – 10 dynes/cm2 
for the hollow fibre and flat sheet membranes respectively. Measured output included cell 
purity, which showed an increase in the relative change in purity (RCP) of 0.2 – 0.5 for the 
hollow fibre modules at 5 dynes/cm2 (n = 5) and was as high as 11.8 at 10 dynes/cm2 for the 
flat sheet membrane cassette (n = 1). A loss of cell membrane integrity, where up to 5 % in 
hollow fibres and up to 55 % in the flat sheet membrane were observed. 
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Thesis outline 
Chapter 1 (Literature review): provides an overview of the challenges facing the cell therapy 
manufacturing industry. It also highlights the potential for developing new technology to 
detect and remove unwanted cell types using immunoaffinity interactions.  
Chapter 2 (Flow tube model): shear stresses capable of differentiating between affinity and 
non-affinity interactive cells are identified in a small-scale glass flow tube model.  
Chapter 3 (Biosensor development): presents a quartz crystal microbalance biosensor with a 
proposed method for measuring cell purity 
Chapter 4 (Affinity membrane development): outlines the development and 
characterisation of two units: a hollow fibre and flat sheet membrane to be used for cell 
separation studies in Chapter 5.  
Chapter 5 (Affinity cell separation): provides a performance comparison of immunoaffinity 
membranes developed in Chapter 4 and compares their purification performance against 
the existing benchmark technology.  
Chapter 6 (Thesis summary and future work): summarises the work of this thesis and 
proposes the design of a new system for affinity cell separation. 
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Chapter 1: Literature review 
1.1. Cell therapies 
Cell therapies involve the administration of human cells into the body to replace, repair, 
regenerate, or enhance the function of tissues (Mason and Dunnill, 2009).  Their therapeutic 
effect is thought to exploit the cell’s natural ability to differentiate and transdifferentiate 
into tissue-specific cells, to secrete paracrine factors to stimulate the survival and recovery 
of localised cells, or to regulate the microenvironment and immune response (Herdrich et 
al., 2008, Li and Fu, 2012). 
The economic potential of the cell therapy industry is also apparent: over 50 publically 
traded companies operate with a combined market capitalization in excess of $7B as of 
2013 with growth projections of 39.5 % (CAGR) from 2015 to 2020. (Mason et al., 2012).   
1.2. Types of cell therapies 
Two forms of human cell transplantion exist: (1) autologous therapies, where patient-
derived cells are re-infused back into the patient with or without manipulation. Autologous 
transplants involve simple operating processes at the expense of more complex regulatory 
constraints (Hourd et al., 2014); and (2) allogeneic cell therapies, where cells are derived 
and expanded from a pool of screened donor material and applied to multiple patients, 
delivering ‘off-the-shelf’ capability. Product scale-up in a cost-effective manner whilst 
identifying and maintaining cell critical quality attributes (CQA) is crucial (Brandenberger, 
2011, Rowley, 2012). Several types of cell therapies exist and are detailed accordingly: 
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T-cells  
T-cell therapy is a form of immunotherapy designed to control the immune system 
response. T-cell transplants aim to induce cytotoxic responses to attack cancer cells via 
autologous immune enhancement therapy or genetic engineering (O'Garra and Vieira, 
2004). T cell therapies have demonstrated clinical efficacy in certain types of leukaemia (Lee 
et al., 2013), but face significant safety constraints related to cytokine release syndrome 
(CRS), a life-threatening infusion reaction caused by the release of cytokines by the patient 
(Davila and Papapetrou, 2014). 
Pluripotent stem cells 
First reported in 1998 as embryonic stem cells, pluripotent stem cells have the capacity to 
differentiate into almost any cell type in the body, forming all three germ layers (mesoderm, 
endoderm and ectoderm) (Thomson et al., 1998). Ethical concerns, owing to the derivation 
of cells from embryos, were mitigated when induced pluripotent stem cells (iPSCs) were 
derived through the insertion of four genes (Oct3/4, Sox2, Klf4, c-Myc), leading to the 
formation of patient-derived immature pluripotent cells  with the same therapeutic 
differentiation ability as embryonic stem cells (Yamanaka and Takahashi, 2011).  
Their pluripotent nature allows near endless supplies of these cells to be created making 
them attractive for pharmacology, disease treatment and drug modelling (Mason and 
Dunnill, 2009). Clinical efforts thus far have been restricted to very small-scale trials, with 
teratoma formation due to impure cell populations being a possible drawback (Lebkowski, 
2011, Schriebl et al., 2012). 
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Mesenchymal stem cells 
Mesenchymal stem cells are primarily sourced from perivascular niches (Hass et al., 2011). 
They have the capacity to differentiate into specialised cells, but to a lesser degree than 
embryonic stem cells (Uccelli et al., 2008). They are thought to have vital roles in the repair 
of disease or damaged tissue (Shi et al., 2010, Gupta et al., 2012) and express anti-
inflammatory and immunomodulatory characteristics (Ma et al., 2014).  
Haematopoetic stem cells 
Haematopoetic stem cells are primarily derived from bone marrow. Transplants were 
originally conceived as a treatment for haematological and lyphoid cancers (Mikkola and 
Orkin, 2006). They have the potential to treat genetic and acquired diseases like 
automimmune and neurodegenerative disorders as well as cancer (Ness et al., 2005, Atkins 
and Freedman, 2013). 
Chapter Scope 
Whilst many different cell therapies exist, this chapter concerns the manufacture of 
pluripotent stem cells and their derivatives (e.g. pluripotent-derived cardiomyocytes). 
However, owing to the lack of scalable or commercial ventures using pluripotent stem cells 
to date, the biological and technical gains made in traditional bioprocessing (Varley and 
Birch, 1999, Velez-Suberbie et al., 2013) and in non-pluripotent stem cell manufacture (Rafiq 
et al., 2013) are considered where relevant and opportunities for implementing new 
technology highlighted.  
1.3. Regulatory constraints 
Governing bodies in respective nations provide oversight on cell therapy products, the 
purpose being to regulate the safe, efficacious supply of treatments to patients. For 
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instance, the Food and Drug Administration (FDA) in the United States, the European 
Medical Agency (EMA) in Europe and the Ministry of Health, Labour and Welfare (MHLW) in 
Japan.  
Cell therapy manufacture must comply with advanced therapy medicinal product (ATMP) 
regulations. The regulatory framework for the United States is in Part 1271 of Title 21 of the 
Code of Federal Regulations (21 CFR Part 127 1): Human Cellular and Tissue-based Products; 
for the European Union it is in Regulation (EC) No. 1394/2007 on Advanced Therapy 
Medicinal Products (ATMPs); and for Japan in the Pharmaceutical Affairs Law (PAL); Act 
regarding Ensuring of Safety of Regenerative Medicine (Regenerative Medicine Law). 
The majority of these regulations are adaptations of existing standard measures for 
pharmaceutical and biological products. Therefore efforts to provide more specific 
regulatory interpretations relevant to the European Union and United States (Table 1-1) 
(PAS 93, 2011, PAS83, 2012) and through case studies performed on commercial-grade cell 
therapy products (Bravery et al., 2013) and FDA recommendations (CFR Title 21) have been 
made.  
1.4. Defining a cell therapy product 
Characterisation is a fundamental part of Cell Therapy Product (CTP) development and 
commercialisation. The purpose is to identify and subsequently quantify cell Critical Quality 
Attributes (CQA) influential in the therapeutic action of the cell Table 1-1). Such assays need 
to be developed early – ideally before Phase 2 and absolutely before Phase 3 in compliance 
with regulatory constraints (PAS93, 2011, Bravery et al., 2013). Quantified CQAs serve as a 
performance benchmark when investigating the effect of processing conditions on the CTP.  
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Table 1-1. Cell Critical Quality Attributes (CQA) 
 
Attribute Description Characteristics used to 
define attributes 
Safety Transplanted cells must be free of genetic abnormalities, microbial 
contamination, as well as undesired cell typesb.  
Karyotype; sterility; 
tumorigenic potential  
Puritya The cell population should comprise the maximum number of 
desirable cells exhibiting the required medicinal action. It should 
exhibit little or no undesirable cells or non-cell-based contaminants 
such as biodegradable materials, human- or animal-derived proteins, 
or enzymatic components such as trypsin (PAS93, 2011). 
Genotype; gene 
expression; 
cell surface marker 
(antigen) expression 
profile; morphology; 
size Identitya Cells exhibiting the required medicinal action of the cell therapy 
product must be present in the product in sufficient quantity.  
Potency Transplanted cells must exert an acceptable level of efficacy through 
defined by biological functionality or better yet therapeutic 
outcome.  
Cytokine secretion; 
cell-to-cell interactions;  
aIt is acknowledged that purity and identity are closely linked and the tests used to confirm both overlap with each other ( 
PAS93, 2011, PAS83, 2012, Bravery et al., 2013); bin the case of cells derived from pluripotent stem cells, undesired cells 
would manifest themselves as undifferentiated or spontaneously differentiated cells. 
 
Non-pluripotent cells 
For non-pluripotent cells, such as mesenchymal stem cells, minimum identification criteria 
includes plastic adherence and in vitro trilineage differentiation, as well as CD105, CD73 and 
CD90 expression and the absence of CD45, CD19, CD79 and HLA-DR extracellular antigens 
(Dominici et al., 2006, Keating, 2012). Commercial CTPs are defined by the expression of 
certain extracellular markers to define product cells (Maziarz et al., 2012), along with the 
secretion of growth factors and cytokines specific to the therapeutic application (Bravery et 
al., 2013). 
Pluripotent cells 
Pluripotent cells must satisfy constraints presented previously, centring on the expression of 
extracellular antigens (SSEA-3 and 4, TRA-1-60, TRA-1-81),  and the absence of SSEA-1, the 
presence of intracellular markers (OCT-4, SOX2 and NANOG), a high cytoplasm-to-cell ratio, 
normal karyotype, the ability to form all three germ layers and the ability to retain a 
pluripotent state for multiple passages (>10) (Thomson et al., 1998). Pluripotent-derived 
stem cells must satisfy criteria specific to each cell type and demonstrate an absence of the 
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aforementioned pluripotent characteristics. Fully differentiated cardiomyocytes, for 
instance, must express an array of markers (MLC2V, VCAM, MYH6, cTnT, SIRPA, ctNL) and 
demonstrate comparable electrophysiology to in naturally sourced cardiomyocytes (Blazeski 
et al., 2012, Chen et al., 2014).  
1.5. Cost of goods 
Cost of goods (COG) in cell therapy manufacturing concerns the value of the therapeutic 
product being manufactured. Given the high cost and high risk of failure for cell therapy 
product (CTP) development, optimising COGs is imperative in the scaled commercialisation 
of cell therapeutics.  
Key features in medical drug manufacture are high costs (> $1.3 – 1.7 billion) and long (~ 15 
years) developmental periods (Collier, 2009). Therefore, the bioprocessing industry has 
implemented different cost structures to that of other industries. The ratio of COGS to sales 
in the automotive sector, for instance, is in excess of 70 %, yet in many pharmaceutical and 
biotechnology companies it is between 15 and 30 % (Basu et al., 2008) due to the high cost 
of product manufacture.  
Large-scale cell therapy manufacturing is dictated by economies of scale (Mason and Hoare, 
2006). The estimated costs for an allogenic cell therapy (for insulin-dependent diabetes) in 
2009 was $20 per 106 cells (Mason and Dunnill, 2009). Technical advances are projected 
reduce the cost to $1 – 5 or less (Rowley, 2014). Future technical advances will no doubt 
lower COGs for cell therapy products, but extracting maximum value from existing 
bioprocessing expertise and technology should be sought throughout the developmental 
process.  
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1.6. Manufacturing process 
Proposed allogeneic cell therapy manufacturing processes (Figure 1-1) resemble traditional 
bioprocesses where mammalian cells are expanded upstream (Velez-Suberbie et al., 2013) 
and retrieved downstream (Gronemeyer, 2014). Owing to the nature of a cell therapy, 
where the cell is a product rather than the host of a product, processing conditions 
complementary to cell physiology are required (Quintanilla, 2013, Wolfe and Ahsan, 2013). 
 
Figure 1-1. Generic cell therapy manufacturing process. The manufacturing process is largely split 
into three different stages: (Blue = upstream) cell sourcing and expansion; (Pink = downstream) cell 
separation and cryopreservation. Tissue acquisition = selection, screening and extraction of cellular 
material; primary cell isolation = identification and isolution of product-related cells; cell expansion  
= increased quantity and maintained quality of product-related cells; harvesting = recovery of cells 
from expansion system; volume reduction = concentration of cellular product; washing = removal of 
waste-related components; formulate and fill = the filling of multiple vials containing 
cryopreservation medium; = cryopreservation = freezing process for long-term product storage 
(Rowley, 2012). 
 
Technology used in a cell therapy manufacturing process should also satisfy the following 
considerations (Table 1-2) to provide safe, cost-effective and consistent performance 
compliant with regulatory standards (Brindley, 2014). The following section selectively 
discusses each of these steps based on their location (upstream or downstream) and the 
technical challenges facing them.  
 
Tissue 
acquisition 
Primary cell 
isolation 
Cell 
expansion Harvest 
Volume 
reduction Washing 
Formulate 
and fill 
Cryopres- 
ervation 
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Table 1-2. Technology requirements recommended for implementation into a cell therapy 
manufacturing process.  
Property Description 
Closed system Functionally closed unit permitting operation in non-GMP settings. 
Single-use Disposable device  
Cost-effective Exert minimal costs on process development or operation  
Scalable Capacity to increase batch sizes whilst maintaining process performance 
Capable of automated operation Integration into robotic processing steps 
GMP compliant Consistent with regulatory constraints surrounding product manufacture 
ISO 9000 certification  Demonstration of dependable quality  
 
1.6.1. Upstream processing 
Upstream processing involves sourcing a cell line for expansion and possible differentiation 
towards a specific lineage. The purpose is to expand cells to a quantity and quality deemed 
sufficient to meet intended supply in a cost-effective manner. Approximately 106 – 109 cells 
will be required per patient dose for each disease, with up to 10,000 to 100,000 patients 
being treated annually (Le Blanc et al., 2008, Braam et al., 2010). Such quantities necessitate 
the use of more cost-effective and scalable technologies. 
1.6.1.1. Tissue acquisition and primary cell isolation 
Cell line selection influences both the efficacy and safety of the CTP. Donor and ingredient 
screening must maximise the CQAs of selected lines to provide a platform for cell bank 
creation and standardised product development (PAS93, 2011, PAS83, 2012, Bravery et al. 
2013). Requirements for both pluripotent and non-pluripotent cells are detailed below. 
Non-pluripotent stem cells 
Non-pluripotent stem cell isolation is often performed based on differences in density and 
antigen expression. Density-based separation has been used to isolate stem cells from bone 
marrow (Juopperi et al., 2007) and umbilical cord blood (Sato et al., 1995). More precise 
methods utilise affinity interactions between extracellular receptors and corresponding 
ligands, such as magnetic and fluorescence-based cell sorting (detailed in Section 1.7.2.2.), 
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offering higher purities. Athersys’ Multistem® utilises magnetic beads to achieve cell purities 
in excess of  99.5 % based on CD45+ and Glycophorin A antigens (Maziarz et al., 2012). The 
company, Osiris uses a combination of anti-fibroblast magnetic beads and fluorescence-
activated cell sorting (FACS) to achieve purities in excess of 99.5 % (Davis-Sproul et al., 1999, 
Jones et al., 2002) for its OTI-010 product. Similarly, Pluristem’s PLX, using cells derived from 
the placenta, relies upon magnetic beads and FACS to sort cells based on CD44+, CD45+, 
CD73+ and CD90+ expression for a purity above 98 % (Duda et al., 2013).  
Pluripotent stem cells 
Embryonic stem cells are sourced from a 3 – 5 day-old blastocyst (Thomson et al., 1998). 
Induced pluripotent stem cells are derived from fibroblasts using a combination of 
reprogramming genes (Yamanaka and Takahashi, 2011). Both cell types are assessed based 
on cell morphology, the retention of their pluripotent state across multiple passages, 
karotypic and genetic stability, antigen expression, sterility and the ability to form each of 
the three germ layers (Thomson et al., 1998, Davidson, 2008). More recent attempts to 
improve product quality have occurred through the removal of cells positive for certain 
antigens associated with teratoma formation (SSEA-5 plus two of the following antigenic 
markers: CD9, CD30, CD50 and CD200) (Tang et al., 2011). Cells that meet these criteria are 
used to create a cell bank for the deployment of research and developmental studies.  
1.6.1.2. Cell expansion 
Cell expansion seeks to increase the quantity of cells produced either through  scale-out or 
scale-up strategies, depending upon projected requirements and process performance 
(Table 1-3). In scale-out strategies, the expansion of cells in multiple systems of smaller 
batches and is more applicable to low-dosage treatments that require few cells (<106 cells) 
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(Thomas et al., 2009, Schwartz et al., 2012). Large dosage treatments (>106 cells) and high 
patient demand (>10,000 treatments/year) require scale-up approaches where cells are 
expanded in three-dimensional formats  to capacities up to 5 x 1012 cells per batch, which 
present significant technical challenges (Rowley, 2012). 
The majority of adherent cell culture scale-up challenges are being addressed through non-
pluripotent cell culture (Rafiq et al., 2013) as opposed to pluripotent cell culture (Prowse et 
al., 2014), owing to the inhibitive cost and understanding of the latter. For instance, 
mesenchymal stem cells are closer to requiring scalable manufacturing technology, not only 
because of clinical progress, but also because of high surface areas for cell growth (2 x 104 
cells/cm2) and high dosages (0.4 – 1 x 106 cells) per patient (Le Blanc et al., 2008, Macmillan 
et al., 2009) are required. In contrast  6 – 8 x 106 cells/cm2 are possible for pluripotent cells 
with dosages of 105 – 106 per patient (Schwartz et al., 2012). Therapies requiring larger 
dosages (108 – 109 cells) are in a less advanced state (Braam et al., 2010), so the use of  
large-scale (>1011 cells/batch)  culture units for pluripotent cell culture is not considered an 
immediate necessity.  
Reactors 
Beyond a certain batch size (approximately 1 – 5 x 1011 cells) two-dimensional culture 
systems are not practical (Rowley, 2012). Therefore, a transition towards larger culture 
systems enabling higher surface area-to-volume ratios are required (Table 1-3) (Rowley, 
2012).  
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Table 1-3. Recommended expansion formats for allogenic mesenchymal stem cell manufacture 
(Rowley, 2012).  
Scale 
(Billion 
cells/lot) 
1 10 50 100 ≥500 
Cell culture 
tool 
T-flask, 
hyper-flask 
(10-layer) 
10 and 40 layer 
hyper-flasks, 
robotics 
40 layer hyperstack 
+ robotics 
Automation of 40-
layer hyperflasks; 
hollow fibre 
bioreactors 
Suspension 
bioreactors 
A cost per number of cells is often cited as determining the cost-effective manufacture of cells. Indeed, progress has 
demonstrated large-scale expansion of MSCs, albeit without their integration into a process. Potential limitations concern 
the replication of the cells in the 3D environment. 
 
The configuration of scalable bioreactors applicable to adherent cell therapy culture are 
summarised below.  However, transitioning to these larger systems presents several 
technical challenges, relating to heterogeneity (Donati, 1997, Lara et al., 2006a) and other 
bulk processing side-effects such as fouling (Drews, 2010) and clumping (Serra et al., 2009). 
Several reactors are relevant for the expansion of adherent stem cells and are detailed 
below.  
Hollow fibre perfusion 
Hollow fibre bioreactors are cylindrical vessels packed with thousands of thin microporous 
fibres. These fibres offer mechanical strength while allowing selective molecule transition 
(Guardia, 1999). During culture, cells are localised on the shell side of the fibres, whilst 
culture medium is circulated through the module, facilitating mass transfer across the 
membrane (Eibl, 2009). Clinical-grade cell lines have also been tested on these devices. 
Athersys’ Multistem® product was recently used to expand 107 cells to over 7.5 x 108 per 
reactor. Whilst restricted to  around 200 mL per unit due to mass transport limitations, 
scale-out procedures do allow operation at up to 20 cartridges per culture unit (Davis, 
2007). Cost-effectiveness is estimated to be at $10 – 15 per 106 non-pluripotent cells (versus 
$50 – 100 for two-dimensional monolayer culture systems) (Rowley, 2014).    
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Stirred tank 
Stirred tank bioreactors are commonly used for the cultivation of mammalian cells in 
suspension (Adamson, 1998). They are typically operated using suspension-grade cells 
(Adamson, 1998), but also enable adherent cell culture through microcarriers (Rafiq et al., 
2013). The basic setup ensures adequate mixing, heating and cooling and includes sensors 
for parameter monitoring. Care must be taken during scale-up to avoid shear stress-induced 
cell damage (Kretzmer and Schügerl, 1991). Given the potential costs associated with scaled 
operation, small-scale (7 mL vessels), high-throughput (up to 24 vessels) systems have been 
developed to overcome these limitations (Warr, 2014). The cost is estimated to be at $1 – 5 
per 106 non-pluripotent cells, which is significantly below that estimated for both hollow 
fibre ($10 - 15) and monolayer ($50 – 100) culture systems (Rowley, 2014), demonstrating 
cost effectiveness.  
Microcarriers 
Microcarriers  are polymer-based beads or chips used to enable two-dimensional adherent 
cell culture in a three-dimensional format. They are usually 10 – 200 µm in size and exhibit 
surface functionalities, morphologies and densities necessary to promote cell adhesion and 
proliferation (Chen et al., 2011, dos Santos et al., 2011).  
Embryoid bodies 
Embryoid bodies are three-dimensional aggregates of pluripotent stem cells. Whilst 
pluripotent cell culture in two-dimensional culture systems is possible, effective scale-up in 
three-dimensional culture systems requires microencapsulation into microbeads to 
overcome heterogeneity (Niwa, 2006, Jing et al., 2010).  
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1.6.1.3. Differentiation 
Cell differentiation involves the controlled transition of an immature cell towards a more 
mature specific lineage (Sathananthan and Trounson, 2005, Murry and Keller, 2008). The 
necessity for differentiation depends upon the maturity of the cell and its application.  
Non-pluripotent stem cell differentiation 
Non-pluripotent stem cells, namely mesenchymal stem cells (MSCs), are multipotent with 
the capacity to differentiate towards osteogenic, adipogenic and chondrogenic cell types. 
Differentiation is considered a key characteristic of MSCs (Dominici et al., 2006), although 
the clinical application occurs in an undifferentiated state (Kim and Cho, 2013).  
Pluripotent stem cell differentiation 
Pluripotent cell differentiation involves a series of complex molecular signalling pathways to 
be initiated by growth factors and small molecule inhibitors (Wagner and Siddiqui, 2007a, 
Wagner and Siddiqui, 2007b, Chen et al., 2014) (Table 1-4). Cells may be differentiated as 
embryoid bodies (Kurosawa, 2007), on flat surfaces under static (Mummery et al., 2003) or 
flow-based conditions (Liu et al., 2013) ideally in three-dimensional arrangements (Lecina et 
al., 2010). 
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Table 1-4. Differentiation of pluripotent human cells to cardiomyocytes (adapted from (Chen et al., 
2014).  
 Pluripotent cell 
expansion 
Cardiomyocyte differentiation 
Stage 1 2 (Day 0 – 4) 3 (Day 4 - 8) 4 (Day 8+) 
Cell specification Pluripotent cell Mesoderm / 
cardiac 
mesoderm 
Cardiac 
progenitors 
Cardiomyocytes 
Markers SSEA-4, Tra-1-60, 
OCT4, SOX2, 
NANOG 
MESP1, KDR, 
PDGFRA, C-KIT 
ISL1, GATA4, 
NKX2.5, TBX5, 
MEF2C, TBX20 
MLC2V, VCAM, 
MYH6, cTnT, 
SIRPA, cTnI 
Biomolecules FGF2, Activin A, 
Insulin 
BMP4, Activin A, 
SB203580, GSK-
3β inhibitors, 
TGF-β1 inhibitors 
VEGF, FGF2, 
DKK1, WNT 
inhibitors 
Insulin 
Biomolecules (growth factors and small molecules) direct pluripotent cell differentiation towards a 
cardiomyocyte lineage. Intracellular and extracellular markers associated with each of the three 
main stages can be used to monitor cell differentiation.  
 
For cardiomyocytes, a range of differentiation efficiencies have been reported, varying 
greatly according to the culture methods, with two-dimensional monolayer cultures 
achieving 25 % (Wong and Bernstein, 2010) and 97.7 % (Minami et al., 2012), embryoid 
bodies achieving 23.6 % (Burridge et al., 2007) to 95.8 % (Takei et al., 2009) with around 20 
% being acheived using microcarriers (Lecina et al., 2010). Improved process understanding 
will no doubt lead to increased purity, but the threat of impure cell populations due to 
reactor heterogenity, either as spontaneously differentiated cells (Sathananthan and 
Trounson, 2005) or those retaining pluripotency attributes (Thomson et al., 1998, Schriebl et 
al., 2012) is of particular concern due to the potential for teratoma formation in vivo 
(Lebkowski, 2001, Schriebl et al., 2012). 
1.6.2. Downstream processing 
The downstream processing of biological products have traditionally centred on cell 
membrane disruption to recover intracellular components, prior to purification using 
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chromatographic techniques (Moser and Hage, 2010). Since the cell is the product, rather 
than the host, methods to maintain or increase the proportion of cells with these attributes 
are desired. Ideally, high-specificity purification methods such as those using affinity-based 
interactions are not needed, with downstream processing instead focussing on undesirable 
waste removal prior to storage.  
1.6.2.1. Harvesting, volume reduction and washing 
Following upstream processing, adherent cells are typically recovered using enzymatic 
digestion. Regulatory requirements stipulate the removal of cell processing medium waste 
components (e.g. cell debris, enzymatic agents xenogenic proteins, etc.) to concentrations 
as low as 1:1,000,000 according to Chapter 21 CFR610.15 on constituent materials of the 
FDA Centre for Biologics Evaluation and Research. Such procedures are simple at small lab-
based scales, but as upstream capacities are expected to increase, larger harvest volumes 
are expected (100 to 1,000 L), rendering conventional equipment for volume reduction 
redundant and necessitating the use of larger, re-designed systems (Table 1-5) to 
concentrate cells to 107 – 108 cells/mL (Pattasseril, 2013).  
Table 1-5. Volume reduction and washing technologies for various batch sizes (adapted from 
(Rowley, 2012).  
Batch Scale  109 1010 5 x 1010 1011 5 x 1011 
Volume reduction 
and washing 
Centrifugation Centrifugation, 
blood 
processing 
equipment 
Tangential 
Flow Filtration, 
continuous 
centrifugation 
Tangential 
Flow Filtration, 
continuous 
centrifugation 
Continuous 
centrifugation 
Input 
concentration (L)a 
0.3 3.3 17 33 167 
Output 
concentration 
volume (L) 
A 0.1 1 5 10 50 
B 0.01 0.1 0.5 1 5 
a Estimated input concentration post-upstream processing. Estimated output concentration based on a requirement of: (A) 
107 to (B) 108 cells/mL (Pattasseril, 2013). 
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Centrifugation 
Centrifugation is used to separate cells from surrounding waste, usually within a few 
minutes (Juopperi et al., 2007) by exploiting differences in cell density relative to the 
surrounding fluid (Fair, 1984). Such devices, typically disc bowl centrifuges, can process 
thousands of litres of cell suspension, offering clean-in-place procedures (Kempken et al., 
1995). However, such devices were designed to recover proteins from inside cells, whilst 
CTP manufacture requires the maintenance of cell integrity, concentration of cells and 
removal of surrounding waste medium (Pattasseril, 2013). Therefore, alternative 
centrifugation systems capable of imparting low physical stress during waste removal are 
desired (Rowley et al., 2013) and have been described (Mehta et al., 2011). 
Membranes  
Membranes are typically used to separate cells or colloids using size exclusion across a 
porous barrier. When applied in cross-flow filtration, the potential to accomodate larger cell 
suspension volumes, particularly in the form of hollow fibre or flat sheet membranes that 
have pore sizes ranging from 0.1 to 10 µm, is possible (Shukla, 2007). Unlike simpler depth 
filters, which are prone to fouling, cross-flow minimises fouling by simultaneously disrupting 
surface-bound debris, effectively regenerating the surface whilst driving waste impurities to 
the filtrate side of the membrane through differences in transmembrane pressure (Prasad, 
2012). However, as with centrifugation, cross flow filtration units must separate cells from 
surrounding medium whilst preserving cell integrity. Conventional ultrafiltration filtration 
membranes utilise higher shear rates (~14,000 s-1), which would translate to higher shear 
stresses (~120 dynes/cm2) and smaller pore sizes (0.1 µm) owing to the greater robustness 
of the cells (Trinh and Shiloach, 1995). For stem cell separation, lower shear rates (2,000 – 
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4,000 s-1 equivalent to ~17 – 35 dynes/cm2) combined with larger pore sizes are preferred 
(0.65 µm), providing greater transmembrane flux yet maintaining cells in suspension and 
minimining shear-induced damage (Rowley et al., 2012). 
1.6.2.2. Purification 
Cell purification (also known as cell separation) in this context refers to the removal of 
undesired cells from a population of product-designated cells using highly selective affinity-
interactive methods. Unlike traditional bioprocessing, where affinity purifications are a 
necessity (Dancette et al., 1999, Hahn et al., 2003), it is absent from downstream 
processing. It is anticpated that cell purity will be controlled upstream using pre-determined 
conditions complementary to cell physiology without resorting to selective purification 
methods (Pinxteren and Craeye, 2012, Schwartz et al., 2012). However, since cell therapy 
manufacturing is an immature industry, overlooking downstream purification is considered 
unwise when reflecting upon previous downstream bottlenecks in traditional bioprocessing, 
where such costs accounted for up to 80 % of overall processing costs (Kelley, 2007, 
Gronemeyer, 2014). Therefore, purification technology to remove unwanted cells is 
considered accordingly.  
Non-pluripotent stem cells 
An affinity separation step is considered unnecessary during non-pluripotent cell therapy 
manufacture, largely due to the absence of a differentiation step and ability to achieve 
sufficient purities. High cell purity (>98 %) is possible in scalable stirred tank bioreactors, 
where cell densities of 1.36 – 1.48 x 105 cells/mL were acheived (albeit at a 2.5 L working 
volume) (Nienow et al., 2014) and cell CQAs satisfied a universal standard (Dominici et al., 
2006). Product-specific CQAs have also been obtained commercially in scalable formats, 
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without the need for purification. In hollow fibres, for instance, 107 non-pluripotent stem 
cells were expanded to 7.5 – 7.8 x 108 cells (Pinxteren and Craeye, 2012) for Athersys’ 
Multistem® product, notably, satisfying relevant CQA in the absence of any affinity 
purification step post expansion.  
Pluripotent stem cells 
A fundamental part of pluripotent cell manufacture will be the controlled differentiation of 
cells towards a specific lineage in vitro. As detailed in Section 1.6.1.3., spontaneous 
differentiation or the retention of a pluripotent state post-differentiation, particularly at 
larger scales (>1011 cells), will generate impure cells with a carcinogenic potential (Schriebl 
et al., 2010b, Schriebl et al., 2012). Small scales and low dosage requirements do not 
necessitate downstream purification steps post-expansion and differentiation. For instance, 
Geron’s oligodendrocytes (Nistor and Keirstead, 2004) and ACT’s retinal pigment epithelial 
cells (Schwartz et al., 2012) were considered 99 % pure post-expansion (<106 per T-flask) 
and did not form tumours in human studies. However, in larger three-dimensional systems 
(>1011 cells per batch), where heterogeneity is harder to control (Donati, 1997, Lara et al., 
2006a) without undergoing cell losses, inefficient differentiation efficiencies are expected 
and the need for purification may be required.  
1.6.2.3. Formulation, filling and cryopreservation 
The final stage of downstream processing concerns the transfer of concentrated cells into 
vessels for cryopreservation and storage. This provides an ‘off-the-shelf’ capability allowing 
large batches of cells to be stored for extended periods (Mandalam, 2005). Scale-out rather 
than scale-up is required to process cells of larger quantities, since the end product is 
dependent on the number of cells per patient dose (105 – 1012). Existing technology requires 
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a transition from small lab-scale devices to larger systems able to process much larger batch 
sizes without compromising cell CQAs (Table 1-6).  
Table 1-6. Cryopreservation technology recommended for various batch sizes (Rowley, 2012).  
Scale (Billion 
cells/lot) 
1 10 50 100 500 
Number of 
vialsa 
102 103 5 x 103 104 5 x 104 
Volume 
reduction and 
washing 
Bench-
controlled 
rate-freezer 
Bench 
controlled 
rate-freezer 
Large-scale 
controlled rate 
freezer 
Large-scale 
controlled rate 
freezer 
Scale-out, large-
scale controlled-
rate freezer 
Based on 107 cells/vial 
Cryoprotective agent, such as dimethyl sulfoxide (DMSO) is used to penetrate cells and 
prevent ice formation during freezing, at the expense of cell health (Mazur, 1984, Mazur, 
1988, Meryman, 2007). Owing to the detrimental effect of cryopreservation on cells, multi-
parameter studies are favoured to  mitigate cell loss (Mitchell et al., 2014).   
1.7. Opportunities for new technologies 
Manufacturing a CTP requires a careful appreciation of how the cell product – in particular 
its critical quality attributes (CQA) is affected by the processing environment. One of the 
four CQA categories presented in Section 1.4 concerns cell purity, which can be correlated 
with clinical outcome (Handgretinger et al., 2002) and in some instances cell potency 
(Maziarz et al., 2012).  
As Section 1.6.2.2. detailed, the purity of non-pluripotent cells is easier to attain as a 
differentiation step post-expansion is ommitted. Yet in the manufacture of pluripotent-
derived cells, differentiation is required (Zandstra et al., 2003, Jing et al., 2010, Zandstra et 
al., 2010). During this process, pluripotent cells may differentiate spontaneously towards an 
undesired lineage different to the targeted tissue (Sathananthan and Trounson, 2005) or 
remain pluripotent (failing to differentiate) (Zandstra et al., 2003, King and Miller, 2007). 
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The administration of such cell into a patient  could induce teratoma formation – a major 
safety and regulatory concern ((CTGTAC), 2008). Bypassing the ethical constraints in 
humans, thresholds based on the proportion of impure cells necessary to induce teratoma 
formation have been made in animals. Geron’s human embryonic-derived oligodendrocyte 
cells (spiked with 10 % undifferentiated cells) formed teratomas in 4/31 immuno-
suppressed mice, whilst lower proportions (1 and 5 %) demonstrated no teratoma 
formation (Lebkowski, 2011). Slightly higher thresholds were observed in other mouse 
models: purities of 99.1 – 100 % yielded no teratoma formation; a reduced range of 97.1 – 
99.7 % containing more pluripotent cells yielded teratomas in 1/9 (Schriebl et al., 2012). 
Generally, comparison and extrapolation to humans is limited by study inconsistency, the 
size of the species in question (humans are ~3000 times larger than mice, whose metabolic 
function is significantly faster, leading to less stable homeostasis and therefore a different 
rate of scenesence) (Demetrius, 2005), as well as the different response of the species to 
tumourogenic material (Mak et al., 2014). At best, the existence of a purity threshold in 
humans may be hypothesized, but this could be patient-dependent.  
Conservative estimates from human haematopoetic stem cell transplants suggest that 1 
cancerous cell per 3.5 x 106 pure cells is tumour-inducing (Prockop, 2010). Even higher 
purities of 1 impure cell per 108 cells have been suggested elsewhere (Schriebl et al., 2010a). 
Human transplants using induced pluripotent stem cells (iPSCs) (albeit delivering only 5 x 
104 cells) showed that threshold purities in excess of 99 % sufficed without teratoma 
formation (Schwartz et al., 2012). However, these findings provide early-stage results and 
may not be universal. For instance, teratoma formation may be both location- and cell-
dependent: subcutaneous infusion yielded teratomas in 84 % of mice, whilst intratesticular 
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infusion yielded 94 % for embryonic stem cells; iPSCs were more aggressive, generating 
teratomas in all instances (Gutierrez-Aranda et al., 2010).  
Overcoming inefficient conversion is considered a significant technical challenge in 
pluripotent cell manufacture (Schriebl et al., 2012, Chen et al., 2014). At larger scales (>1011 
cells per batch) where homogeneous bioreactor conditions are harder to maintain (Donati, 
1997) without compromising cell physiology (Lara et al., 2006a), it is predictable that a 
larger proportion of cells will remain pluripotent. Therefore, methods to prevent, suppress 
or remove such cells are of particular interest.   
Of the characteristics used to define pluripotent cells (Section 1.4.), the extracellular Stage 
Specific Embryonic Antigen 4 (SSEA-4) is highly representative and is expressed on up to 95 
% of cells considered pluripotent (Thomson et al., 1998, Shibata et al., 2006, Fong et al., 
2009). The use of this – and/or any other universal pluripotency extracellular marker (e.g. 
SSEA-3 or SSEA-4) currently in existance is considered an ideal characteristic to address 
these challenges.  
1.7.1. Technologies to control cell purity 
The previous section has outlined the challenges in achieving cell purity in a large-scale 
manufacturing process. This section introduces two new technologies to overcome these 
challenges: (1) biosensors, to better understand cell differentiation through regular 
sampling or real-time sensing; and (2) methods to destroy or remove impure cells during or  
after differentiation. In both instances, the technology will focus upon the use of an 
antigenic marker – in this case the SSEA-4 antigen, which is considered the most resolute 
characteristic for cell identification and separation, but will also consider more novel ones. 
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1.7.1.1. Biosensors 
Biosensors are analytical devices that connect biological interactions to physicochemical 
detection systems to generate output signals (Scheller et al., 1991). Their ability to reliably 
measure certain analytes is subject to device accuracy and precision, as well as robustness 
and reproducibility (Kisaalita, 1992). Such devices are considered vital to manufacturing a 
CTP and have been encouraged through the FDA’s Process Analytical Technology (PAT) to 
create “a system for designing, analysing, and controlling manufacturing through timely 
measurements of critical quality and performance attribute of raw and in-process materials 
and processes, with the goal of ensuring final quality.”   
 
In cell culture, conventional sensors allow favourable conditions for mammalian cell culture 
to be established and maintained, typically based on pH, dissolved oxygen and metabolite 
monitoring in culture systems (Hanson et al., 2007). However, feedback regarding cell CQA 
(Section 1.4), such as antigen and gene expression, karyotype, morphology and biological 
functionality, which should form the basis of a CTP (Section 1.4) (Bravery et al., 2013) are 
not provided. Instead, such attributes are measured using separate instruments (e.g. flow 
cytometers, fluorescent microscopes and polymerase chain reaction (PCR) techniques) that 
are often expensive, time consuming and complex to use. More informative sensors with 
faster feedback times and smaller, more integrated designs are desirable. The following 
section reviews technologies with potential as biosensors for cell detection.  
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Optical 
Optical biosensors measure a range of parameters including light absorption, fluorescence, 
Raman scattering and reflectance, etc (Scheller et al., 1991, Shantilatha, 2003).  In this 
instance they are categorised as either fluorescent or label-free methods.  
Fluorescence-based detection 
In fluorescence-based detection, target components (e.g. intra- or extra-cellular markers) 
are labelled with fluorescent ligand-based conjugates for identification and quantitation 
based on emitted light (Resch-Genger et al., 2008) (Table 1-7). This is commonly exploited in 
flow cytometry, which offers very high resolution (allowing the identification of single cells) 
and the capacity to identify (and sort) cells based on multiple markers (Fong et al., 2009, 
Basu et al., 2010). However, substantial training is required for operation and maintainence, 
systems typically cost around £60 k. 
 
More novel devices utilising micro-electro mechanical systems (MEMS) in closed-system 
setups offer alternative means of detection and sorting. These micro-electro mechanical 
systems (MEMS), exemplified by Miltenyi’s recently launched MACSQuant system 
purportedly have the capacity to measure (and if necessary purify) cells based on intra- or 
extra-cellular fluorescence (Foster et al., 2014). Cells are categorised and gated using the 
MEMS actuator based on measured fluorescence (Foster and Grummitt, 2014). Whilst 
promising, demonstrable performance is absent and these devices appear to require similar 
bench space to flow cytometers (their primary purpose is sterile sorting), possess similar 
pricing structures and also require extensive operator training.  
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Table 1-7. Fluorescent methods for measuring cell purity.  
Type Application Method Performance State Reference 
Fluorescence 
microscopy 
Identification and 
isolation of stem 
cells from non-
stem cells 
Relies on the 
measurement of 
fluorescence emitted 
from cells based on 
mitochondrial 
structure. 
Non-
quantitative 
Separate 
unit, not 
integrated. 
(Chuck, 
2011)a 
Identification and 
isolation of 
pluripotent  and 
non-pluripotent 
stem cells 
Relies on the 
measurement of 
fluorescence emitted 
from intracellular lipid 
bodies, which act as 
endogeneous markers 
for cell pluripotency 
(Panicker 
et al., 
2014)b 
Identification of 
stem cells based 
on fluorescence 
and syncytia 
Relies on measurement 
of fluorescence from 
fixed cells in absence of 
extraneous or 
exogeneously added 
fluorescent dyes 
(Gostjeva 
and Thilly, 
2010) 
Flow 
cytometry 
Cell sorter and 
purity 
measurement 
Not a closed system – 
cells are exposed to 
atmosphere (albeit in a 
sterile environment). 
Cell purity is based on 
fluorescence 
Up to 100 % 
accurate 
Separate 
unit, not 
integrated. 
(Foster et 
al., 2014) 
MEMS sorter 
(based on 
fluorescence) 
Cell sorter and 
purity 
measurement 
Closed system 
comprising a semi-
conductor chip 
containing MEMS 
setup. Cells are tagged 
and separated on the 
basis of fluorescence.  
Quantitative, 
performance 
currently 
unknown  
Separate 
unit, not 
integrated. 
(Foster et 
al., 2014) 
a Isolation is not performed, rather it is cited as ; b isolation method is not disclosed 
 
Label-free-based detection 
Label-free spectroscopic detection methods such as Raman and Fourier Transform Infra-red 
(FTIR) interpret biomolecules in their natural form (Fan et al., 2008), providing a non-
invasive alternative to fluorescent methods. Having been originally developed to idenitify 
certain bonds in chemical components (Waterhouse et al., 2001), these methods are 
increasingly applied to cells to measure intracellular components (Table 1-8) and are 
amenable to well-studied CTP lines either as quality control or research tools.  
Chapter 1: Literature review 
 
44 
 
In FTIR, for instance, vibrational modes in macromolecular molecules (e.g. proteins, lipids, 
carbohydrates and nucleic acids) yield identifiable functional group bands, indicating 
relative concentrations and specific chemical structures (Pijanka et al., 2010). Recent 
attempts have demonstrated the utility of FTIR for elucidating differences in the spectra of 
human and mouse embryonic stem cells from their derivatives (Heraud et al., 2010, Cao et 
al., 2013). 
Raman spectroscopy focusses a laser beam to illuminate particles, such that scattered light 
can be detected and analysed. Inelastically scattered light is called a Raman spectrum. 
Particle molecular composition and structure can be obtained from positions, intensities 
and line-widths of Raman sprecta peaks. However, the method has a low signal intensity, 
which must be distinguished from Rayleigh scattered light of the same frequency, but can 
be separated using filters, gratings or other wavelength separation devices.  
However, in both techniques, complex methods of data interpretation and a lack of unity 
across different cell lines limits their use as a simpler lab-based tool (Sandt et al., 2012, Hung 
et al., 2013). 
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Table 1-8. Label-free detection for measuring cell purity 
Type Application Method State Performance Reference 
Raman 
spectroscopy 
Cancer cell 
detection 
Cells are illuminated in 
electromagnetic 
radiation wherein 
Raman spectra are 
generated. Differences 
in spectra are used for 
cell analysis using 
Principle Component 
analysis. Cells are 
trapped using laser 
tweezers and a Raman 
spectrum is obtained 
from cells.  
Portable  95.5 – 98.3 % cell 
detection 
accuracy; based on 
differences in 
intracellular DNA 
and protein 
concentration; 
3 minute 
evaluation time 
per cell. 
(Chan et 
al., 2010) 
Identification 
and isolation 
of cells based 
on 
pluripotency 
Cells illuminated in 
incident light, where 
differentiated cell 
generates a different 
second-harmonic light 
from the 
undifferentiated cell. 
Potential to detect cells 
in fluid flow also cited 
Separate 
unit, not 
integrated. 
Differentiated cell 
accuracy ~97.1 %; 
correlated with 
osteogenic 
induction time and 
differentiation 
maturation level 
during 
osteogenesis in 
MSCs; 5 regions 
per 30 seconds 
(Chan and 
Lieu, 
2013) 
 
(Hung et 
al., 2013) 
FTIR 
spectroscopy 
Pluripotent 
cell screening 
to detect 
cellular 
phenotypes 
Utilises vibrational 
modes in 
macromolecular 
functional groups 
within cells to generate 
identifiable bands 
within FTIR spectrum. 
Methods are combined 
with principle 
component analysis to 
facilitate the 
identification of 
patterns evident 
between different cell 
types and states. 
63 – 100 % 
prediction 
accuracy 
depending on cell 
type; antigen 
expression and 
intracellular gene 
expression. 
 
 
 
(Cao et 
al., 2013) 
 
 
 
 
 
 
 
86.4 – 88.6 % 
prediction 
accuracy in under 
5 minutes. 
Validated based 
on cytochemical 
assays 
(Ami et 
al., 2008) 
 
Acoustic biosensors 
Acoustic sensors are a class of biosensor that measure acoustic waves to detect a physical 
phenomenon (Marx et al., 2003). Signal generation  by an acoustic unit, typically a quartz 
crystal microbalance (QCM) exploits the piezoelectric effect of quartz whereby changes in 
the inertia of the vibrating quartz crystal alter the resonance frequency, allowing surface-
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localised interactions to be detected (Voinova et al., 2002, Lucklum and Hauptmann, 2006). 
Applying an AC voltage causes the sensor to resonate at a fundamental resonance 
frequency, generating a transverse standing shear wave across the crystal (Babacan et al., 
2002).  
Adsorbed components are quantified through changes in the frequency and dissipation of 
the crystal via mass (Sauerbrey, 1959) and/or viscosity (Malmström et al., 2007). 
Applications include the measurement of certain chemicals in gases (Brousseau and 
Mallouk, 1997) and liquids (Ying et al., 2008) through chemical reactions, as well as 
biomolecules based on affinity interactions (Shantilatha, 2003, Nileback et al., 2011). Those 
involving cells have typically comprised two methods where: (1) cells are cultured on the 
sensor surface, creating living biosensors to monitor cell growth (Reyes et al., 2013, Lee et 
al., 2012), or (2) where certain cell types are detected in mixed cell suspensions, as 
demonstrated with aptamer-conjugated to magnetic beads to target leukemia cells (Pan et 
al., 2010) or microbial contaminants (Table 1-9). 
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Table 1-9. Acoustic methods for measuring cell purity. 
Application Method State Performance Method of quantification Reference 
Detection and 
identification 
of bacteria 
and micro-
organisms 
Relies upon an 
interaction 
between specific 
analytes to detect 
and quantify 
specific molecules 
on the surface 
based on the 
piezoelectric effect 
Portable 
hand held 
Not disclosed Presumed to be a 
correlation between 
frequency and molecule 
number, through various 
equations that convert 
frequency into yield as a 
function of component 
physical attributes. One 
instance could be through 
the Sauerbrey equation 
(Sauerbrey, 1959) or 
viscosity equation 
(Malmström et al., 2007) 
for piezoelectric sensors, 
or through a calibration 
chart created using known 
component samples.  
(Edmonson 
et al., 
2010) 
Detection of 
particles such 
as molecules 
and microbial 
cells in a fluid 
Portable or 
bench-top 
instrument 
Not disclosed (Sheppard 
et al., 
2005) 
Detection of 
particles in a 
fluid 
Utilises living cells 
on the sensor 
surface to detect 
changes induced 
by drugs or 
biomolecules in 
real-time via the 
piezoelectric effect 
Not 
disclosed 
N/A (Marx et 
al., 2003) 
Measurement 
technique for 
the binding of 
cell 
membrane-
localised 
molecules 
Monitors change in 
cell signal in 
response to 
specific bonds 
formed between 
target molecules 
and immobilised 
ligands 
Not 
disclosed 
N/A (Gizeli and 
Saitakis, 
2009) 
Selective 
detection of 
human acute 
leukemia cells 
Cell detection 
performed using 
magnetic beads 
conjugated with 
aptamers to attach 
target cells to 
magnetised quartz 
sensor 
Bench top 
instrument 
LODa = 8 x 
103 cells/mL 
Calibration chart created 
using known component 
samples.  
(Pan et al., 
2010) 
a LOD = limit of detection 
 
1.7.1.2. Elimination and removal of unwanted cells  
Beyond improved process understanding and control, several methods exist to minimise 
cell-based impurities based on either elimination or purification, where unwanted purities 
are removed from the cell suspension.  
Elimination 
Alternatives to affinity-based cell separation centre on the targeted destruction of cells 
positive for a certain marker using a cytotoxic component (Schriebl et al., 2012), which could 
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either replace or enhance separation technologies. Such methods would also need to 
demonstrate that the cytotoxic component does not affect the biological characteristics of 
the product cells. Other systems explore the possibility of embryonic stem cell destruction 
based on their metabolic state (Alexander et al., 2011) or through gene transfer for 
enhanced differentiation (Zandstra et al., 2003). Whilst exhibiting the potential to increase 
purity, the implementation of such methods into the manufacture of a clinical product 
would require extensive evaluation to ensure that the product cells remain safe and 
efficacious. 
Purification 
The following section considers the use of affinity-based cell purification technology to 
improve cell purity during scaled manufacture. Several types exist and are discussed 
accordingly.  
Fluorescence-activated cell sorting (FACS) 
Fluorescence-activated cell sorting (FACS) involves the separation of fluorescently-
conjugated cells from unconjugated cells. Cells are injected into a laser-based sorter, where 
they are assigned an electrostatic charge based on their measured fluorescence, enabling 
flow-based separation (Fukuda et al., 2006). Extremely high purities (up to 100 %) are 
possible (Table 1-10), although separation is very slow (104 cells/s = ~2 x 109 cells/hr), the 
device is not a closed system and shear stress exposure during processing may be 
detrimental to cells, either through membrane rupture (Fong et al., 2009) or more subtle 
changes associated with cell functionality (Li et al., 2012). The latter point should be 
considered irrespective of scale and is perhaps why certain companies such as Athersys 
prefer magnetic separation instead (Maziarz et al., 2012). Flow cytometry sorters also 
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occupy large bench spaces, require extensive operator training, device maintenance and are 
extremely expensive (> £100 k).  
Table 1-10. Fluorecence-based cell separation technologies.  
Methoda Cells Performance Scale Clinical output Reference 
FACS with SSEA-4 IgG 
antibody  
Heptocellular 
carcinoma cells 
spiked with 
undifferentiated 
ESCs 
100 % 2 x 105 
cells 
N/A (Fong et 
al., 2009) 
FACS with Sox1 
antibody 
Dopaminergic 
neurons from 
mouse embryonic 
stem cells 
100 % 2 x 105 
cells 
Cells expressing  (Fukuda et 
al., 2006) 
FACS with SSEA-4 IgG 
antibody removed 
from haematopoetic 
precursor cells 
Monkey 
embryonic stem 
cell-derived 
haematopoetic 
precursors 
100 % 0.16 – 
78 x 106 
cells 
Tumour formation in 
unsorted cell 
populations. Absence 
of tumour formation 
in sorted cell 
populations. 
(Shibata et 
al., 2006) 
aPerformance is based solely on antigen expression.  
Magnetic-activated cell sorting (MACS)  
Magnetic separation involves the incubation of antibody-coated ferromagnetic iron oxide 
particles with cell suspensions (Miltenyi et al., 1990). Here, cells positive for the target 
antigen are tagged with beads via an affinity interaction, whilst cells negative are not. The 
injection of cells into the magnetic column leads to the retention of cells conjugated to 
beads based on magnetic force, whilst unlabelled cells pass through. Presumably, magnetic 
beads are detached or absorbed and digested by cells, posing no obvious effect on the cell 
(Miltenyi et al., 1990, Grutzkau and Radbruch, 2010).  
Log10 clearance rates in the range of 2.8 – 4.1 with recoveries of 45 – 95 % having been 
reported for various cell types (Table 1-11) (Handgretinger et al., 2002, Schriebl et al., 
2010b), demonstrating clinical efficacy (Gratwohl, 2010). Whilst apt for single patient 
transplants, magnetic limitations (the magnetic field strength decreases as a function of the 
distance squared from the magnet, leading to reduced pulling strength) (Zborowski, 2008) 
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and so-called ‘drafting’, whereby untagged cells become trapped and drawn to the magnet 
by tagged cells (Lara et al., 2006b), limit the ability to process larger quantities beyond 1011 
cells, with the rate of separation being approximately 107 cells/s, making them unacceptable 
for batches in excess of 1011 cells. Magnetic separation is cost-effective as a lab-based tool, 
but is more expensive at larger scales (>1010 cells), owing to the increased consumption of 
antibodies. Bead toxicity has been reported, but such instances are attributed to excessive 
concentrations and such findings would contradict clinical studies (Handgretinger et al., 
2002, Tiwari et al., 2003, Gratwohl, 2010). 
Table 1-11. Magnetic bead separation technologies.  
Method Cells Performance Scale Clinical output Reference 
CliniMACS system 
using anti-CD34 
antibody-
conjugated beads 
Human CD34+ 
stem cell 
enrichment 
81.7 – 99.7 %; 
recovery = 14 – 77 
%; log10 depletion 
= 2.0 – 4.4.  
31 – 
450 x 
108 
cells 
9/18 patients 
free of disease 
over 55-month 
median follow-
up 
(Handgretinger 
et al., 2002) 
MS MiniMACS 
using anti-SSEA-1 
IgG IgM antibody 
–conjugated 
beads 
Murine 
pluripotent 
(SSEA-1 
positive) 
depletiona 
95 - 99 %; recovery 
= 85 – 95 %. Log10 
depletion = 0.05 – 
0.5 
2.2 – 
22 x 
106 
cells 
N/A (Schriebl et al., 
2010b) 
97.2 – 99.7 %; 
recovery = 63 – 91 
%.  
1.0 – 
2.5 x 
107 
cells 
1/9 animals 
possessed 
tumoursc 
(Schriebl et al., 
2012) 
Purity: 9.1 – 100 %b 0/9 animals 
possessed 
tumoursc 
a = murine cells express SSEA-1 antigen when in a pluripotent state, in contrast to human pluripotent cells; b = study 
combined with cytotoxic antibody; c 100 % of animals in a control model developed tumours.  
Membranes 
Membranes are used extensively for filtration purposes to isolate cells from surrounding 
waste medium (Section 1.6.2.1.). Their convective geometry, favouring low mass transport 
resistance and high throughput has also been exploited for affinity-based cell separation. 
Cell enrichment using shear stress has been applied to recover cells adsorbed on the inner 
lumen of hollow fibres at values up to 200 dynes/cm2 (Slowiaczek, 1998), as well as the 
application of shell-side back-pressure (Colton, 1996), enzymatic digestion (Nordon et al., 
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1996) and acidic elution (pH 1) (Mandrusov et al., 1995) being utilised. Such instances 
demonstrated performance similar to magnetic separation (Table 1-12), but were not 
commercialised owing to no identifiable performance- or cost-related benefits versus the 
benchmark CliniMACS® magnetic separation technology. Nevertheless, such membranes are 
scalable and could be used to process larger batch sizes (>1011) cells, either through scale-up 
and/or scale-out procedures where up to 20 vessels may be used (Davis, 2007), particularly 
when considering that axial mass transport, a common limitation in hollow fibre bioreactors 
(Pinxteren and Craeye, 2012), is neglected in shear stress-induced cell separation (Nordon et 
al., 1996, Nordon et al., 2004).  
Table 1-12. Membrane-based separation technologies. 
Method Cells Performance Reference 
Hollow fibre membrane. Oxidised IgG 
immobilisation onto hydrazide-functionalised 
fibres. Back-pressure-induced elution. 
HLA-60 cells Selectivity: 93.4 %a; viability: 
90 ± 10 % (mean± SEM);  
(Colton, 
1996)c 
 
Immobilisation of rPrA onto epoxy-
functionalised fibres.  Back-pressure-induced 
elution.  
Selectivity: 99.8 %a; viability: 
80 – 97 %; 400 – 500 cells per 
cm fibreb.  
Hollow fibre membrane. Oxidised IgG 
immobilisation onto hydrazide-functionalised 
fibres. Enzymatic digestion-induced cell 
elution coupled with shear stress (0.2 – 10 
dynes/cm2).  
CD34+ 
enrichment 
Purity: 86.1 – 93.1 %; 
enrichment factor: 400 – 600; 
recovery: 53 – 60 %; capacity: 
1.67 x 108 cells. 
(Slowiaczek, 
1998) 
 
94.4 ± 3.1 % (mean ± SEM);  
3.3 ± 0.1 log10 depletion; 
recovery: 61 ± 9 % (mean ± 
SEM); viability: > 95 %; 1.3 ± 
0.2 x 108 (mean ± SEM) 
 
(Nordon et 
al., 1996) 
No clinical output. a = selectivity b = surface area was 7.9 and 4.1 m2/mL mv for hydrazide and epoxy fibres respectively; c 
cells were separated based on differences in adhesion strength in individual studies.  
Monoliths 
Monoliths are polymer-based gels of highly interconnected pores (typically in the range of 
1,000 to 100,000 nm) making them suitable for cell separation. They are considered 
alternatives to traditional beaded formats for protein purification, especially larger 
molecules such as pDNA, IgM antibodies and viral particles (Willoughby, 2009). Whilst 
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beaded formats rely upon molecule diffusion into and out of  their pores, leading to mass 
transport restrictions, monoliths have fewer dead-end zones, promoting convective mass 
transport (Jungbauer and Hahn, 2004). Therefore, the interaction of molecules with an 
affinity-activated substrate occurs parallel to the direction of fluid flow (Pfaunmiller et al., 
2013), reducing processing times and shifting the rate limiting step to a kinetic, rather than 
mass transport one, making them ideal for Protein A–IgG separations (Leblebici et al., 2014).  
Larger pore sizes and the potential for convection-driven separation makes the monolith 
format suitable for cell separation. Demonstrations have centred on yeast and CD34+ cell 
separation achieving recoveries in excess of 95 % and incurring viability losses less than 10 % 
for yields of 2 x 107 cells (Kumar et al., 2003, Kumar and Srivastava, 2010, Mattiasson, 2011) 
(Table 1-13). Such units offer the potential for scaled separation, with sizes up to 8 litres 
being cited as possible (Jungbauer and Hahn, 2004). However, significant developmental 
and demonstrative investment is required to present them as competitive alternatives to 
magnetic separation or as scalable units.  
Table 1-13. Monolith-based cell separation technologies.  
Type and method Cells Performance Reference 
Protein A-coupled epoxy-activated 
polyacrylamide-based cryogel. Used 
to enrich IgG-tagged cells via bind 
and elute mechanisms.a,b 
Yeast Recovery: (1) flow-induced 
detachment = 9 - 29 %; (2) eluent 
= 9 - 36 %; (3) squeezing: 35 – 82 
%. Separation time: < 20 minutes 
(Mattiasson, 
2011) 
Lymphocytes 
(CD34+ 
enrichment) 
Recovery: 60 – 70 %; Viability: 90 
%. Separation time: < 30 minutes 
(Kumar et al., 
2003) 
Binding: Recovery: 70 - 95 %; 
purity: >90 %; viability ~90 %; 
separation time: < 30 minutes. 
1.6 x 106 cells/mL adsorbent 
(Kumar and 
Srivastava, 
2010) 
a = bind and elute constitutes competitive elution or cryogel compression; b performance only evaluated in columns ≤ 2 mL 
in volume, although column sizes up to 15 mL are cited as being possible.  
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1.8. Technological approach 
Identifying and separating cells based on their phenotype requires the identification of a 
reliable and interactive characteristic. This is important to distinguish pluripotent-
derivatives from their undifferentiated counterparts. In pluripotent cells, several unique 
characteristics exist relating to gene expression, growth characteristics and physical 
structure (Section 1.4), but are hard to exploit. 
Of the characteristics previously considered, the SSEA-4 antigen expressed by pluripotent 
cells and down-regulated by their derivatives (Thomson et al., 1998, Schriebl et al., 2010b) 
does provide the basis for selective identification and separation (up to 95 %) (Fong et al., 
2009). Using a previously demonstrated method of shear stress-induced affinity separation 
(Nordon et al., 1996, Nordon et al., 2004), it may be possible to differentiate between cells 
positive and negative for the SSEA-4 antigen, providing a basis for identification and 
purification. 
As the previous section has shown, many methods exist to detect cells using biosensors. 
Optical, label-free methods are particularly attractive, relying solely upon light emittance for 
non-invasive cell analysis. However, a lack of technical maturity, overly complex analytical 
requirements and intellectual property restrictions limit spectroscopic methods. Acoustic 
sensors, in particular the quartz crystal microbalance (QCM), are simple to use and 
interpret, cost-effective (as little as £20 k) and could provide adequate resolution as affinity 
cell detection tools.  
In affinity cell separation devices, the lack of scalability in existing systems (magnetic- and 
fluorescent-based sorting) limits their deployment at larger scales (>1011 cells per batch). 
However, convection-driven systems such as membranes that employ flow-based means of 
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separation are attractive owing to their capacity for scale-up, provided that relevant 
hydrodynamic conditions can be satisfied.  
In both instances, shear stress-induced affinity separation can be used for selective cell 
identification and purification. More explicitly, this method relies upon the application of 
hydrodynamic force to differentiate between cells adsorbed with and without affinity 
interactions. Its application may be two-fold: (1) as a means to identify cells based on their 
pluripotency, whereby net changes in cells adherent on the sensor surface before-after 
shear stress indicate those with affinity interactions (Figure 1-2), and (2) for the depletion of 
unwanted cells through retention, thus increasing the purity of product cells that would be 
recovered (Figure 1-3). As such, shear stress-induced affinity cell separation will therefore 
be the underlying theme of this thesis. The theoretical challenges are detailed in the 
following section.  
 
Figure 1-2. Quartz crystal microbalance biosensor for shear stress-induced affinity cell separation. 
Measurements would be performed in real-time. The net change in cells on the surface would be 
used to indicate those with affinity interactions (i.e. those with the target antigen), thus indicating 
cell purity. Letters are denoted accordingly: F = frequency; to = time prior to shear stress exposure; t 
= time after shear stress exposure.  
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Figure 1-3. Generic cell separation process to retain impure cells through affinity interactions and 
permit the recovery of product cells, thereby increasing purity.  
1.9. Biological impact 
Understanding the biological impact of shear stress-induced affinity separation on 
recovered cells is vital to determine process feasibility. Primary sources of physiological 
stress are anticipated to be: (1) external hydrodynamic forces  acting on the cell membrane 
due to shearing effects, (Kretzmer and Schügerl, 1991, Chisti, 2000, Avraham-Chakim et al., 
2013) or (2) force-induced detachment of the cell from the surface (Christ, 2011), which 
could lead to membrane tearing (Rubbi et al., 1993, Xia et al., 1994), which is associated 
with cell death (Kroemer et al., 2009).  
When subjected to shear stress, cellular membranes morphologically change, spreading or 
forming ellipsoid structures, leading to intracellular changes – the extent of which being 
determined by the severity of the forces applied. Milder shear stress, resembling the natural 
environment of the cell can induce physiological changes that can be exploited. For 
instance, shear stresses of 1.5 – 15 dynes/cm2, applied over several days up-regulated 
endothelial marker genes (Nsiah et al., 2014) and encouraged differentiation towards 
cardiac and vascular cell types (Yamamoto et al., 2005, Adamo et al., 2009), by activating 
signalling pathways (Stolberg and McCloskey, 2009). 
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Shear stress can also be detrimental to the cell, leading to disease or death via 
mechanotransduction (Jaalouk and Lammerding, 2009). Mechanotransduction concerns 
cellular processes that convert mechanical stimuli, such as sound waves, pressure and 
gravity into biochemical signals allowing cells to adapt to their environments through 
physiological processes (Figure 1-4) (Ingber, 2006, Wang et al., 2009). 
 
Figure 1-4. Various examples of mechanotransduction extracted from (Jaalouk and Lammerding, 
2009). a: stretch-activated ion channels in the plasma membrane open in response to membrane 
strain and allow the influx of calcium and other ions; b: in endothelial cells, the glycocalix, a layer of 
carbohydrate-rich proteins on the cell surface, can mediate mechanotransduction signalling in 
response to fluid shear stress; c + d: cell-cell junctional receptors or extracellular (ECM)-cell focal 
adhesions allow cells to probe their environments; e: force-induced unfolding of ECM proteins, such 
as fibronectin, can initiate mechanotransduction signalling outside the cell; f: intracellular strain can 
induce conformational changes in cytoskeletal elements such as filaments, crosslinkers or motor 
proteins, thereby changing binding affinities to specific molecules and activating signalling pathways; 
g: the nucleus itself has been proposed to act as a mechanosensor. Intracellular deformations can 
alter chromatin conformation and modulate access to transcription factors or transcriptional 
machinery; h: compression of the intracellular space can alter the effective concentration of 
autocrine and paracrine signalling molecules.  
 
Detrimental effects are also dependent on the intensity and duration of shear stress 
exposure, (Kretzmer and Schügerl, 1991, Zoro et al., 2008, Mulhall et al., 2011), as well as 
cell size, with larger cells being more susceptible to damage (Born et al., 1992, Al-Rubeai, 
1995). Quantitative estimates have indicated that the membranes of red blood cells may 
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withstand up to 20 dynes/cm for short periods (Rand, 1964), although the membranes of 
most mammalian cells are likely to fail beyond 4-6 dynes/cm (Vlahakis and Hubmayr, 2000). 
1.10. Theoretical considerations 
The theoretical considerations of shear stress-induced affinity cell separation are presented 
below. They comprise three main stages (Figure 1-5): (1) cell transportation; (2) cell 
adsorption and affinity interaction; and (3) the retention of cells with affinity interactions 
and detachment of cells without affinity interactions using fluid flow.  
 
Figure 1-5. Cell separation protocol describing the transport of cells to a ligand-coupled surface 
under fluid flow (A); the adsorption of cells to the surface with and without affinity interactions 
under static adsorption conditions (B); and the selective detachment of cells without affinity 
interactions and retention of cells with affinity interactions in response to fluid flow (C). 
 
1.10.1. Cell transport 
Cells are highly dynamic in nature, with a membrane that changes according to external 
forces (Kasza et al., 2007). Their transport depends primarily on: (1) convection, owing to 
the size of the cell (5 – 20 µm) and density similar to that of water (1,077 vs. 1,000 kg/m3) 
and (2) sedimentation, consistent with Stoke’s Law (Howe, 2006). Separation devices, such 
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as membranes exploit these mechanisms by encouraging convective mass transport and 
providing a high surface area-to-volume ratio. 
1.10.2. Cell-substrate interactions 
In affinity separations, cell-substrate interactions comprise affinity and non-affinity 
interactions which are dependent on the cell-substrate contact area.  
Non-affinity interaction 
Three forces constitute non-affinity interactions between the cell and the substrate surface: 
(1) electrostatic forces; (2) steric stabilisation; and (3) van der Waals forces (Christ, 2011). 
Other factors determine the extent of these forces. In vivo cell adhesion is facilitated by the 
extracellular matrix (ECM), a collagen-based biological scafold which is critical to cell 
proliferation, migration and functionality (Engler et al., 2009). Cells adherent to ECM-coated 
surfaces are more resistant to detachment, owing to a variety of extracellular adhesion 
molecules that anchor cells to the surface (Freeman, 2000). The adhesion strength of a cell 
to a synthetic material via non-affinity interactions is estimated to be approximately 100 pN 
per µm2 cell-surface contact area (Bell, 1978, Bell et al., 1984, Bryers, 2005). It is influenced 
by three properties that enhance adhesion strength as a function of time: (1) surface 
charge: cells are negatively charged entities electrostatically attracted to positively charged 
surfaces and are repulsed by negatively charged ones such as glutaraldehyde (Gallant et al., 
2005); (2) hydrophobicity: moderately hydrophilic surfaces promote the deposition and 
adsorption of cell attachment proteins such as fibronectin, in turn promoting greater cell 
adhesion strength (van Oss, 2006, Bacakova et al., 2011); (3) cell type: certain cells are more 
prone to spreading as a function of time or physical force than others, thus leading to a 
larger cell-surface contact area and therefore more adhesive connections (Christ, 2011). 
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Minimising the adhesion strength of non-affinity interactions between the cell and the 
substrate is a desirable method for increasing selectivity during affinity-based separation. 
Selective cell adsorption onto an oxidised IgG-hydrazide surface was lower (85.3 %) versus 
an aldehyde-terminated surface relying upon cell-tagged IgG binding to surface-coupled 
Protein A (99.1 +/- 0.4 %) (Colton, 1996). Lower adhesion strengths can be achieved by 
selecting surfaces with a negative charge, such as glutaraldehyde to repel cells (Henry, 
2009). Blocking agents such as bovine serum albumin (BSA) are also used to enhance 
repulsive forces (Hermanson, 1992 and 2008, Patel et al., 2008), thus improving selectivity 
in affinity cell separations (Colton, 1996, Kumar and Srivastava, 2010).  
Affinity interactions 
Affinity-based cell separation exploits an exclusive interaction between extracellular 
antigens localised on target cells and antibodies coupled to a support matrix (Miltenyi et al., 
1990, Nordon et al., 1996) or conjugate (Fong et al., 2009). This form of separation is 
derived from affinity chromatography, where a ligand, such as an antibody, is immobilised 
onto a polymeric support for the selective capture of a receptor molecule, in this case an 
antigen, forming a reversible complex (Wilchek, 1999, Wilchek, 2000). 
𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 + 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 ↔ 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎. 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 
An affinity interaction between an antibody and antigen comprises several forces. The 
binding site between the antigenic determinant on the cell (epitope) and the antigen-
combining site on the antibody (paratope) recruits small sections of molecules to create a 
connection area of 0.4 – 0.8 nm2. These binding sites comprise many aromatic amino acids, 
enabling van der Waals forces, hydrophobic interactions and less commonly hydrogen 
bonds. Generally, hydrophobic and van der Waals forces operate over very short ranges to 
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draw both regions together in a complementary shape. Electrostatic interactions between 
side chains and hydrogen bonds that bridge oxygen and/or nitrogen atoms, accommodate 
specific features or reactive groups to strengthen the overall interaction (Reverberi and 
Reverberi, 2007). Unlike proteins, cells possess many extracellular antigens (103 - 107) and 
so enable multiple affinity interctions to form between the cell and an an antibody-coupled 
surface. 
1.10.3. Creating an affinity support matrix 
Importantly, the IgG antibody has various regions and functional groups for various 
immobilisation or conjugation methods (Figure 1-6), the protocols of which have been 
detailed extensively (Hermanson, 1992). The three types of IgG antibody coupling methods 
are detailed accordingly: 
1. Primary amines abundant across the antibody provide a simple platform for 
immobilisation with surface epoxy (Mateo et al., 2000) or aldehyde functionalities, 
with the latter reaction further stabilised through reductive amination (Yoshioka et 
al., 1991). However, adsorption is random causing non-orientated coupling and 
rendering some antigen binding sites inaccessible.  
2. Carbohydrate moieties, located at the Fc region of IgG antibodies, can be oxidized in 
sodium meta-periodate to generate active aldehydes (Morehead et al., 1991). This 
enables orientated IgG coupled to a hydrazide-functionalised surface via a bond that 
can be further stabilised in sodium cyanoborohydride (Brillhart and Ngo, 1991, 
Holton and Vicalvi, 1991). 
Chapter 1: Literature review 
 
61 
 
3. Conjugates may be created when a protein molecule, such as Protein A  is coupled to 
the surface to adsorb IgG antibodies via their Fc regions (Kumar and Srivastava, 
2010) derived from the purification of IgG antibodies using Protein A adsorbents 
(Hahn et al., 2003). 
 
Figure 1-6. IgG antibody structure and labelling sites: they contain two identical heavy chains of 
about 50 kDa and two identical light chains of about 25 kDa, generating a tetrameric quaternary 
structure. The two heavy chains are linked to each other and to a light chain each by disulphide 
bonds. The resulting tetramer has two identical halves: a Fab and Fc region, which together form the 
characteristic Y-shape. Each end of the fork contains an identical antigen binding site capable of 
targeting antigens on cell. The Fc regions of IgGs bear a highly conserved N-glycosylation site 
(Hermanson, 1992).  
 
Ideally, antibodies will be coupled to the substrate through strong, covalent bonds where 
antigen binding sites are easily accessible. Orientated coupling provides greater binding 
efficiencies – often several orders of magnitude higher than passive adsorption methods, 
particularly for smaller molecules (Wang et al., 2012b). Whilst the same principles apply to 
cells, the binding mechanism is different: antigens are not isolated components – instead 
they are expressed by the body of the cell, localised at its surface. This presents the 
opportunity for mutli-valent site binding and is a function of the cell-substrate contact area 
– itself a function of the cell’s propensity for deformation. 
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1.10.4. Cell adsorption 
Affinity and/or non-affinity bond formation will occur after cell adsorption onto the surface. 
Affinity bond formation under static conditions may be described mathematically: 
𝑎𝑎𝑑𝑑
𝑎𝑎𝑎𝑎𝑎𝑎
= 𝑘𝑘𝑓𝑓0𝑁𝑁𝐿𝐿(𝑅𝑅𝑇𝑇 − 𝑑𝑑) − 𝑘𝑘𝑟𝑟0𝑑𝑑 
 
1.1. 
, where C = the number of antigen-antibody complexes, ta is the attachment time, RT = 
attachment time for affinity interactions to form within the contact area, and kf0 and kr0 are 
the forward and reverse rate constants. kr0/kf0 = the equilibrium dissociation constant 
(equivalent to the reciprocal of the affinity constant, K0) (Cozens-Roberts et al., 1990). The 
number of affinity interactions is also dependent on the cell-surface contact area. Whilst not 
a measure of its three-dimensional state, the cell-substrate contact area may be expressed 
as a function of shear stress and estimated accordingly (Bose, 2009):  
𝑟𝑟𝜏𝜏 = 𝑟𝑟𝑚𝑚𝑎𝑎𝑚𝑚 − (𝑟𝑟𝑚𝑚𝑎𝑎𝑚𝑚 − 𝑟𝑟𝑚𝑚𝑚𝑚𝑚𝑚)𝑎𝑎𝑒𝑒𝑒𝑒(𝜏𝜏 𝜏𝜏𝑜𝑜⁄ ) 1.2. 
 
, where rτ = contact radius of cell at applied shear stress; rmax = maximum contact radius of 
cell; rmin = minimum contact radius of cell; τ = applied shear stress; τo = measure of the 
rigidity of the cell.  
Assuming that rmax = 2 µm; rmin = 0.5 µm; τ = 0 – 25 dynes/cm2; τo = 15 dynes/cm2 for a 10 
µm cell based on (Bose, 2009), the contact radius would range from 0.2 – 1.7 µm for 0 – 25 
dynes/cm2, equating to a surface area of 0.5 – 2.3 µm2.  
1.10.5. Force-induced cell detachment 
Several methods of antibody-antigen dissociation exist: pH adjustment commonly used for 
proteins (Wilchek and Miron, 1999) (and demonstrated for cells (Mandrusov et al., 1995)), 
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ionic adjustment (Ohlson et al., 1997), as well as enzymatic digestion (Firer, 2001).  But such 
methods to enrich cells  are not considered complementary to cell physiology – especially 
more sensitive cells such as pluripotent cells – and likely to result in damage or undesirable 
changes. Instead, force-induced separation is preferrable, resembling the natural 
environment of the cell (where the shear stress is typically <50 dynes/cm2) (Lipowsky et al., 
1978, Stolberg and McCloskey, 2009). The concept has been illustrated both theoretically 
(Bell, 1978, Kuo and Lauffenburger, 1993) and practically (Slowiaczek, 1998, Nordon et al., 
2004). However, many instances have relied upon enrichment strategies – the use of higher 
forces (up to 200 dynes/cm2) to recover cells adsorbed with affinity interactions – without 
much consideration beyond membrane permeability as to how the conditions might affect 
the cells (Nordon et al., 1996 and 2004, Slowiaczek, 1998). Instead, the depletion of 
unwanted cells and the recovery of product cells using lower shear stresses (≤ 25 
dynes/cm2) is preferred as it would expose cells to milder processing conditions, mitigating 
harmful effects.  
1.10.6. Calculating shear stress 
Since the cell suspension is assumed to act as a Newtonian fluid with a density of 1000 
kg/m3 (Kasza et al., 2007), laminar flow (<< 2,100) may be calculated using the Reynold’s 
number equation (Rothfus et al., 1957): 
𝑅𝑅𝑎𝑎 = 𝑄𝑄 𝜌𝜌
𝐷𝐷 µ 1.3.  
 
, where Q = flowrate (m3/s); p = fluid density (kg/m3); µ = dynamic viscosity (kg/m.s); D = 
chamber diameter (m). Shear stress may be calculated for both tubular (Equation 4.2) (Bird, 
2007) and parallel plate (Equation 2.1) models (Bacabac et al., 2005).  
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1.10.7. Force acting on cells 
The calculation of shear stress allows drag forces acting on adherent cells to be estimated, 
assuming a non-deformable sphere adjacent to the vessel wall (Goldman et al., 1967): 
𝐹𝐹𝑑𝑑𝑟𝑟𝑎𝑎𝑑𝑑 = 6𝛼𝛼𝛼𝛼𝜏𝜏𝑤𝑤𝑟𝑟2 1.4. 
 
where α = 1.7, a dimensionless drag coefficient (Brooks, 1996), r = cell radius (m) and τw = 
shear stress (1 Pa = 10 dynes/cm2). The force applied per affinity bond, may be calculated 
using: 
𝐹𝐹𝑏𝑏 = 𝐹𝐹𝑑𝑑𝑟𝑟𝑎𝑎𝑑𝑑𝑁𝑁𝑏𝑏  1.5. 
 
, where Fb = the force per bond; Fdrag = the drag force acting on the non-deformable 
spherical cell and Nb = the number of bonds (-).  
The effect of different bond densities may be considered: assume that a 10 µm diameter cell 
with a surface contact area of 0.5 µm2 is subjected to a shear stress of 25 dynes/cm2 
(equivalent to a drag force of 2,000 pN). If antigen density ranges from 103 – 107 (Cozens-
Roberts et al., 1990) this would equate to 1.6 – 1.6 x 104 possible cell-surface affinity 
interactions. Across this range, applied force per bond, Fb, would range from 0.12 – 1.2 x 103 
pN, which could determine whether an adsorbed cell remains adherent or detaches in 
response to shear stress.  
1.10.8. Equilibrium dissociation constant 
The equilibrium dissociation constant (KD), an indicator of the propensity of the cell-surface 
complex (in this instance an antibody-antigen interaction) to reversibly split into two 
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separate entities is also decisive in cell detachment and has been expressed by (Kuo and 
Lauffenburger, 1993):  
𝐹𝐹𝑡𝑡
𝑅𝑅𝑐𝑐
= 2𝑘𝑘𝐵𝐵𝛩𝛩
𝐼𝐼𝐵𝐵
ln �1 + 𝑁𝑁𝐿𝐿
𝜂𝜂𝐾𝐾𝐷𝐷
� 
1.6. 
, where Ft = the total force required to detach a cell; Rc = receptor number per cell in contact 
area; kB = Boltzmann constant; Θ = absolute temperature; IB = extent of bond stretch; NL = 
surface ligand density; η = conversion parameter for KD; KD = equilibrium dissociation 
constant.  
To demonstrate the effect of different KD values (1 x 10-5 to 1 x 10-10 M) on cell adhesion 
strength, the following assumptions may be made using Equation 1.7, where NL = 3.5 x 1012 
#/cm2; Rc = 1,000 #/cm2; IB = 8.8 Å; kB = 1.38 x 10-23 J/K; Θ = 296 K (23 oC); η = 1.38 x 10-23 J/K 
are fixed and the data are shown in Figure 1-7, where KD ranges from 10-10 – 10-5 M and is 
inversely proportional to the force per receptor required to break affinity interaction bonds 
(Ft/Rc). These findings are consistent with previous estimates (Bell, 1978, Bell et al., 1984), 
where the adhesion strength was estimated to be 1 – 10 µdynes (10 – 100 pN) per affinity 
interaction, which is much higher than that of ~0.4 µdynes (4 pN) per non-affinity bond 
(equivalent to 100 pN/µm2 contact area). 
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Figure 1-7. Adhesion strength per receptor present in the contact region (Ft/Rc) as a function of the 
dissociation constant (KD). Adhesion strengths were determined from Equation 1.6. KD ranges from 
10-10 – 10-5 M.  
1.10.9. Cell adhesion strength 
The flowrate required to detach cells adherent with affinity interactions may be estimated 
by linking threshold bond strengths to shear stress. Drag forces required to detach a cell 
may be estimated by re-arranging Equation 1.7 to account for the force per cell:  
𝐹𝐹𝑡𝑡 = 2𝑅𝑅𝑐𝑐𝑘𝑘𝐵𝐵𝛩𝛩𝐼𝐼𝐵𝐵 ln �1 + 𝑁𝑁𝐿𝐿𝜂𝜂𝐾𝐾𝐷𝐷� 
 
1.7. 
Quantitative output can then be converted into shear stress, as displayed in Figures 1-8 and 
1-9 for high (10-6 M) and low (10-9 M) KD values. Accounting for non-affinity adhesion forces, 
estimated to be ~100 pN per µm2 contact area (Bell, 1978, Bell et al., 1984, Bryers, 2005), 
the shear stress required to detach cells adherent with non-affinity interactions may be 
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calculated by rearranging Equation 1.5 to calculate the equivalent shear stress to induce 
detachment: 
𝜏𝜏𝑤𝑤 = 𝐹𝐹𝑑𝑑𝑟𝑟𝑎𝑎𝑑𝑑6𝛼𝛼𝛼𝛼𝑟𝑟2 1.8. 
 
, where Fdrag is equivalent to Ft, the force required to detach a cell from the surface, such 
that for a 10 µm diameter cell with a contact area of 0.5 µm2, a drag force of ~0.12 Pa (1.2 
dynes/cm2) would be sufficient for detachment. Presented differences in the calculated 
adhesion strengths of cells with and without affinity interactions show good agreement with 
practical studies (Nordon et al., 1996 and 2004; Slowiaczek, 1998). These equations to 
calculate the force acting on a cell assume a hard sphere, meaning that force- (Nordon et al., 
2004) or time-induced (Cuvelier et al., 2007) cell deformation is unaccounted for and actual 
forces acting on the cell – in particular the stressed bonds – may be lower.  
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Figure 1-8. Effect of increasing ligand density and receptor number versus shear stress for a KD value 
of 10-6 M. The ligand density ranges across from 1 x 1010 – 5 x 1012 per cm2. The receptor density in 
the contact area ranges across 10, 50, 100 and 300 per cm2. The non-affinity adhesion strength per 
cell is estimated to be equivalent to 1.2 dynes/cm2. Data are calculated from Equation 1.7 and 1.8. 
 
 
 
Figure 1-9. Effect of increasing ligand density and receptor number versus shear stress for a KD value 
of 10-9 M. The ligand density ranges across from 1 x 1010 – 5 x 1012 per cm2. The receptor density in 
the contact area ranges across 10, 50, 100 and 300 per cm2. The non-affinity adhesion strength per 
cell is estimated to be equivalent to 1.2 dynes/cm2. Data are calculated from Equation 1.7 and 1.8. 
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1.10.10. Detachment mechanisms 
The precise mechanism of cell detachment is thought to occur via two possible mechanisms. 
The first is through a peeling mechanism; bonds at the side of the cell facing fluid flow are 
stressed more than those at the rear of the cell, initiating sequential rupturing (Chang and 
Hammer, 1996, Décavé et al., 2002). However, measurements of individual bond strengths 
(Dammer et al., 1996), or those using synthetic spheres coated with ligands incapable of 
extension (Kuo and Lauffenburger, 1993), where peeling would be more obvious, contradict 
this theory. In the second, the cell is assumed to adapt to shear stress through bond 
reinforcement (Choquet et al., 1997, Demali, 2004), resembling a tensegrity system (Ingber, 
2014) where detachment occurs when the collective bond strength of all interactions is 
exceeded.  
1.11. Summary 
Many of the technical gains made by the cell therapy industry have occurred using 
conventional bioprocessing technology. It is anticipated that the scaled manufacture of 
pluripotent-derived cells will be subject to certain purity thresholds with reference to the 
presence of impure undifferentiated cells. These cells, caused by inefficiencient cell 
differentiation, can form teratomas in vivo and are a primary safety concern. Such impurities 
are expected to occupy a greater proportion of cells in larger batch sizes. Existing 
technologies do not have the capacity to effectively monitor or control impure cells during 
manufacturing at scale. Two technologies are therefore proposed to improve the 
performance of a pluripotent cell therapy manufacturing process: (1) a quartz crystal 
microbalance biosensor to detect impure cell populations either in real-time or at regular 
intervals during the cell differentiation process and (2) a scalable membrane to retain 
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impure cells and recover product cells post-differentiation, to increase cell purity to a safe 
level. Both systems will utilise shear stress-induced cell separation to differentiate between 
cells adsorbed with and without affinity interactions.  
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Chapter 2. Flow tube model 
2.1. Introduction 
For cells derived from pluripotent cells, ensuring higher purities (≥95 – 99 %) can prevent 
tumour formation (Lebkowski, 2011, Schriebl et al., 2012). This may be through: (1) the 
detection mechanisms of an acoustic biosensor to better understand the factors affecting 
pluripotent cell differentiation towards designated lineages or (2) through the use of a 
separation device to remove impure cells, thus increasing product cell purity. In pluripotent 
cell manufacture, the SSEA-4 antigen is present on undifferentiated pluripotent cells 
(Thomson et al., 1998) and is downregulated on differentiated cells (Chen et al., 2014). 
Shear stress-induced affinity cell separation can be applied to differentiate between cells 
positive and negative for this SSEA-4 antigen. In transferring this concept to the acoustic 
QCM biosensor or a membrane separation device, as little as 5 dynes/cm2 may be used to 
recover >95 % of product cells adsorbed without affinity interactions, with higher shear 
stresses (up to 200 dynes/cm2) being required to recover  cells adsorbed with affinity 
interactions (Slowiaczek, 1998, Nordon et al., 2004).  
To study these interactions at a single-cell level, a small-scale device is necessary. Many 
methods exist for the study of cell-based affinity interactions, ranging from magnetic beads 
(Schriebl et al., 2010b) to flow cytometers (Quintanilla, 2013) and optical tweezers (Wang et 
al., 2011), but do not replicate the hydrodynamic environment of shear stress-induced 
affinity cell separation.  However, transparent flow chambers provide visual and possibly 
quantitative feedback about how cells respond to shear stress (van Kooten et al., 1992, Xia 
et al., 1994). Indeed, a number of approaches have been used to study shear stress-induced 
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cell separation at small scales (Nordon, 1994, Pomianek, 1998, Nordon et al., 2004), 
providing the basis for larger separations capable of single-patient CD34+ cell transplants 
(Colton, 1996, Nordon et al., 1996, Slowiaczek, 1998). 
To perform separation studies in glass flow tubes, antibody-coupled surfaces are required. 
Glass surfaces must first be modified to generate chemical functionalities, of which many 
methods have been presented (Vandenberg et al., 1991, Funk et al., 2012). Hydroxyl groups 
on cleaned glass can be chemically modified with aminosilanes, such as (3-
aminopropyl)triethoxysilane to create terminal amine groups (Zhang et al., 2010, 
Terracciano, 2013) (Figure 2-1). Amine-functionalised surfaces provide a reactive platform 
to facilitate the deposition of glutaraldehyde, a homobifunctional cross-linker possessing 
aldehyde functionality (Figure 2-2). The aldehyde functionality can then react covalently 
with amine functionalities on glass and those present on proteins (Miller and Robyt, 1983, 
Kumar and Srivastava, 2010). However, the direct adsorption of IgG antibody onto such 
surfaces will lead to non-orientated immobilisation. Therefore, coupling  Protein A to the 
surface (Figure 2-3), which has the capacity to bind IgG antibodies via their Fc base (Moks et 
al., 1986) would promote orientated immobilisation. Thus, when a cell suspension is 
introduced to the Protein A-coupled substrate, only cells tagged with IgG antibodies will be 
able to generate affinity interactions (Figure 2-4). Untagged cells, negative for the target 
antigen, will possess weaker cell-surface interactions and therefore have a higher 
propensity for detachment when exposed to shear stress (Nordon et al., 1996, Slowiaczek, 
1998). 
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Figure 2-1. Reaction of cleaned glass with 3-APTES to create an amine-terminated surface.  
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Figure 2-2. Reaction of glutaraldehde in the presence of sodium cyanoborohydride to 
reduce reversible Schiff bases into stable secondary amine bonds. 
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Figure 2-3. Immobilisation of rPrA via Schiff base formation and subsequent reduction to 
create a stable secondary amine bond.  
 
 
 
 
Figure 2-4. Reaction of immobilised rPrA with IgG-tagged cells. Cells adherent with multiple 
affinity interactions, in this instance facilitated by IgG-rPrA interactions (A), have a greater 
resistance to shear stress-induced detachment than those without (B).  
 
Chapter aims and objectives: 
• Develop a small-scale model to visually observe and determine a range of shear 
stresses capable of differentiating between cells adsorbed with and without affinity 
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• Extract quantitative data and develop models to project cell separation inside an 
acoustic QCM biosensor and in a scalable separation device 
2.2. Materials and methods 
The following section details the materials and methods ultimately used to create, 
characterise and test rPrA-coupled glass flow tubes for cell adhesion studies.  
2.2.1. Glass surface chemical modification 
Glass microslides (borosilicate, 10 mm diameter; Fisher Scientific, Loughborough, UK) and 
beads (borosilicate, 212-300 µm; Sigma-Aldrich, Munich, Germany) were chemically 
modified to study create functional surfaces for chemical and morphological analysis and 
protein immobilisation.  
2.2.2. Cleaning 
Glass was cleaned in an ultrasonic bath first with acetone (2 minutes), followed by 95 % 
(v/v) ethanol and then 2 % (v/v) Liquinox (Cole-Parmer, London, UK), both for 20 minutes, 
before rinsing in deionised water and drying in a DCPro oven (BioCare Medical, Berkshire, 
UK) for 2 hours at 130 oC using a method described previously (Rowland et al., 1995).  
2.2.3. Amination  
Cleaned glass slides were then immersed in a 5 % (v/v) solution of 3-
aminopropyltriexthoxysilane (APTES) (Sigma-Aldrich, Munich, Germany) in toluene for 1 
hour, before rinsing successively in toluene and then deionised water in an ultrasonic bath 
for 10 minutes each. For glass micro-slides, care was taken to avoid rotation and ensure 
inter-batch consistency, since inverted slides exhibited different surface properties. The 
same procedure was repeated for glass beads, except that more vigorous washing was 
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implemented by manually shaking the beads aggressively before and after ultrasonic bath 
washing. Washed samples were then dried at 50 oC overnight in a DCPro drying oven 
(BioCare Medical, Berkshire, UK) (Terracciano, 2013).  
2.2.4. Aldehyde functionalization 
Amine-functionalised glass was immersed in 2.5 % (v/v) glutaraldehyde solution in 0.1 M 
sodium phosphate with 0.15 M sodium chloride (PBS) and 0.075 M sodium 
cyanoborohydride (pH 7) for 4 hours  for glutaraldehyde deposition (Figure 2-2). Glass 
samples were then washed twice successively in methanol, acetone (Fisher Scientific, 
Loughborough, UK) and deionised water. 
2.2.5. Protein adsorption 
2.2.5.1. Recombinant Protein A (rPrA) and bovine serum albumin (BSA) 
Recombinant Protein A (rPrA) (Prospec Bio, Ness-Ziona, Israel) was incubated with 
aldehyde-functionalised glass beads at a concentration of 1 mg/mL in PBS (pH 7) for 18 
hours under agitation on an IKA VRX Vibrax horizontal shaking platform (Fischer Scientific, 
Loughborough, UK) at room temperature (~ 22 oC). rPrA-coupled glass beads were then 
sequentially washed in PBS, 1 M NaCl and de-ionised water, twice, using a micropipette to 
remove weakly adsorbed proteins. Reductive amination was then performed in 0.075 M 
sodium cyanoborohydride in PBS at pH 7 for 1 hour at room temperature on an orbital 
platform shaker (Cole-Parmer, London, UK), prior to washing in the aforementioned 
procedure. rPrA-coupled and rPrA-free aldehyde-functionalised glass beads were then 
blocked in 1 % (w/v) BSA (Sigma-Aldrich, Munich, Germany) in PBS for a further 2 hours at 
room temperature and rinsed in washing buffer. The adsorbed protein content of glass 
beads was quantified using the BCA assay (Section 2.4.5.). 
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2.2.5.2. IgG antibody adsorption 
IgG binding capacity studies were performed using CD20 IgG antibody across a range of 
concentrations from 0 – 1.28 mg/mL to determine the adsorption capacity of rPrA-coupled 
beads. CD20 IgG antibody was purchased from The University of Birmingham Hospital 
(Birmingham, UK) at a concentration of 10 mg/mL (The CD20 IgG antibody is a chimeric 
mouse/human monoclonal antibody (mAb), comprising of a glycosylated IgG1 kappa 
immunoglobulin with murine light and heavy-chain variable regions and human kappa and 
gamma-1 constant regions (Fc domain). It is commercially marketed as Mabthera®.) 
Samples were diluted in PBS (pH 7) from a 10 mg/mL stock solution and incubated for up to 
2 hours in PBS with rPrA-coupled or rPrA-free aldehyde-functionalised glass beads blocked 
with 1 % BSA (w/v). Samples were then rinsed three times in PBS to remove unbound IgG. 
Adsorbed IgG was then eluted in 0.5 mL of 0.1 M sodium citrate at pH 2.5 following a 10 
minute incubation period. IgG antibody in eluted samples was calculated using a Nanodrop 
2000 UV spectrophotometric instrument (Thermo Scientific, Loughborough, UK) by placing 2 
µL on the sensor and recording the absorbance at 280 nm. 
2.2.5.3. Glass flow tube modification  
The same chemical modification and rPrA coupling procedures were then transferred to 
transparent glass flow tubes to enable the study of cell responses to shear stress.  
2.2.5.4. Chemical modification 
Glass flow tubes (Camlab, Cambridge, UK) (length 5 cm; width 3 mm; thickness 0.3 mm) 
were treated in a similar fashion as the glass microslides and beads described above. 
However, chemical modification was performed under flow (5 mL/hr) using a peristaltic 
pump (Watson-Marlow, Falmouth, UK). Following cleaning and drying, where cells were 
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dipped in respective cleaning solutions outlined in Section 2.2.2., dried flow tubes were 
wrapped in cellophane (0.5 x 2 cm) at the inlet and connected to Gore® STA-PURE tubing 
(Watson-Marlow, Falmouth, UK). Tubes were then chemically modified by flowing APTES 
through the tube at 5 mL/hr, followed by rinsing (20 mL/hr) using both toluene and de-
ionised water, applied sequentially, twice, for 10 minutes each to remove physisorbed 
layers (Section 2.2.3). For cleaning, tubes were removed dried separately as described for 
glass beads and slides.  Thereafter, glutaraldehyde treatment was also performed as 
detailed in Section 2.2.4.  
2.2.5.5. PrA and BSA protein adsorption 
Aldehyde-modified glass flow tubes were then connected to a 100 µL micropipette via tygon 
tubing (Cole-Parmer, London, UK) and cellophane tape. A 1 mg/mL solution of rPrA in PBS 
(pH 7) was then injected into the tube and incubated for 4 hours at room temperature. 
Protein solution was agitated using a connected micropipette every 30 minutes. Following 
incubation, excess protein was removed by gently rinsing with PBS. Reductive amination in a 
0.075 M sodium cyanoborohydride solution in PBS was then performed for 1 hour at room 
temperature. Excess solution was then removed and tubes were rinsed in PBS, 1 M NaCl and 
de-ionised water. Thereafter, tubes were blocked in 1 % (w/v) BSA for 2 hours in PBS, prior 
to washing in PBS, 1 M NaCl and de-ionised water prior to cell adsorption studies.  
2.2.6. Cell detachment studies 
2.2.6.1. Process setup 
Aldehyde-functionalised flow tubes for cell adhesion studies were inserted into the process 
presented in Figure 2-5. The inlet and outlets were wrapped in cellophane, connected to 
tygon tubing at both ends and attached to a microscope slide (dimensions: 6 x 2.5 cm) 
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(Sigma-Aldrich, Dorset, UK) using autoclave tape. The microscope slides were then 
positioned underneath an inverted Nikon microscope lens which was set at x10 
magnification and connected to a Nikon DS L3 LCD monitor (Nikon, Tokyo, Japan). The tube 
inlet was then connected to an Alaris IVAC P7000 syringe pump (CareFusion, St Albans, UK) 
containing a 50 mL syringe filled with 1 % BSA (w/v) in PBS via a 3-way valve. The side inlet 
of the 3-way valve was then attached to a 10 mL syringe containing 1 % (w/v) BSA in PBS. 
Tubes were washed for 5 minutes at 50 mL/hr and then incubated statically in 1 % (w/v) BSA 
in PBS for 2 hours. Prior to cell binding, tubes were washed in in PBS at 20 mL/h for 5 
minutes to remove excess BSA.  
 
Figure 2-5. Unit schematic for cell binding studies. Components are listed as follows: 1 = 50 
mL syringe connected to a syringe pump; 2 = 3-way valve; 3 = 1 mL syringe for cell injection 
with a needle to be injected into the side inlet tubing; 4 = 10 mL syringe; 5 = microscope 
connected to camera; 6 = flow tube; 7 = connection lead; 8 = camera display screen; 9 = 50 
mL collection vessel.  
 
2.2.6.2. Cell culture 
Two B-lymphocyte cell lines were used: (1) Toledo CD20 antigen-positive B-lymphocytes 
cells from ATCC (LGC Standards, Middlesex, UK) with an affinity for the IgG CD20 antibody 
and (2) CCRF-HSB-2 HLA-A2 antigen-positive B-lymphocytes from Sigma-Aldrich (Dorset, UK)  
with no affinity for CD20 IgG. 
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Cells were cultured in 90 % RPMI-1640 with 2 mM glutamine and 10 % (v/v) foetal bovine 
serum (FBS) supplemented with 1 % Pen-Strep (Sigma-Aldrich, Munich, Germany). Cell 
cultures were maintained at 3x105 to 1x106 cells/mL in 5 % CO2 and 95 % O2 atmospheric 
content at 37 oC using a Heracell 150i CO2 incubator (Thermo Scientific, Loughborough, UK) 
and cultured every 2-3 days.  
Additional cell details are displayed in Table 2-1 below. The purpose was for the CD20+ cells 
to mimic pluripotent stem cells expressing the SSEA-4 antigen, whilst HLA-A2+ cells were 
intended to mimic pluripotent-derived cells, such as cardiomyocytes, where the SSEA-4 
antigen had been down-regulated. 
Table 2-1. Cell types and properties. 
 Toldeo CCRF-HSB-2 
Cell type B-lymphocyte 
Location Peripheral blood 
Species Human 
Antigen expression CD10, CD19, CD20, CD38 HLA-A1, HLA-A2, HLA-B17, Cw2, CD5, CD7  
Cell sizea 11.0 ± 7.2 um 11.5 ± 6.0 um 
Status Target, non-product cell Non-target, product cell 
CD20 antigens 109,000b - 
a determined using a Nucleocell Counter; b Experimental estimate (Ginaldi, 1998) 
2.2.6.3. Cell detachment 
Cells were harvested on the condition that viability (based on trypan blue membrane 
exclusion) blue was in excess of 99 %. Cells were centrifuged in a HeraeusTM Labofuge 400 
(Thermo Scientific, Loughborough, UK) at 1,200 rpm for 5 minutes and re-suspended twice 
in 1 % (w/v) BSA in 1 X Dulbecco’s Phosphate Buffered Saline (DPBS) (Sigma-Aldrich, Dorset, 
UK) to a concentration of 3x107 cells/mL and incubated with or without 10 µg/mL of CD20 
IgG antibody at 4 oC for 30 minutes. Prior to injection, cells were centrifuged and re-
suspended twice in 1 % (w/v) BSA in DPBS to remove unbound IgG and achieve a final 
concentration of 3x106 cells/mL. The cell suspension was then drawn up into a 1 mL syringe, 
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after which a needle was attached. Air was removed by rotating the syringe vertically and 
tapping the needle whilst simultaneously forcing fluid out of the nozzle.  
The side inlet of the 3-way valve was then positioned to allow fluid from the 10 mL syringe 
to enter into the tube. The cell suspension in the 1 mL syringe was then injected into the 
tygon tubing of the side inlet port (connected to syringe 4 in Figure 2-5). The addition of 
cells into the flow tube using the side inlet syringe (4) was monitored by measuring the 
microscopic output from the camera screen. The injection was ceased when the surface 
appeared saturated and cells were evenly distributed. The 3-way valve was then positioned 
to allow flow from the syringe pump into the tube whilst blocking side-inlet flow. Adsorbed 
cells were then incubated for a 30 minute period, prior to detachment studies being 
performed.  
Detachment studies involved the sequential application of shear stress over 1, 5, 10 and 25 
dynes/cm2 for 3 minute intervals. Images of cells were taken at six regions across the flow 
tube following the application of each shear stress over a 2 minute period. Pooled cells were 
collected in a 50 mL tube and concentrated by centrifuging at 1,200 rpm. Viability, based on 
membrane exclusion using trypan blue, was then measured for pooled cells.   
A second study was performed to qualitatively assess how adsorbed cells responded in real 
time to applied shear stress. Video recordings of the camera screen were performed prior 
to, during and after applied shear stresses of 5 and 25 dynes/cm2 until steady state was 
reached.  
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2.3. Theoretical considerations 
The controlled application of shear stress relies on the geometric arrangement inside the 
device as well as the volumetric flowrate. Such calculations rely on the assumption of 
laminar flow within the system (Re << 2100) determined using Equation 1.3  (Rothfus et al., 
1957). Cells are assumed to have the same density as that of water (1,000 kg/m3) so that the 
suspension resembles a Newtonian fluid, transported via convective processes with a 
density of 1000 kg/m3 (Kasza et al., 2007). 
2.3.1. Shear stress 
Shear stresses within the flow tube were estimated at the wall of the vessel based on the 
equation for a parallel plate model (Bacabac et al., 2005): 
 
𝜏𝜏 = 3𝑄𝑄µ2𝑤𝑤(ℎ 2⁄ )2  2.1. 
 
, where Q = flowrate (m3/s); µ = dynamic viscosity (kg/m.s); w = chamber width (m); h = 
chamber height (m); and τ = shear stress (1 Pa = 0.1 dynes/cm2). The cell-surface contact 
area can be estimated as a function of shear stress (Bose, 2009) and is represented 
previously by Equation 1.2. 
The number of moles of protein on the surface may be calculated from: 
 
 𝑀𝑀𝑎𝑎𝑀𝑀𝑎𝑎𝑀𝑀 𝑎𝑎𝑜𝑜 𝑒𝑒𝑟𝑟𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 (𝑚𝑚𝑎𝑎𝑀𝑀) = 𝑚𝑚𝑎𝑎𝑀𝑀𝑀𝑀 𝑒𝑒𝑟𝑟𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 (𝑎𝑎)
𝑚𝑚𝑎𝑎𝑀𝑀𝑎𝑎𝑚𝑚𝑚𝑚𝑀𝑀𝑎𝑎𝑟𝑟 𝑤𝑤𝑎𝑎𝑎𝑎𝑎𝑎ℎ𝑎𝑎 𝑒𝑒𝑟𝑟𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 ( 𝑎𝑎𝑚𝑚𝑎𝑎𝑀𝑀) 2.2 
 
, where 1 kDa = 1,000 Da = 1,000 g/mol.  
Number of moles of protein in solution may be calculated from: 
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 𝑀𝑀𝑎𝑎𝑀𝑀𝑎𝑎𝑀𝑀 𝑎𝑎𝑜𝑜 𝑒𝑒𝑟𝑟𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 �𝑚𝑚𝑎𝑎𝑀𝑀
𝐿𝐿
� × 𝑚𝑚𝑎𝑎𝑀𝑀𝑎𝑎𝑚𝑚𝑚𝑚𝑀𝑀𝑎𝑎𝑟𝑟 𝑤𝑤𝑎𝑎𝑎𝑎𝑎𝑎ℎ𝑎𝑎 𝑒𝑒𝑟𝑟𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 � 𝑎𝑎
𝑚𝑚𝑎𝑎𝑀𝑀
�= 𝑚𝑚𝑎𝑎𝑀𝑀𝑀𝑀 𝑎𝑎𝑜𝑜 𝑒𝑒𝑟𝑟𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑎𝑎𝑎𝑎 𝑀𝑀𝑎𝑎𝑀𝑀𝑚𝑚𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 �𝑎𝑎
𝐿𝐿
� 
2.3 
 
Number of protein molecules in both instances determined from Equations X and Y may be 
calculated from: 
 
 𝑁𝑁𝑚𝑚𝑚𝑚𝑎𝑎𝑎𝑎𝑟𝑟 𝑎𝑎𝑜𝑜 𝑚𝑚𝑎𝑎𝑀𝑀𝑎𝑎𝑚𝑚𝑚𝑚𝑀𝑀𝑎𝑎𝑀𝑀 (#)= 𝐴𝐴𝐴𝐴𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑟𝑟𝑎𝑎 𝑚𝑚𝑎𝑎𝑎𝑎𝑀𝑀𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 (𝑚𝑚𝑎𝑎𝑀𝑀−1)  × 𝑚𝑚𝑎𝑎𝑀𝑀𝑎𝑎𝑀𝑀 𝑎𝑎𝑜𝑜 𝑒𝑒𝑟𝑟𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 (𝑚𝑚𝑎𝑎𝑀𝑀) 
 
2.4 
 
, where the Avogadro constant = 6.02 x 1023 mol-1.  
2.4. Analysis and characterisation 
2.4.1. Atomic force microscopy 
An Explorer atomic force microscope (Bruker TESP, Coventry, UK) was used to assess the 
surface topography of modified glass at an approximate frequency of 330 kHz and k = 20-80 
N/m. Duplicate images at different sites were taken for each sample. 
2.4.2. X-ray photoelectron microscopy (XPS) 
XPS was performed on chemically modified glass slides using a K-AlphaTM X-ray 
Photoelectron Spectrometer (ThermoScientific, Loughborough, UK). Photoelectrons were 
excited using mono-chromated Al K alpha x-rays (1486.6 eV). Spectra were collected at an 
electron emission angle of 90 degrees with respect to the sample surface plane. High-
resolution scans (50 eV pass energy) of all elements were taken and reported as duplicates 
from different batches for each condition. The sampling depths at 90 degree electron take-
off angles were estimated to be 100 nm. High resolution scans were performed on carbon, 
nitrogen, silicon and oxygen. A curve-fitting program that uses a Gaussian function was used 
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to deconvolute the XPS peaks. The samples were dried and stored in a desiccator prior to 
analysis. 
2.4.3. TNBS assay 
2,4,6-trinitrobenzenesulfonic acid (TNBS) was used to quantify silane deposits via a reaction 
with amine groups (Hermanson, 1992). A solution containing 10 µL of 1 M TNBS (Sigma-
Aldrich, Munich, Germany) and 1.5 mL of 0.05 M (Borax) (Sigma-Aldrich, Munich, Germany) 
was mixed with glass beads and heated to 70 oC, prior to cooling. Supernatant was then 
removed and glass material was washed sequentially in deionised water, 50 % (v/v) acetone 
in deionised water, 100 % acetone and deionised water using a plastic micropipette. After 
washing, samples were then heated to 70 oC in 1.5 mL of 1 M NaOH and supernatant was 
measured at 410 nm using a UV spectrophotometer (Shimazdu, Tokyo, Japan) to quantify 
the amount of picricsulfonic acid eluted. A calibration chart was created using known 
amounts of picric acid. This was used to convert measured absorbance into amine deposits 
on the basis of a 1:1 reaction.  
2.4.4. Silver mirror test 
Aldehyde functionalities were measured using Tollen’s reagent on both APTES and 
glutaraldehyde-treated glass (Fieser, 1987). Prior to conducting the reaction, all tubes were 
cleaned with 10 % (v/v) sodium hydroxide. Thereafter, 1 mL of 0.2 M sodium nitrate solution 
was then mixed with 1 mL of 10 % (w/v) sodium hydroxide solution (Sigma-Aldrich, Munich, 
Germany) to create silver oxide. Dilute ammonia solution (2 %, v/v) was then added slowly 
to dissolve the silver oxide. Both APTES and glutaraldehyde-treated APTES beads were then 
soaked in this solution in a water bath at 37 oC for 15 minutes. Beads were then removed 
with tweezers and rinsed in de-ionised water prior to imaging.  
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2.4.5. BCA assay 
The adsorbed protein content of aldehyde-functionalised glass beads was determined using 
the BCA assay (Pierce Biotechnology, Illinois, USA) (Figure 9). Beads were incubated in 0.1 
mL of PBS and 1.9 mL of working reagent for 30 minutes at 37 oC. Supernatant was 
extracted, inserted into a polystyrene cuvette (Fischer Scientific, Loughborough , UK) and 
absorbance was measured at 562 nm using a UV spectrophotometer (Shimazu, Tokyo, 
Japan). Stock solutions containing known amounts of protein samples were used to create 
standard curves to determine the amount of protein adsorbed. 
2.4.6. Contact angle 
Contact angles on modified glass slides were measured using deionised water to assess 
surface hydrophobicity. A 2 µL droplet of deionised water was deposited onto each type and 
the contact angle was measured using a DataPhysics OCA 20 system and device software 
(Data Physics Instruments GmBH, Filderstadt, Germany). 
2.4.7. BET surface area 
The Brunauer Emmett-Teller (BET) method was used to determine the surface area of 
aldehyde-functionalised glass beads. Weighed samples were degassed initially at 90 oC for 
2,000 minutes and then at 140 oC for 600 minutes under a vacuum of < 10 µmHg. To 
determine the surface area the sample was cooled to a cryogenic temperature (77 K) and an 
adsorptive (nitrogen) was admitted to the sample in controlled increments. After each dose 
of nitrogen, the pressure was allowed to equilibrate and the quantity of gas was calculated, 
indicating the external surface area and pores of an assumed monolayer.  
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2.4.8. Fluorescent IgG staining and binding to cells 
CD20 antigen distribution across Toldeo (CD20+) and CCRF-HSB-2 (HLA-A2+) cells was 
qualitatively assessed using fluorescein-tagged CD20 IgG. The CD20 IgG antibody was 
incubated with an NHS-fluorescein conjugate for 1 hour at room temperature, before the 
solution was purified in a 7 K MWCO Zeba spin column (Thermo Fischer Scientific, 
Cramlington, UK). The conjugate was subsequently incubated with Toledo and CCRF-HSB-2 
cells respectively for 30 minutes at 4 oC in 1 % BSA (w/v) in DPBS. Cells were then 
centrifuged at 1,200 rpm and re-suspended in 1 % BSA (w/v) in PBS twice, prior to 
visualisation using a fluorescent microscope.  
2.4.9. Cell counting 
A high-throughput cell counting method was devised using computational software to 
quantify adherent cells. Images were recorded at x10 magnification on microscope and 
analysed with NIS-Elements AR software (Nikon, Tokyo, Japan) in MCH mode. Red, green 
and blue absorbance channels were adjusted to 60 – 130, 0 – 20 and 0 - 180 nm, 
respectively, to distinguish cells from the flow tube surface. Sizes above or below 10 – 50 
pixels were eliminated from the analysis to avoid debris affecting the interpretation. 
2.5. Results and Discussion 
A range of tests were performed to assess the chemical functionality and morphological 
arrangement of deposited layers on the glass surface. XPS, based on the elemental 
composition of the first 100 nm depth of glass microslides was used to assess each surface 
following sequential cleaning, silanization (using 3-APTES) and glutaraldehyde treatment. 
Elemental compositions are presented in Table 2-2 and high resolution scans of nitrogen 
and carbon in Figures 2-6 and 2-7.  
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Nitrogen spectra, absent on cleaned glass, were present on APTES- and glutaraldehyde-
treated glass. Peaks at 401.5 (NH3+) and 399 eV (NH2) were detected. The protonated peak 
was attributed to terminal amine reactivity with adjacent hydroxyl groups of APTES 
molecules or glass, as reported elsewhere (Gao, 2006, Metwalli et al., 2006, Martin et al., 
2007).  A reduction in the nitrogen peak intensity and elemental content post-
glutaraldehyde treatment was attributed to carbon content in glutaraldehyde (Martin et al., 
2007). Nitrogen content in both APTES- and glutaraldehyde-treated APTES glass showed it 
to be several times higher than that observed for monolayers, which are typically 1 – 2 % 
(Metwalli et al., 2006), suggesting multilayer formation (Vandenberg et al., 1991, Williams 
et al., 2012).  
Carbon was detected on all surfaces, although peaks at 284.8 eV (C-C), 286 eV (C-O-C) and 
289 eV (O-C=O) on glass were attributed to adventitious carbon contamination (Smirnova, 
2009) which was much higher (8.4 ±0.1 %) (mean ± SEM) than previous studies (< 2%) (Barr 
and Seal, 1995, Evans et al., 2004), suggesting that either the solvent-based cleaning 
method was ineffective and that a more aggressive acid-based washing (Chandradoss et al., 
2014) is preferable, or that the cleaning environment was contaminated. More pronounced 
carbon peaks were identified on both the APTES- and glutaraldehyde-treated APTES surface: 
the 284.4 eV peak was attributed to the propyl group in APTES and the pentyl group in 
glutaraldehyde; 288.5 eV (present on glutaraldehyde-treated APTES slides only), was 
ascribed to the aldehyde group of glutaraldehyde (Smirnova, 2009).  
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Figure 2-6. High resolution nitrogen 1s scans on cleaned glass (A), APTES-glass (B) and APTES-glass 
treated with glutaraldehyde (C).  
 
 
Figure 2-7. High resolution XPS carbon 1s scans on cleaned glass (A), APTES-glass (B) and APTES-glass 
treated with glutaraldehyde (C). 
 
Table 2-2. XPS elemental composition of the first 100 nm depth of modified glass slides and contact 
angle measurements for modified glass slides  
Material coating Terminal layer XPS elemental composition (%) 
Carbon Oxygen Silicon Nitrogen 
Glass Hydroxyl 8.4 ±  0.1 63.1 ± 0.3 28.5 ± 0.3 0 ± 0 
APTES Amine 46.1 ± 0.8 27.4 ± 0.0 16.1 ± 0.4 10.5 ± 1.2 
Glutaraldehyde Aldehyde 58.7 ± 2.6 24.6 ± 0.1 9.9 ± 1.6 6.8 ± 0.8 
Data are displayed as the mean ± SEM for n = 2 runs for XPS and mean ± SD for n = 9 runs for Contact angle measurements 
2.5.1. Surface analysis 
The hydrophobicity of modified glass surfaces was determined using contact angle 
measurements. Data are displayed in Table 2-3 and images in Figure 2-8.  Cleaned glass 
surfaces were hydrophilic (contact angle under 90o), although measured contact angles 
were higher than those attained elsewhere (Hong et al., 2007, Williams et al., 2012), owing 
to the higher surface tension of contaminated glass (Ebnesajjad, 2006). Following APTES 
treatment, contact angles increased but remained hydrophilic, resembling those of thicker 
deposits (>40 o) (Williams et al., 2012). A small increase in hydrophobicity following 
glutaraldehyde treatment, contrasting with the more hydrophilic equivalents observed 
elsewhere (Hong et al., 2007), was attributed to the greater surface roughness of the slides 
(Yoshimitsu et al., 2002). 
A B C 
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Table 2-3. Contact angle measurements for chemically modified glass slides. 
Material coating Terminal layer Contact angle 
Glass Hydroxyl 32.2± 6.7a 
APTES Amine 55.7 ± 3.1b 
Glutaraldehyde Aldehyde 61.2 ± 2.7c 
Surfaces with the same subscripts are not statistically different at the 5 % significance level based on a T-test. n = 9 runs 
were performed per sample. Data displayed as mean ± SD.  
 
 
Figure 2-8. Contact angles for cleaned glass (A); APTES-treated glass (B) and APTES-glass treated with 
glutaraldehyde (C).  
 
Surface roughness (Table 2-4) and representative micrographs (Figures 2-9 to 2-12) are 
presented below. Micrographs revealed that glass was flat, abrasive and with low surface 
roughness (Figure 2-9). Conversely, APTES treatment yielded smoother deposits, but was 
rougher and thicker due to aggregate formation (Figures 2-10 and 2-11), consistent with the 
high nitrogen content reported from XPS analysis (Williams et al., 2012). Glutaraldehyde-
treated APTES revealed similar morphology, with large deposits and a rougher variable 
surface rendering it indistinguishable from APTES-treated glass (Figure 2-12).    
Table 2-4. Surface roughness for modified glass slides using AFM 
Terminal surface Roughness (nm) Thickness (nm) 
Ra Rrms 
Glass 0.95 ± 0.10 1.60 ± 0.14 4.19 – 5.13 
APTES 9.35 ± 2.08 12.75 ± 2.86 24.70 – 57.78 
Glutaraldehyde 25.25 ± 4.84 33.90 ± 4.67 19.11 – 30.76 
 
Roughness data are displayed as the mean ± SEM for n = 2 samples. Ra = roughness average; Rrms = root mean squared  
roughness. Image dimensions are 2 x 2 µm. 
 
A B C 
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Figure 2-9. AFM images for glass (2 x 2 µm) in a two-dimensional display (A) and a three-dimensional 
display. 
 
 
Figure 2-10. AFM images for aminated glass (2 x 2 µm) in a two-dimensional display (A) and a three-
dimensional display. 
 
 
Figure 2-11. AFM images for aminated glass (20 µm x 20 µm) in a two-dimensional display (A) and a 
three-dimensional display. 
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Figure 2-12. AFM images for aldehyde-treated aminated glass (2 x 2 µm) in a two-dimensional 
display (A) and a three-dimensional display. 
 
Taken together, these findings indicate chemical deposition onto glass surfaces, but they 
also demonstrate excessive APTES physisorption through aggregation. APTES 
polymerisation, enhanced by time (Williams et al., 2012) and a higher APTES concentration 
(5 %) than typically used (Vandenberg et al., 1991), are most likely to blame for aggregate 
formation. The ineffective removal of these deposits from glass slide surfaces was attributed 
to the inability to employ aggressive washing procedures using glass microslides. This 
limited their usability in protein adsorption studies;  physisorbed materials often lead to 
ligand leaching (Hong et al., 2007), which is undesirable for cell separation. Thus, glass beads 
were created using the same protocol, but were subjected to a more vigorous washing 
procedure to remove deposits. 
2.5.2. Chemical group functionality measurements 
BET surface area analysis performed on aldehyde-functionalised glass beads revealed an 
approximate surface area of 0.0296 ± 0.0013 m2 per gram of aldehyde-functionalised beads 
(mean ± SD). This enabled aminosilane deposits to be quantified using the TNBS assay 
(Hermanson, 1992). A calibration chart (Figure 7-3) allowed surface APTES deposits to be 
estimated based on picric acid elution and data are presented in Table 2-5. APTES-treated 
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glass was consistent with monolayer formation (1 – 10 deposits/nm2) (Kurth and Bein, 1993) 
and APTES beads treated with glutaraldehyde demonstrated a coverage efficiency above 90 
%.  
Table 2-5. Number of APTES deposits on APTES and glutaraldehyde-treated APTES glass beads. 
Surface No. of APTES deposits/nm2 
Amine 7.2 ± 2.5 
Aldehyde 0.7 ± 0.6 
 
Signals generated by glass were deemed to be negligible (< 0.2 per nm2). Both surfaces were statistically significant at the 5 
% level. The TNBS calibration chart is displayed in Figure 7-3.  
 
Aldehyde functionalities were qualitatively measured using Tollen’s reagent. APTES-coated 
glass slides stained a red/brown colour, possibly indicating reactivity with amine 
functionalities or contaminants (Ahluwalia, 2000), whilst the aldehyde-functionalised beads 
stained black (Figure 2-13). The latter reaction was consistent with the oxidation of 
aldehyde functional groups to create silver metal (represented by black precipitate) (Fieser, 
1987, Ahluwalia, 2000).  
 
Figure 2-13. Representative staining images of APTES (A) and glutaraldehyde-treated APTES (B) glass 
beads stained using Tollen’s reagent. 
 
2.5.3. Static protein binding studies 
Protein adsorption capacities onto aldehyde-functionalised glass beads are presented in 
Table 2-6. The purpose was to estimate the adsorption capacities of glass flow tubes, which 
have a very low surface area-to-volume ratio by using non-porous glass beads, which have a 
much higher surface area-to-volume ratio. Accounting for the BET surface area, the rPrA 
density on aldehyde-modified beads ranged from 1,272 – 5,004 molecules per nm2 (n = 5), 
A B 
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equating to  approximately 12 – 17 nm per molecule, assuming monolayer formation and no 
aggregation. For BSA, the density was 1,004 – 1,673 molecules per µm2 with spacing of 24 – 
32 nm (n = 5). BSA adsorbed on rPrA-coupled beads was 1,039 – 2,430 molecules per nm2 
with spacing between 20 – 31 nm. Whilst variable, perhaps owing to functional group 
heterogeneity, these findings are similar to those reported for previous cell separation 
studies relying on affinity interactions (Colton, 1996). 
Table 2-6. Protein binding onto aldehyde-functionalised glass beads 
Adsorbed protein Density (#/µm2) Distance (nm/molecule) 
rPrA 1,272 – 5,004 12 – 17 
BSA 1,004 – 1,673 24 – 32 
rPrA-BSAa 1,809 – 2,266 20 – 31 
Molecule arrangement assumes a monolayer with square-lattice formation. Data points are displayed as the minimum and 
maximum. Each rPrA and BSA molecule are assumed to represent a square 50 Å and each BSA molecule occupies a square 
35 Å. a refers to BSA adsorption only. Data were subtracted from the mean values generated by aldehyde-functionalised 
beads, and in the care of rPrA-BSA, rPrA-coupled beads. Calibration curves for rPrA and BSA are displayed in Figure 7-1 and 
7-2 respectively. Data are displayed as the range (minimum – maximum). BCA calibration charts are displayed in Figures 7-
1 and 7-2 for rPrA and BSA respectively.  
2.5.4. IgG binding capacity 
Whilst a high ligand density is desirable, the IgG binding capacity of rPrA, will determine the 
number of affinity interactions between the cell and the surface. On most Protein A 
adsorbents, IgG:PrA ratios are approximately 1:1, in spite of the possible 5 – 7 Fc binding 
domains available (Moks et al., 1986, Hahn et al., 2003). Observed differences in the IgG:PrA 
ratio are often attributed to variable surface chemistries (Castilho et al., 2000). To deduce 
this, the binding capacity was determined from a binding saturation curve (Figure 2-14) with 
accompanying data Table 2-7. 
The IgG binding capacity of BSA-blocked rPrA-coated surfaces was 0.042 ± 0.007 ng/cm2 
(1.37 ± 0.18  x 1011 IgG molecules per cm2) of IgG for rPrA-coated beads. The binding 
equilibrium constant, Kd, was 2.16 ± 0.01 x 10-6 M and the non-specific binding was 0.0052 ± 
0.0035 ng/cm2. These equate to an approximate IgG to rPrA ratio of 0.71 ± 0.16, which is 
Chapter 2. Flow tube model 
 
93 
 
lower than that observed in other studies (Colton, 1996, Castilho et al., 2000). The 
equilibrium constant, Ka, was ~4.6 x 105 M-1, which is marginally in excess of that 
recommended for ligand leakage (Ohlson et al. 1997, Castilo et al., 2000). This could be 
either attributed to inefficient elution, rPrA aggregation or experimental inaccuracies in rPrA 
measurements. 
 
Figure 2-14. Binding saturation curve for IgG adsorption onto rPrA-coupled glass beads (specific) (n = 
3) and onto BSA only beads (non-specific) (n = 5). B = IgG adsorption onto the substrate and C = the 
concentration of IgG in solution. Glass bead surface area was deduced from BET surface area 
analysis. Data are displayed as the mean ± SD. 
 
Table 2-7. Binding data for IgG adsorption onto rPrA-coupled glass beads and onto BSA only beads.  
Parameter Value  Unit 
Bmax 0.042 ± 0.007 ng/cm
2 
Bmax (nsb) 0.005 ± 0.004 ng/cm
2 
Kd 0.160 ± 0.006 mg/mL 
 2.16 ± 0.01 x 10-6 M 
IgG:rPrA 0.71 ± 0.16 - 
Glass bead surface area was deduced from BET surface area analysis. Data are displayed as the mean 
± SD. 
 
2.5.5. IgG binding to cells 
CD20 IgG binding to cells was qualitatively assessed by conjugating fluorescein to the IgG 
antibody. Fluorescent microscopy revealed specific, heterogeneous and clustered CD20 IgG 
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antibody binding to CD20+ cells (Figure 2-12 A), but an absence of CD20 IgG antibody 
binding to HLA-A2+ cells (Figure 2.12 B). Based on an estimated number of CD20 antigens 
per CD20+ lymphocyte cell (mean = 109,000) (Ginaldi, 1998) and the density of rPrA on the 
surface, the number of possible immunoaffinity interactions between the cell and the 
surface is approximately 960 ± 126 per µm2. 
 
Figure 2.15. Fluorescent microscopy images at x10 magnification of (A) CD20+ cells stained with 
CD20 IgG antibody, indicated by green fluorescence and (B) HLA-A2+ cells showing no evidence of 
staining from CD20 IgG antibody. The difference in the image brightness is due to an attempt to 
maximise any fluorescent signal. The variation in CD20+ cell staining suggests that cells express a 
range of CD20 antigens across a given cell population.  
 
2.5.6. Cell detachment studies 
Differences in the adhesion strength of cells adsorbed to the surface with and without 
affinity interactions were investigated. Cells with affinity interactions have greater adhesive 
strengths than those without (Bell, 1978, Bell et al., 1984), requiring higher shear stresses to 
induce removal (Nordon et al., 1996 and Nordon et al., 2004, Slowiaczek, 1998). Lower 
shear stresses (0 – 25 dynes/cm2) were preferred, since the purpose was to identify 
conditions to maximise product cell recovery (without affinity interactions) under milder 
conditions and retain cells with affinity interactions, providing a basis for the purification of 
mixed cell populations.  
A B 
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2.5.7. Counting adherent cells 
Surface-adherent cells were quantified using image analysis software (Figure 2-16). To 
validate, a comparison of the software-based cell counting method versus manual cell 
counting (n = 12) was performed. Data (Figure 2-17), revealed good agreement, with an R2 
value of 0.94, although the software counting appeared to underestimate the number of 
adsorbed cells (intercept = 45), due to the inability to identify cells in very close proximity, 
indicating limitations in the method for higher densities (≥500 cells/cm2 image). It is also 
worth noting that the cells exhibit negligible deformation, even after a 30 minute incubation 
period, meaning that shear stress-induced separation (Nordon et al., 1996) is more 
preferable to back-pressure (Pomianek, 1998) due to the greater surface area of the cell 
exposed to tangentially applied fluid flow.   
        
Figure 2-16. Actual image of adsorbed cells (A) and software-modified image of cells used for cell 
counting (B). Each image is at x10 magnification and equates to 1.125 mm2. Cells are detected in red 
with green outlines. 
 
A B 
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Figure 2-17. Calibration chart comparing software-based counting to manual counting (n = 12). A line 
of best fit was inserted (R2 = 0.94). The slope is 0.98 and the intercept is 45. An idealised line is 
plotted through the centre of the y-x axis 0. 
 
2.5.8. Cell detachment as a function of shear stress 
Detachment isotherms using non-linear regression were fitted to experimental data (mean ± 
SEM) and are presented for cells without affinity interactions HLA-A2+ (n = 3) and CD20+ 
cells (n = 3) in Figures 2-18 and 2-19 respectively. The detachment of CD20+ cells with 
possible affinity interactions is presented in Figure 2-20 (n = 3), where linear regression was 
performed.     
Cells without affinity interactions exhibited a lower resistance to detachment. The 
maximum detachment capacities (Rmax) were 97 ± 1 % and 92 ± 1 % (after 25 dynes/cm2) 
and the equilibrium constant (Kd) was 1.60 ± 0.56 dynes/cm2 and 2.997 ± 1.40 dynes/cm2 for 
CD20+ and HLA-A2+ cells respectively, indicating that cells without affinity interactions were 
more resistant to detachment than previous studies (Slowiaczek, 1998, Nordon et al., 2004) 
, where shear stresses ≤ 5 dynes/cm2 were sufficient to remove ~95 % of cells. The increased 
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adhesion strength was primarily attributed to the longer incubation time used (30 minutes) 
versus that of previous studies (5 – 15 minutes) (Slowiaczek, 1998, Nordon et al., 2004). This 
is because cell deformation increases as a function of incubation time (Dong and Lei, 2000, 
Cuvelier et al., 2007), leading to a greater contact area and more cell-substrate attraction 
(Sagvolden et al., 1999, Zaidel-Bar et al., 2007), as well as a more hydrodynamic cell profile, 
so greater shear stresses are required to induce detachment. Positively charged amine 
groups of APTES which were not completely covered with glutaraldehyde (Section 2.5.2.) or 
blocked with BSA could have also increased adhesiveness with negatively charged cells 
(Bacakova et al., 2011, Christ, 2011).  
Conversely, CD20+ cells pre-incubated with CD20 IgG were more resistant to detachment. 
Across 0 – 25 dynes/cm2, only 20 ± 19 % of cells were removed. This greater cell resistance 
to detachment was attributed to affinity interactions, which were estimated to be up to 960 
± 126 per cell, assuming a 0.7 µm2 contact area (determined from Equation 2.3). This 
increased resistance compared to non-affinity interactions was consistent with both 
practical (Xia et al., 1994, Pomianek, 1998) and theoretical studies reported elsewhere 
concerning force-induced cell detachment (Bell, 1978, Bell et al., 1984, Kuo and 
Lauffenburger, 1993) and is also consistent with the projections in Chapter 1. 
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Figure 2-18. HLA-A2+ cell detachment without CD20 IgG affinity interactions with the rPrA-coupled 
glass flow tubes. Experimental data as a function of shear stress with detachment isotherm, where 
Rmax = 97 %; Kd = 1.93 ± 0.79 dynes/cm2. Data are displayed as the mean ± SEM (n = 3).  
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Figure 2-19. CD20+ cell detachment without CD20 IgG affinity interactions with the rPrA-coupled 
glass flow tubes. Experimental data as a function of shear stress with detachment isotherm, where 
Rmax = 97 %; Kd = 3.63 ± 0.64 dynes/cm2. Data are displayed as the mean ± SEM (n = 3).  
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Figure 2-20. CD20+ cell detachment with CD20 IgG affinity interactions with the rPrA-coupled glass 
flow tubes. Experimental data as a function of shear stress with detachment isotherm, where R2 = 
0.84 and the slope = 0.79 ± 0.17 %/(dynes/cm2). Data are displayed as the mean ± SEM (n = 3).  
Representative images used to illustrate these findings across 0 – 25 dynes/cm2 for CD20+ 
and HLA-A2+ cells without affinity interactions are displayed in Figure 2-21 and 2-22, whilst 
images for CD20+ cells with affinity interactions are displayed in Figure 2-23. The 
experimental setup was such that siz gated regions were created on each flow tube. Images 
were recorded at random within each region over a two minute period following the 
application of shear stress. The average number of cells in these siz images constituted one 
single run. These gated regions were utilised due to notable heterogeneity inside the flow 
tubes. 
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Figure 2-21. Microscope images of CD20 cells incubated with CD20 IgG antibody, introduced into the flow tubes and incubated for 30 minutes prior to 
washing over shear stresses of 0, 1, 5, 10 and 25 dynes/cm2 applied sequentially for 3 minute intervals each. 
 
 
Figure 2-22. Microscope images of CD20 cells incubated without CD20 IgG antibody, introduced introduced into the flow tubes and incubated for 30 
minutes prior to washing over shear stresses of 0, 1, 5, 10 and 25 dynes/cm2 applied sequentially for 3 minute intervals each (control study for non-specific 
cell adhesion). 
 
 
Figure 2-23. Microscope images of HLA-A2 cells (CD20-) incubated with IgG antibody, introduced into the flow tubes and incubated for 30 minutes prior to 
washing over shear stresses of 0, 1, 5, 10 and 25 dynes/cm2 applied sequentially for 3 minute intervals each (control study for non-specific cell adhesion). 
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2.5.9. Cell detachment in real time 
Responses of CD20+ cells with affinity interactions (Figures 2-24 and 2-25) and HLA-A2+ cells 
without affinity interactions (Figures 2-26 and 2-27) to shear stresses of 5 and 25 dynes/cm2, 
respectively, were also monitored in real-time. From video analysis following exposure to 
shear stress, one of two scenarios occurred: (1) cells detached, usually within 2 seconds or 
(2) remained adherent, undergoing morphological change.  
    
    
Figure 2-24. CD20+ cells adsorbed with affinity interactions subjected to a shear stress of 5 
dynes/cm2. Images (left to right) are recorded in real time over a 1-4 second period. Each image (A – 
H) is equivalent to 0.25 seconds. Cells in this instance remain adherent with negligible detachment 
after the application of shear stress. Negligible changes were observed over the full 2 minute period.  
 
    
    
Figure 2-25. CD20+ cells adsorbed with affinity interactions subjected to a shear stress of 25 
dynes/cm2. Images (left to right) are recorded in real time over a 1-4 second period. Each image (A – 
H) is equivalent to 0.25 seconds. Cells in this instance remain adherent with negligible detachment 
after the application of shear stress. Negligible changes were observed over the full 2 minute period. 
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Figure 2-26. HLA-A2+ cells adsorbed without affinity interactions subjected to a shear stress of 5 
dynes/cm2. Images (left to right) are recorded in real time over a 1-4 second period. Each image (A – 
H) is equivalent to 0.25 seconds. Cells in this instance demonstrate a high level of detachment 
shortly after the application of shear stress. Negligible changes were observed over the full 2 minute 
period following initial detachment.  
 
    
 
    
Figure 2-27. HLA-A2+ cells adsorbed without affinity interactions subjected to a shear stress of 25 
dynes/cm2. Images (left to right) are recorded in real time over a 1-4 second period. Each image (A – 
H) is equivalent to 0.25 seconds. Cells in this instance demonstrate a high level of detachment 
shortly after the application of shear stress. Negligible changes were observed over the full 2 minute 
period following initial detachment.  
 
Cells resistant to detachment exhibited morphological and positional changes, usually 
forming ellipsoid shapes, with the bulk of the cytoplasm shifting away from the original 
anchor point (Figure 2-28). However, this observed phenomenon was temporary; cells 
returned to their original spherical shape once shear stress was ceased, irrespective of 
possible affinity interactions, contradicting previous work which suggested the change to be 
permanent and indicative of new affinity interaction formation (Nordon et al., 2004). 
Ascertaining whether cell detachment resembled that of a tensegrity system, where the cell 
adapted and stressed bonds equally (Ingber, 2014) or a peeling mechanism, where bonds 
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were stressed sequentially (Chang and Hammer, 1996) remained elusive, owing to 
experimental limitations.  
 
Figure 2-28. Cells exposed to shear stress undergo changes in morphology. Adherent cells with (C 
and D) and without (A and B) the potential for immuno-affinity interactions under static conditions 
(A and C) and following exposure to 25 dynes/cm2 (B and D).  
2.5.10. Cell viability 
A loss of membrane integrity, often associated with but not indicative of cell death 
(Kroemer et al., 2005), was used to determine the effect of shear stress-induced 
detachment on desorbed cells. Data in Table 2-8 show no difference at a 5 % significance 
value in membrane integrity after applied shear stress or static incubation, where values 
were equal to or above 99 %. However, since the assay is a measure of membrane integrity 
and long-term cell viability was not determined, the actual effect on the cell could not be 
determined. Nevertheless, lower shear stresses (~≤ 25 dynes/cm2) for cell recovery would 
expose cells to less physical stress than observed previously, where losses in cell viability, 
albeit minor (≤ 10 %), were observed (Nordon et al., 1996, Pomianek, 1998). Indeed, 
pluripotent cell differentiation is even enhanced under mild shear stresses (1.5 – 15 
dynes/cm2) (Yamamoto et al., 2005, Wlofe et al., 2012 and 2013, Nsiah et al., 2014).  
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Table 2-8. Cell viability assay using trypan blue staining.  
 Affinity interaction Before (%) After (%) Control (%)a 
CD20a Yes 99.5 99 100 
CD20b No 99.5 99 100 HLA-A2b 100 99.5 100 
Represents cells collected over 1-25 dynes/cm2 for n = 3 runs. a pre-incubation period with CD20 IgG; b pre-incubation 
period without CD20 IgG; c cells were not exposed to shear stress and were instead stored in the same solution.  
2.5.11. Projected performances 
Experimental data provide information about individual cell detachment in response to 
shear stress. When combined, these findings may project the purity of HLA-A2+ product 
cells recovered from the device relative to the retention of non-product ‘impure’ CD20+ 
cells, providing the basis for the separation of mixed cell populations. Thus, several 
assumptions were made:  
1. Cells without affinity interactions (HLA-A2+) exhibit a range of adhesion strengths 
within a given population. This contradicts Chapter 1 which suggested that non-
affinity cell adhesion strength was constant for a given cell type.   
2. A mass balance on an idealised version of the separation system assumes three 
states: 
𝐼𝐼𝑎𝑎 = 𝑂𝑂𝑚𝑚𝑎𝑎 + 𝐴𝐴𝑎𝑎ℎ𝑎𝑎𝑟𝑟𝑎𝑎𝑎𝑎𝑎𝑎 
, where In = the input fraction; Out = the detached and collected fraction and Adherent = 
cells adsorbed on the device surface.  
3. The adhesion strength, represented by the purity of recovered cells, is assumed to 
be independent of the surface area of the device.  
4. Two cell types are being separated: CD20 cells with affinity interactions (designated 
as impurities) and HLA-A2+ cells without affinity interactions (designated as product 
cells).  
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5. The effect on the health of the cell is neglected.  
2.5.12. Large-scale separation device 
The purpose of a depletion-based large scale cell separation device is to retain impurities 
(e.g. SSEA-4-positive undifferentiated pluripotent cells) and recover product cells (e.g. SSEA-
4-negative differentiated cells, such as cardiomyocytes), therefore improving purity and 
minimising the risk of teratoma formation in vivo. Other extracellular pluripotent markers 
may also be targeted simultaneously as a means to further enhance purification 
performance, such as the SSEA-3 antigen (Thomson 1998). Projecting changes in purity as a 
function of shear stress will enable the selection of favourable operating constraints. 
Therefore, the following equations were generated to assess performance: 
Separation performance 
The recovery of CD20+ cells – those positive for target antigens – (%), BC,n, may be given as a 
function of shear stress by considering a linear equation: 
 𝐵𝐵𝐶𝐶,𝑚𝑚 = 𝑚𝑚. 𝑆𝑆𝑚𝑚 + 𝑚𝑚 
 
2.5 
, where m = slope (% / (dynes/cm2)); Sn = shear stress (dynes/cm2); c = Y-intercept.  
The recovery of HLA-A2+ cells – those negative for target antigens – (%), BH,n may be given 
as a function of shear stress using a detachment isotherm: 
 
𝐵𝐵𝐻𝐻,𝑚𝑚 = 𝐵𝐵𝐻𝐻,𝑚𝑚,𝑚𝑚𝑎𝑎𝑚𝑚.𝑆𝑆𝑚𝑚𝐾𝐾𝑑𝑑 + 𝑆𝑆𝑚𝑚  
 
2.6 
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, where Bmax = maximum HLA-A2 cell recovery using shear stress based on experimental 
output (%); Kd = detachment constant (dynes/cm2); Sn = shear stress estimated to detach 50 
% of cells (dynes/cm2).  
The log10 depletion for CD20+ cells removed from collected fractions of HLA-A2+ cells may 
be given by: 
 
𝐿𝐿𝑎𝑎𝑎𝑎10𝑎𝑎𝑎𝑎𝑒𝑒𝑀𝑀𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 = 𝐿𝐿𝑎𝑎𝑎𝑎10 � 𝑁𝑁𝐶𝐶,𝑚𝑚0𝑅𝑅𝑑𝑑𝐶𝐶,𝑚𝑚.𝑁𝑁𝐶𝐶,𝑚𝑚0� 
 
2.7 
, where NC,n0 = the number of adsorbed CD20+ cells prior to shear stress exposure; RCC,n = 
the fraction of CD20+ cells originally adsorbed that are recovered from the surface at a 
shear stress ‘n’ (to be determined through prior experimentation).  
Output from these projections is shown in Table 2-9. As shown in the detachment 
isotherms, HLA-A2+ cell recovery, calculated from Equation 2.6, would increase with shear 
stress, although it is lower versus other studies; ≥95 % of cells adsorbed without affinity 
interactions were recovered after exposure to 5 dynes/cm2 (Nordon 1996; Slowiaczek 
1998). Here, the recovery of equivalent quantities would require higher shear stresses (25 
dynes/cm2), leading to greater amounts of CD20+ cells being recovered, ultimately reducing 
the purity of the collected fractions.  
The CD20+ cell log10 depletion of collected fractions, calculated from Equation 2.5, shows 
comparable findings to those reported elsewhere, which range from 0.5 – 2.5 for depletion 
strategies (Barfield et al., 2004, Lara et al., 2006b) and 3 – 5 for enrichment (Martin-Henao 
et al., 2001, Handgretinger 2002).  
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Table 2.9. Projected cell depletion and recovery performance as a function of shear stress. 
Shear stress (dynes/cm2) 0 1 5 10 25 
Cell recovery (%) - 37 73 84 91 
Log10 depletion - 1.4 1.2 1.0 0.7 
Note: data were based upon the average of n = 3 runs. 
Estimating HLA-A2+ cell purity of detached cells 
The log10 depletion expression indicates the removal of impure CD20+ cells but does not 
indicate the purity of HLA-A2+cells. Therefore the projected purity (%), RPH,n, for recovered 
fractions of HLA-A2+ cells originally adsorbed at a given shear stress is determined instead 
from: 
 
𝑅𝑅𝑅𝑅𝐻𝐻,𝑚𝑚 = 𝑅𝑅𝑑𝑑𝐻𝐻,𝑚𝑚.𝑁𝑁𝐻𝐻,𝑚𝑚0𝑅𝑅𝑑𝑑𝐻𝐻,𝑚𝑚.𝑁𝑁𝐻𝐻,𝑚𝑚0 + 𝑅𝑅𝑑𝑑𝐶𝐶,𝑚𝑚.𝑁𝑁𝐶𝐶,𝑚𝑚0 
 
2.8 
, where RCH,n = the fraction of HLA-A2+ cells originally adsorbed that are recovered at a 
specific shear stress (%) (to be determined prior through prior experimentation); NH,n0 = the 
number of HLA-A2+ cells adsorbed prior to shear stress exposure (cells); RCC,n = the fraction 
of CD20+ cells originally adsorbed recovered using shear stress (%); NC,n0 = the number of 
CD20+ cells adsorbed prior to shear stress exposure.  
Using Equation 2.8, the projected purity of recovered fractions for mixed cell populations 
across purities of 1 – 90 % are presented in Figure 2-29 across 0 – 25 dynes/cm2. The purity 
of HLA-A2+ cells in recovered fractions is projected to increase to a peak (estimated to be < 
5 dynes/cm2), before declining with increasing shear stress as more CD20+ cells are 
removed. The trend is in agreement with practical studies, where the majority of cells are 
recovered without affinity interactions (equivalent to HLA-A2+ cells here) at ≤ 5 dynes/cm2 
(Nordon 1996; Slowiaczek 1998). 
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Further, Figure 2-29 also shows that the purity of HLA-A2+ cells in collected fractions was 
projected to depend upon the starting purity. Populations with higher HLA-A2+ cell starting 
purities were projected to exhibit smaller increases in purity since fewer CD20+ cells with 
affinity interactions would be present for a given cell surface density.  
 
Figure 2-29. Projected HLA-A2+ cell purity as a function of shear stress for a range of starting 
purities (10 – 99 %). Relies upon adhesion data from individual studies using CD20+ and 
CD20- (HLA-A2+) cells. Assumes that adhesion strength is represented by a Guassian 
distribution for both cell types, where increasing fractions of cells are removed as a function 
of shear stress. 
2.5.13. Biosensor development 
For the QCM biosensor (Chapter 3), cell purity measurements will rely upon the net change 
in cells adsorbed on the sensor surface – before and after a designated shear stress is 
applied – to distinguish between cells adherent with and without affinity interactions. Here, 
adsorbed CD20+ cells (without affinity interactions) would need to be retained relative to 
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HLA-A2+ cells (with affinity interactions) following shear stress exposure to maximise the 
signal-to-noise ratio generated by the biosensor.  
However, this chapter has shown that a higher proportion of HLA-A2+ cells (no affinity 
interactions) are resistant to shear stress-induced cell detachment compared to that 
observed elsewhere (Nordon 1994 and 2004) for cells without affinity interactions – and 
some CD20+ cells which should remain adherent with affinity interactions detach. 
Therefore, any projections must account for the fraction of these HLA-A2+ cells retained to 
accurately determine the purity of CD20+ cells present. To identify a shear stress capable of 
providing a sufficient signal-to-noise ratio, cell detachment data for CD20+ and HLA-A2+ 
cells was incorporated from Section 2.5.8. 
Cell surface density 
Initially, the number of surface adherent cells for a given cell density must be considered. 
This study utilised densities in the range of 2 – 4 %, although up to 8% (equivalent to 
100,000 cells assuming a 10 µm diameter per cm2 surface) have been reported (Nordon 
1994). Assuming a cell density of 4 % over a surface of 1 cm2 (the same surface area as the 
QCM sensor), the total number of cells present per unit surface area without shear stress 
exposure (NT,n) is given by: 
 
𝑁𝑁𝑇𝑇,𝑚𝑚0 = �𝑆𝑆𝑆𝑆𝑆𝑆𝑑𝑑𝑆𝑆𝑆𝑆� . 0 2.9 
 
, where SSA = sensor surface area available for cell adsorption (cm2); CSA = surface area 
occupied per cell (cm2/cell); 0 = percentage of the sensor surface occupied by cells, 
assuming a monolayer (%). 
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Effect of shear stress on the density of surface-adsorbed cells 
CD20+ cells 
The number of CD20+ cells on the sensor surface after washing at a given shear stress (NC,n) 
may be calculated from: 
 𝑁𝑁𝐶𝐶,𝑚𝑚 = 𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚0.𝑅𝑅𝑅𝑅𝐶𝐶,𝑚𝑚.𝑁𝑁𝑇𝑇,𝑚𝑚0 
 
2.10 
, where SPC,n0 = surface purity of CD20+ cells adherent on the surface prior to shear stress 
exposure; RTC,n = fraction of CD20+ cells originally adsorbed on the surface retained at a 
given shear stress (-) (to be determined through experimental observation); NT,n0 = total 
number of cells present prior to shear stress exposure.  
HLA-A2+ cells 
The number of HLA-A2+ cells on the surface after washing at a given shear stress (NH,n) may 
be calculated from: 
 𝑁𝑁𝐻𝐻,𝑚𝑚 = 𝑆𝑆𝑅𝑅𝐻𝐻,𝑚𝑚0.𝑅𝑅𝑅𝑅𝐻𝐻,𝑚𝑚.𝑁𝑁𝑇𝑇,𝑚𝑚0 
 
2.11 
, where SPH,n0 = surface purity of HLA-A2+ cells adherent on the surface prior to shear stress 
exposure; RTH,n = fraction of HLA-A2+ cells originally adsorbed on the surface retained at a 
given shear stress (-) (to be determined through experimental observation).  
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Total cells 
By combining CD20+ (NC,n) and HLA-A2+ (NH,n) cell quantities on the surface obtained from 
individual experimentation studies in Section 2.5.8., the total number of cells on the surface 
in a combined model at a given shear stress may be determined by: 
 𝑁𝑁𝑇𝑇,𝑚𝑚 = 𝑁𝑁𝐻𝐻,𝑚𝑚 + 𝑁𝑁𝐶𝐶,𝑚𝑚 
 
2.12 
, where NT,n = the total number of cells retained on the surface following the application of a 
given shear stress (cells).  
The total number of cells on the sensor surface for a range of starting purities across 0 – 25 
dynes/cm2 is projected in Figure 2.30 based on the individual studies conducted in Section 
2.5. In scenarios where CD20+ cell purity is lower, the number of cells removed from the 
surface increases, owing to a higher proportion of HLA-A2+ cells, which do not possess 
affinity interactions strong enough to resist shear stress-induced detachment. Moreover, 
there are a limited number of affinity interactive sites on the surface, so these are more 
likely to be occupied by HLA-A2+ cells when those cells are in higher quantities than CD20+ 
cells.  
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Figure 2.30. Total number of cells on the surface (NT,n) as a function of shear stress (0 – 25 
dynes/cm2) for starting purities ranging from 1 – 90 %. Relies upon adhesion data from 
individual studies using CD20+ and CD20- (HLA-A2+) cells. Assumes that adhesion strength is 
represented by a Guassian distribution for both cell types, where increasing fractions of cells 
are removed as a function of shear stress. 
CD20+ cell purity post-shear stress 
Since the number of both cell types adsorbed at a given shear stress can be determined 
from Equations 2.10 and 2.11, the purity of CD20+ cells on the sensor surface (SPC,n) may 
therefore be deduced: 
 
𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚 = 𝑁𝑁𝐶𝐶,𝑚𝑚𝑁𝑁𝐶𝐶,𝑚𝑚 + 𝑁𝑁𝐻𝐻,𝑚𝑚 
 
2.13 
CD20+ cell surface purity has therefore been plotted as a function of shear stress for various 
starting purities (Figure 2-31). 
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Figure 2-31. CD20+ cell purity on the sensor surface as a function of shear stress for starting 
purities ranging from 1 – 90 %. Relies upon adhesion data from individual studies using 
CD20+ and CD20- (HLA-A2+) cells. Assumes that adhesion strength is represented by a 
Guassian distribution for both cell types, where increasing fractions of cells are removed as 
a function of shear stress. 
By calculating and plotting the total number of cells on the sensor surface post-shear stress 
(NT,n) versus the purity of CD20+ cells also post-shear stress (SPC,n) (determined from 
individual experimental studies), it is possible to determine the projected CD20+ cell purity 
retained on the surface. 
Plotting (SPC,n) versus (NT,n) for a variety of starting purities at a given shear stress (in this 
instance using 25 dynes/cm2) will yield Figure 2-32. 
Chapter 2. Flow tube model 
 
114 
 
0 1 0 0 0 0 2 0 0 0 0 3 0 0 0 0 4 0 0 0 0
0
5 0
1 0 0
N T , n  (c e lls )
S
P
C
,n
 (
%
)
 
Figure 2-32. CD20+ cell purity on the sensor surface following washing at a given shear 
stress across a range of purities (based on Figure 2-28) versus the total number of cells on 
the surface. The R2 value is 0.9943. Note: at 0 % CD20+ cell purity the number of cells 
retained on the surface after washing is > 0. This is because in spite of how much washing is 
applied when a 4 % cell coverage is used, around 9 % of HLA-A2+ cells will remain adherent. 
This is because the model assumes: (1) cells comprise a mixture of HLA-A2+ and CD20+ cells 
and (2) cell surface density must start at 4 %. The applicability of the model at CD20+ cell 
purities < 1 % is not deemed viable.  
The equation used to estimate the CD20+ cell purity on the sensor surface (SPC,n) is given by: 
 𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚 = 𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚∗ + �𝑅𝑅𝑀𝑀𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑚𝑚 −  𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚∗�. �1 − exp (−𝐾𝐾.𝑁𝑁𝑇𝑇,𝑚𝑚)� 
 
2.14 
, where SPC,n = CD20+ cell purity on the surface for a given number of total cells (NT,n) 
following washing at a given shear stress (25 dynes/cm2) (cells); SPC,n* = calculated CD20+ 
cell purity on the sensor surface when zero cells are present (%); Plateau = the SPC,n value at 
an infinite number of cells on the surface (%); K = the rate constant expressed in reciprocal 
of the NT,n axis units (1/cells). 
Note: there will always be cells on the surface since a residual amount of HLA-A2+ cells are 
resistant to detachment.  (Look at the HLA-A2+ cell total on the surface – the graph 
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accounts for that – these cells cannot be removed at 25 dynes/cm2). Second, the fact that a 
4 % cell density is required means that there will always be a population of cells on the 
surface – in this instance HLA-A2+ cells, which remain adherent.  
Table 2.10. Parameters used to determine cell purity.  
Constant Data Unit 
SPC,n* -100.9 % 
K 0.0002077 1/cells 
Plateau 96.40 % 
 
The number of CD20+ cells on the surface after washing at a given shear stress can be 
calculated using: 
 𝑁𝑁𝐶𝐶,𝑚𝑚 = 𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚.𝑁𝑁𝑇𝑇,𝑚𝑚 2.15 
 
, where NC,n = the number of CD20+ cells on the surface after washing at a given shear 
stress; SPC,n = the purity of CD20+ cells on the surface after washing at a given shear stress; 
NT,n = the total number of cells on the surface after washing at a given shear stress. 
Recall the equation for the number of CD20+ cells on the sensor surface after washing at a 
given shear stress (NC,n): 
 𝑁𝑁𝐶𝐶,𝑚𝑚 = 𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚0.𝑅𝑅𝑅𝑅𝐶𝐶,𝑚𝑚.𝑁𝑁𝑇𝑇,𝑚𝑚0 2.16 
 
, where SPC,n0 = surface purity of CD20+ cells adherent on the surface prior to shear stress 
exposure; RTC,n = fraction of CD20+ cells originally adsorbed on the surface retained at a 
given shear stress (-) (to be determined through experimental observation); NT,n0 = total 
number of cells present prior to shear stress exposure.  
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The determination of SPC,n for a given cell number can then be used to aid in the calculation 
of the original starting purity. By re-arranging Equation 2.7 and inserting Equation 2.12, the 
following may be derived to determine the purity of cells on the surface prior to washing: 
 
𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚0 = 𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚.𝑁𝑁𝑇𝑇,𝑚𝑚𝑅𝑅𝑅𝑅𝐶𝐶,𝑚𝑚.𝑁𝑁𝑇𝑇,𝑚𝑚0 2.17 
 
, where SPC,n is known from Figure 2-29; RTC,n is known from initial experimental study using 
individual populations of cells to assess a range of adhesion strengths; NT,n and NT,n0 are 
known from the determination of cells on the sensor surface (to be presented in Chapter 3). 
A worked example for this calculation is presented in Chapter 7 (Appendix).  
2.6. Conclusions 
rPrA-coupled glass flow tubes were generated using aldehyde-functionalised surface 
chemistry. Shear stresses (1, 5, 10 and 25 dynes/cm2) were applied sequentially to identify 
differences in the adhesion strength of cells adsorbed with (CD20+) and without (CD20+ and 
HLA-A2+) affinity interactions.  
Cells adsorbed with affinity interactions were thought to comprise multiple connections 
between surface-coupled rPrA and the Fc region of CD20 IgG antibody tagged to CD20+ 
cells. These interactions, estimated to be up to 960 ± 126 per µm2 (mean ± SEM), provided 
greater cell adhesion strength relative to cells adsorbed without affinity interactions. For 
instance, at 25 dynes/cm2, only 20 ± 19 % (mean ± SEM) of CD20+ cells adsorbed with 
affinity interactions detached. Yet for cells without affinity interactions – CD20+ and HLA-
A2+ cells, around 97 ± 1 and 92 ± 1 % (mean ± SEM) detached, respectively. These findings 
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will enable performance projections to be made for large-scale cell separation and the 
development of a QCM biosensor utilising shear stress-induced affinity interactions. 
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Chapter 3. Biosensor development 
3.1. Introduction 
For several decades, the performance of mammalian cell culture has been enhanced with 
sensors that measure dissolved oxygen content, pH and temperature (Ahn et al., 2008, 
Sunley and Butler, 2010). However,  successful CTP manufacture requires the measurement 
and control of more sophisticated characteristics (Table 3-1) inherent to the cell, such as cell 
antigen and gene expression, morphology, chromosomal stability, as well as the capacity to 
demonstrate biological functionality (Bravery et al., 2013). Such characteristics require much 
more sophisticated technologies in order to be measured. These cannot be easily integrated 
into existing bioreactor systems, often acting as separate devices that require extensive 
operator training, large bench spaces and high costs.  
The large-scale manufacture of pluripotent-derived cells has the capacity to yield large 
quantities of cells for a variety of treatments. However, bioreactor inefficiencies at larger 
scales (> 1011 cells) are expected to generate impure cell populations. Safe thresholds for 
these cells are expected to be in excess of 99 % based on animal (Schriebl et al., 2012) and 
human studies (Schwartz et al., 2012). Undifferentiated pluripotent cells express the SSEA-4 
antigen (Thomson et al., 1998), making affinity separation to selectively remove these cells 
possible (Shibata et al., 2006, Schriebl et al., 2012). 
The measurement of cell purity during process development or routine lab-based research 
using simpler, cheaper alternatives to flow cytometry (> £60 k) is highly desirable. Many 
biosensors exist, primarily relying on acoustic (Pan et al., 2010) and optical (Brauchle et al., 
2014) techniques. However, the majority of these will require complex analytical tools to 
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isolate specific parameters. Conversely, the quartz crystal microbalance (QCM) is a form of 
acoustic sensor, which can monitor mass and density related changes at the surface of a 
quartz disc, relying on the piezoelectric effect to provide quantitative data (Voinova et al., 
2002) and are much cheaper (~£20 k).  
The QCM has the potential to measure cell purity through affinity interactions, based on 
extracellular protein interactions with immobilised antibodies. The system is able to relay 
the mass of adsorbed components (e.g. cells) on a sensor surface via a measured output 
signal (frequency), thus providing quantitative data (Figure 3-1). Antibody-coupled sensors 
can be used to differentiate between cells adherent with and without affinity interactions. 
As detailed in Chapter 2, shear stress can be used to exploit differences in adhesion strength 
based on whether or not a cell has affinity interactions. This can be used to correlate net 
changes in the measured output signals with cell purity.  
 
Figure 3-1. Key aspects of the QCM system: Gold-coated quartz crystal (A) and QCM system 
schematic (B): when mass is deposited on the surface of an oscillating gold-plated quartz crystal, it 
causes a change in the frequency of oscillation, which can be measured and quantified.  
 
Chapter aims and objectives: 
• Generate a surface capable of affinity interactions with proteins and cells 
Chapter 3. Biosensor development 
 
120 
 
• Investigate the response of adherent cells to shear stress inside the QCM chamber 
• Propose methods for converting measured output signal into a cell number and 
purity 
3.2. Materials and methods 
A protocol concerning the creation of a Protein A-terminated complex for oriented IgG 
antibody immobilisation onto quartz sensor chips treated with a PEG derivative to yield a 
surface added monolayer (SAM) was implemented (Nileback et al., 2011).  
3.2.1. Chemical modification  
Gold-coated AT-cut 5 MHz quartz crystals (Q-Sense AB, Gothenburg , Sweden) were cleaned 
in an ultraviolet ozone cleaner (UV/O3) (NL-UV253, Nippon Laser and Electronic Laboratory, 
Tokyo, Japan). After rinsing with de-ionised water, purified using a Milli-Q system (MilliPore, 
Molsheim, France), sensors were dried under a flow of nitrogen and placed 0.5 in a mM 
solution of an oligo(ethylene glycol) (OEG) disulfides with a hydroxyl terminal group (dS-
OEG-OH) (PlasmChem GmbH, Berlin, Germany) with a mole fraction of 0.1 % for an 
oligo(ethylene glycol) (OEG) disulfides with a biotin terminal group (dS-OEG-biotin) 
(Polypure, Oslo, Norway) dissolved in spectroscopic-grade ethanol (Sigma-Aldrich, Munich, 
Germany). Following a 16 hour incubation period in a light-free dessicator, sensors were 
rinsed in ethanol (100 %) and ultra-sonicated in an Elma S10 ultrasonic bath (Fischer 
Scientific, Loughborough, UK) for 3–5 min in ethanol to remove non-covalently bound 
disulfides.  
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3.2.2. System operation 
Successive protein layers and subsequent analyte studies were performed in the QCM-D 
system (Q-Sense AB, Gotenbugy, Sweden). The flow was controlled using an Ismatec IPC-N 4 
peristaltic pump (Wertheim-Mondfeld, Germany). All measurements were performed at 
room temperature (22 °C). Data was collected at the fundamental frequency and overtones 
of 1 – 13 MHz, of which only the 7th overtone was used in analysis.  
3.2.3. Surface characterisation 
3.2.3.1. Contact angle measurements 
Contact angle measurements on cleaned gold and PEG-treated gold sensors were used to 
indicate surface hydrophobicity. A 2 µL droplet of de-ionised water was deposited onto the 
sensor surface and the contact angle was measured with a DataPhysics OCA 20 system (Data 
Physics Instruments GmBH, Filderstadt, Germany).  
3.2.3.2. Surface charge 
Non-specific binding sites were estimated by incubating biotin-terminated sensors inside 
the chamber in a 1 % (w/v) BSA (Sigma-Aldrich, Munich, Germany) in PBS, prior to washing 
at 100 mL/min until the frequency change was approximately less than 5 Hz/hr. The net 
change in frequency was used to indicate the extent of adsorption.  
3.2.4. Protein adsorption  
A Protein A-terminated complex was created to provide a basis for future experiments 
(Figure 3-2) relying on a complex described previously (Nileback et al., 2011). Proteins were 
introduced, incubated and washed as detailed in Table 3-1. This complex was created to 
enable the immobilization of IgG antibody via the Fc region onto the sensor through a 
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Protein A interaction (all protein solutions diluted in PBS). Successive layers were rinsed in 
PBS at 100 µL/min. 
 
Figure 3-2. Protein A terminated surface. dS-PEG-OH/-biotin treated gold sensors were successively 
exposed to streptavidin, Protein A-biotin to create a platform for orientated IgG antibody adsorption 
via the Fc base.  
 
Table 3-1. Analyte and component deposition 
Step Protein/chemical Concentration Static incubation time (minutes) 
1 Streptavidin 25 µg/mL 10 
2 SDS 50 mM - 
3 BSA 10 mg/mL 30 
4 Protein A-biotin 25 µg/mL 10 
5 
CD20 IgGa 
HLA-A2 IgGb 
Glycophorin A IgGb 
10 µg/mL 40 
a = applied to CD20 IgG only ; b = applied to cells only 
Protein L and A binding 
CD20 IgG was introduced to bind to the underlying protein complex at a concentration of 10 
µg/mL in PBS and incubated for 30 minutes at room temperature (~23 oC). Following 
washing, Protein L and A (100 µg/mL) were introduced into separate chambers and allowed 
to statically incubate for 20 minute prior to washing. The ratio of Protein L to Protein A was 
used as a basis to determine IgG presence and orientation. 
3.2.5. Cell adsorption studies 
3.2.5.1. Cell culture 
CCRF-HSB-2 B-lymphocytes positive for the HLA-A2 antigen were cultured in 90 % RPMI-
1640 with 2 mM glutamine and 10 % (v/v) foetal bovine serum (FBS) supplemented with 1 % 
Pen-Strep (Sigma-Aldrich, Munich, Germany). Cell cultures were maintained at 3x105 to 
Chapter 3. Biosensor development 
 
123 
 
1x106 cells/mL in 5 % CO2 and 95 % O2 atmospheric content at 37 oC using a Heracell 150i 
CO2 incubator (Thermo Scientific, Loughborough, UK) and cultured every 2-3 days. Red 
blood cells were received from donor blood through the National Blood Transfusion Centre 
and were stored at 4 oC prior to use.  
3.2.5.2. Cell adsorption 
Exploratory cell binding studies were performed using two different cell types: B-
lymphocyte cells across a range of 5 x 104 – 5 x 105 cells/mL and red blood cells at 1 x 106 
cell/mL (Table 3-2). For each experiment cells with a viability in excess of 99 % based on 
trypan blue exclusion were centrifuged at 1,200 rpm and re-suspended in 1 % BSA (w/v) in 
PBS.   
Cells suspensions were injected into Q-Sense QCM-D chambers, (Gothenburg, Sweden) onto 
sensors with IgG antibodies immobilised. These antibodies had an affinity for the cells being 
introduced. Cells were then incubated for 30 minutes at room temperature prior to washing 
at 5 dynes/cm2 with PBS until line stabilisation. 
Table 3-2. Cell adsorption study conditions.  
Cell type Antibody Cell concentration 
(cells/mL) 
Incubation time 
(minutes) 
Shear stressa 
(dynes/cm2) 
CCRF-HSB-2 B-
lymphocytes 
HLA-A2 0.5 – 5 x 105 
30 5 
Red blood cells Gly-A 1 x 106 
No control studies using cells negative for the target antigen or cells without adsorbed antibody were performed. a = shear 
stress applied during washing following a 30 minute incubation period of cell adsorption.  
3.3. Theoretical considerations 
Replicating the same hydrodynamic conditions inside the QCM chamber (Figure 3-3) as 
those used for the glass flow tube in Chapter 2 required the use of computational modelling 
software. The most sensitive location on the QCM sensor is the centre of the electrode and 
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it is important that the hydrodynamic conditions are more uniform here to provide a 
reliable signal.  
COMSOL modelling software (Multiphysics 4.2a) was used to evaluate the fluid dynamics 
inside the chambers. Second order elements for velocity characteristics were discretized 
with first order characteristics for pressure for the fluid, which was assumed to be water, 
possess laminar flow characteristics (Reynolds number << 2,100) and obey the Navier-
Stokes equation for fluid motion. 
 
Figure 3-3. QCM chamber schematic. The chamber dimensions are: inlet/outlet diameter = 0.65 mm; 
height = 0.35 mm; diameter (also the sensor diameter) = 12 mm. 
3.4. Results 
3.4.1. Computational modelling 
COMSOL-simulated fluid dynamics inside the QCM are presented in Figures 3-4 and 3-5. 
Surface shear stress and pressure gradients (Figure 3-4) are localised near the inlet and 
outlet ports with more uniform regions apparent at the centre. Fluid velocity gradients 
associated with depth (Figure 3-5) are evidently negligible. Taken together, these findings 
show that fluid flow within the QCM chamber is uniform near the central region, which is 
important for cell detection as this region provides the greatest signal strength.  
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Figure 3-4. Top-down view of shear stress (A) and pressure (B) on the surface of the QCM chamber 
along the z-y axis of the QCM-D chamber. Red indicates a higher value, while blue indicates a lower 
one. Not to scale. 
 
Figure 3-5. Side-views of fluid velocity in (A) and (B) inside the QCM chamber from the inlet to the 
outlet. Red indicates a higher value, while blue indicates a lower one. Not to scale. 
 
3.4.2. Surface characterisation 
The surface hydrophobicity of both clean gold (n = 3) and the dS-PEG-OH/-biotin (1%) 
treated gold sensors (n = 3), as well as the charge of the latter (n = 2) were investigated 
using contact angle measurements (mean ± SD) and BSA adsorption (Figure 3-6). Data in 
Table 3-3 show that the contact angle of gold was 85.0 ± 1.5 o, whilst that of the SAM is 
Inlet  
Outlet Outlet 
Inlet 
Inlet
 
  
Outlet 
Outlet 
Inlet
 
  
A B 
A B 
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much lower at 17.9 ± 0.8o. The frequency change for BSA adsorption on biotin-coupled 
surfaces was 2.6 – 6.4 Hz (Figure 3-7).   
Table 3-3. Contact angle and frequency shifts for cleaned gold and dS-PEG-OH/-biotin (1%) treated 
gold sensors.  
Surface Contact angle (o) Frequency shift (Hz) using 1% BSA (w/v) 
Gold 85.0 ± 1.5 N/A 
HS-PEG-OH -- HS-PEG-biotin (1 %) 17.9 ± 0.8  2.6 – 6.4 
Contact angle measurements are displayed as the mean ± SEM. N/A = not applicable. 
 
Figure 3-6. Contact angle images for (A) cleaned gold and (B) dS-PEG-OH/-biotin treated gold 
sensors.  
 
 
Figure 3-7. Frequency and dissipation vs. time for BSA adsorption onto gold-coated sensors treated 
with dS-PEG-OH/-biotin (1 %). Frequency is displayed on the blue line (left axis); dissipation is 
displayed on the red line (right axis). 
 
3.4.3. Protein binding 
Protein L and Protein A were used in replacement of a CD20 antigen to detect IgG presence 
and orientation. Data are summarised in Table 3-4 below. Protein L was shown only to elicit 
A B 
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a net change in frequency when IgG antibody was present, with a frequency change of 16.6 
– 22.3 Hz (Figure 3-8) compared to only 1.1 Hz (Figure 3-9) without IgG antibody. 
Conversely, Protein A adsorption indicated a minor increase of -3.5 Hz, which was attributed 
to background variation (Figure 3-10). 
Table 3-4. Protein L and Protein A analyte responses during QCM-D runs in the presence and 
absence of CD20 IgG antibody. 
Ligand Analyte Frequency change (Hz) 
IgG Protein L 16.6 – 22.3 
Protein A -3.5 
No IgG Protein L 1.1 
IgG is the CD20 IgG antibody. 
 
 
 
Figure 3-8. Frequency and dissipation changes vs. time for Protein L binding to CD20 IgG-based 
complex. Frequency is displayed on the blue line (left axis); dissipation is displayed on the red line 
(right axis). 
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Figure 3-9. Frequency and dissipation vs. time Protein L binding to CD20 IgG-absent complex. 
Frequency is displayed on the blue line (left axis); dissipation is displayed on the red line (right axis). 
 
 
Figure 3-10. Frequency and dissipation vs. time for Protein A binding to CD20 IgG-based complex. 
Frequency is displayed on the blue line (left axis); dissipation is displayed on the red line (right axis). 
 
Chapter 3. Biosensor development 
 
129 
 
3.4.4. Cell binding 
Cell binding studies were used with Protein A-terminated sensors for HLA-A2 or Glycophorin 
A IgG antibody immobilisation to determine affinity interactions with B-lypmphocytes (n = 2) 
and red blood cells (n = 2) respectively (Table 3-5).  B-lypmphocytes (Figure 3-11) exhibited a 
small net change in frequency following washing at 5 dynes/cm2, ranging from 2.5 – 5.7 Hz. 
Conversely, red blood cells (Figure 3-12) exerted a much larger change in frequency ranging 
from 44 – 85 Hz. No control studies without corresponding IgG antibody were performed.  
Table 3-5. Signal responses generated by cell adsorption onto IgG coupled surfaces 
Cell type Ligand surface Cell concentration (cells/mL) Frequency response (Hz) 
CCRF-HSB-2 HLA-A2 IgG 4 x 104 – 5 x 105 5.7 
5 x 104 2.5 
Red blood cells Gly A 1 x 106 44 – 85 
 
 
Figure 3-11. Frequency and dissipation vs. time for HLA-A2 B-lymphocyte cell binding to HLA-A2 IgG 
complex. Frequency = left y-axis, blue line, dissipation = right y-axis, red line. 
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Figure 3-12. Frequency and dissipation vs. time for red blood cell binding to Glycophorein A IgG 
complex. Frequency = left y-axis, blue line, dissipation = right y-axis, red line. 
3.5. Discussion 
This chapter has proposed the use of shear stress-induced affinity cell separation inside a 
QCM as a means to measure cell purity. The application of shear stress has been shown to 
differentiate between cells adsorbed with and without affinity interactions, both 
theoretically (Kuo and Lauffenburger, 1993) and practically in previous studies (Nordon et 
al., 1996 and 2007) and in Chapter 2.  
3.5.1. Surface hydrophobicity and charge 
A functional surface for IgG immobilisation was created based on published work (Nileback 
et al., 2011). Briefly, gold-coated sensors were chemically modified to create a hydrophilic 
biotin-terminated surface added monolayer (SAM). The surface was hydrophilic, although 
atmospheric contamination via adventitious carbon (identified in Section 2.5.1.), was 
probably present given the high quantities of BSA content adsorbed compared to the cited 
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study (Nileback et al., 2011), as well as the contact angle of gold, which was greater than 
that characteristic of a cleaned gold surface (Abdelsalam et al., 2005).  
3.5.2. Protein L and Protein A 
IgG binding elicited a similar response to the aforementioned protocol, where the net 
change in frequency was 28.2 ± 3.6 Hz. IgG orientation was determined using Protein L and 
Protein A as analytes, which bind exclusively to the light kappa (Nilson et al., 1993) and Fc 
region (Moks et al., 1986) of IgG antibodies respectively. In this instance, a high Protein L to 
Protein A binding ratio would suggest orientated immobilisation of the adsorbed antibody. 
Protein L binding was almost 20 times greater when IgG was present compared to binding in 
the absence of IgG antibody. A similar trend was observed using Protein A, which was also 
markedly lower than Protein L. Conceivably, these findings show that it could be possible to 
use Protein L and A in replacement of antigens to indicate IgG orientation and presence, but 
this work is limited by the lack of experimental rigour and would be confined to certain 
antibodies that have an affinity for both Protein L and Protein A interactions.  
3.5.3. Cell adsorption 
B-lymphocytes and red blood cells were investigated for affinity interactions. Since no 
control study could be performed (i.e. antibody-free or using cells negative for the target 
antigen), it is not possible to determine whether cells were adherent with or without affinity 
interactions. Surfaces exposed to cells showed a net change in frequency following 
incubation and washing at 5 dynes/cm2, consistent with the deposition of mass onto the 
sensor surface. B-lymphocytes exhibited a lower net change in frequency than red blood 
cells, which was attributed to the lower concentration of B-lymphocytes used (0.5 – 5 x 105 
cells/mL), which was below concentrations (>3 x 106 cells/mL) typically used in previous 
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studies (Nordon et al., 1996, Slowiaczek, 1998, Nordon et al., 2004). Cell shape was also 
attributed to differences in signalling strength; Chapter 2 revealed that blood-bourne B-
lymphocytes underwent no visible deformation over the incubation period, unlike that of 
most adherent cells, which flatten shortly after surface adsorption (Pierres et al., 2003). 
Conversely red blood cells are thin and flat, meaning that a higher proportion of the 
cytoplasm and nucleus is within range of the shear wave and were therefore able to 
generate a stronger signal.  
3.5.4. Quantifying adherent cells 
QCM methods for quantifying adsorbed material utilise density (Sauerbrey, 1959) and 
viscoelastic properties (Voinova et al., 2002). The application of such methods to quantify 
adsorbed cells is not considered feasible, owing to the complex structure of the cell, its 
dynamic nature (Kasza et al., 2007) and the fact that only a fraction of the cell would be in 
contact with the surface. Therefore, direct calibration to correlate changes in frequency 
with an adsorbed cell density (Redepenning et al., 1993), is deemed more appropriate. 
Correlating the number of adsorbed cells with frequency output will permit cell purity to be 
inferred using the same approach detailed in Section 2.5.12. This will allow shear stress to 
be used to differentiate between cells adherent with and without affinity interactions 
(Figure 3-13). 
Chapter 3. Biosensor development 
 
133 
 
 
Figure 3-13. Output signal generated by difference in cell detachment. For a given number of 
adsorbed cells on the QCM sensor surface, determined through a correlation with the change in 
frequency, the purity may be determined using the approach developed in Chapter 2 (Section 
2.5.11).  
 
The following section assumes that two cell types are present; one positive for a specific 
antigen with an affinity for immobilised antibody and the other negative. These may 
represent a suspension of SSEA-4 antigen-negative product cells containing impure 
undifferentiated pluripotent cells negative for the SSEA-4 antigen. Therefore, for a given 
number of cells adsorbed on the sensor surface, the recorded change frequency (ΔF) 
relative to the baseline signal is given as: 
∆F0 → FT = NT 3.3  
 
, where FT = the frequency for a population of adsorbed cells (Hz); NT = the number of cells 
adsorbed on the sensor surface. By introducing a range of different cell numbers onto the 
sensor surface to quantify with microscope-based cell counting procedures, the change in 
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frequency per cell may be deduced from the following equation based on a linear plot of 
frequency versus cell number: 
𝐹𝐹𝑇𝑇 = 𝐴𝐴𝑇𝑇 .𝑁𝑁𝑇𝑇 3.4 
 
, where AT = the slope (Hz/cells). This allows the number of adsorbed cells to be estimated 
from the change in frequency without manual quantification. Chapter 2 proposed that 
based on the shear stress-induced detachment data of cells with and without affinity 
interactions, it is possible to correlate the number of adherent cells on a surface with their 
respective inlet purities. To determine the purity of cells adsorbed onto the sensor surface, 
the number of cells must be correlated with the resultant frequency change. The change in 
frequency for cells adsorbed onto the surface without washing (FTo) (Hz) may be given by: 
𝐹𝐹𝑇𝑇0 = 𝐹𝐹𝑇𝑇,𝑡𝑡0 − 𝐹𝐹𝑜𝑜 3.5 
 
 
, where Fo = the baseline frequency prior to cell addition (Hz); FT,to = the change in frequency 
following the adsorption of cells on the surface, prior to washing (Hz); n = the shear stress 
applied (dynes/cm2). Following washing at a critical shear stress able to differentiate 
between cells adherent with and without affinity interactions (e.g. 1 – 25 dynes/cm2), the 
change in frequency for the total number of cells remaining on the surface (FTn) (Hz) is given 
by: 
𝐹𝐹𝑇𝑇𝑛𝑛 = 𝐹𝐹𝑇𝑇,𝑚𝑚 − 𝐹𝐹𝑜𝑜 
 
3.6 
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, where FT,n = the change in frequency after washing at a given shear stress (e.g. 25 
dynes/cm2) (Hz). An example of the cell adsorption and detachment output signal that 
would be generated in response to shear stress is presented in Figure 3-14.  
 
Figure 3-14. Example frequency vs. time plot. The graph plots a baseline signal (Fo) the static 
adsorption of cells onto a surface (Fto) and the subsequent detachment of cells (Ft) in response to 
shear stress. The net change in frequency (Ft - Fo) indicates the number of cells remaining on the 
surface. 
 
The number of cells on the surface at any given point may be determined from by re-
arranging Equation 3.4, generated from experimental data, to convert frequency into cell 
number: 
𝐹𝐹𝑇𝑇,𝑚𝑚
𝐴𝐴𝑇𝑇
= 𝑁𝑁𝑇𝑇,𝑚𝑚 
 
3.7 
 
, where NT,n = the total number of cells on the surface following washing at a given shear 
stress (cells).  
The purity of target cells (e.g. CD20+ cells) on the surface following washing at a given shear 
stress (SPC,n) may be given by utilising the approach devised in Chapter 2 to convert the 
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number of cells on the surface post-washing at a given shear stress into purity prior to 
washing (SPC,n0): 
𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚0 = 𝑆𝑆𝑅𝑅C,n.𝑁𝑁T,n𝑅𝑅𝑅𝑅𝐶𝐶,𝑚𝑚.𝑁𝑁𝑇𝑇,𝑚𝑚0 
 
2.17  
 
, where RTC,n = fraction of CD20+ cells originally adsorbed on the surface retained at a given 
shear stress (-) (a constant determined through experimental observation); NC,n = the 
number of CD20 cells on the surface following washing at a given shear stress (cells); NT,no = 
the total number of cells on the surface prior to washing (cells); SPC,n = the purity of CD20+ 
cells on the surface after washing at a given shear stress. The purity of cells on the surface 
prior to washing would equate to the purity of the cells that would be injected into the 
device.  
3.5.5. System feasibility 
The QCM has many applications as a biosensor, but the purpose here would be to measure 
the level of impure SSEA-4 antigen-positive cells during a multi-day differentiation process 
(Figure 3-15) (Chen et al., 2014) to indicate the efficiency of the differentiation process. The 
feasibility of the QCM for this purpose would depend upon its practical operation and 
several quantitiative constraints that would need to be identified, as detailed below. 
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Figue 3-15. Sampling process for pluripotent cell differentiation towards a cardiomyocyte lineage. 
Undifferentiated pluripotent cells undergoing the transition to a differentiated state cease SSEA-4 
antigen expression and this process can be measured as a function of time.  
 
3.5.5.1. Operation 
A proposed sampling and measurement protocol that is potentially faster than flow 
cytometry is presented in Table 3-6 below. The estimated time to measure a specific sample 
would range from 50 – 75 minutes for IgG-Protein A (utilised in this thesis) and 25 – 50 
minutes if the IgG antibody is immobilised to the surface prior. Conversely, flow cytometry 
sample preparation typically ranges from 35 – 50 minutes. 
Table 3-6.  Protocol proposed for the detection of cells using the QCM biosensor 
Task Description Time 
(minutes) 
Sampling Extraction of cell suspension from a bioreactor  2 
Counting Determination of cell number based on manual or automatic cell counting 5 
Centrifugation Centrifugation (1,200 rpm) to remove waste components 5 
Re-suspension Aspiration of waste supernatant and addition of a known volume of 
processing buffer (1 % BSA in PBS) to attain desired concentration 
3 
IgG incubationa Addition of IgG antibody to cell suspension and subsequent incubation for a 
set period 
15 
Centrifugationa Centrifugation (1,200 rpm) to remove waste components 5 
Re-suspensiona Aspiration of waste supernatant and addition of a known volume of 
processing buffer (1 % BSA in PBS) to attain desired concentration 
3 
Sample injection Injection of cell sample into biosensor unit 2 
Sample 
incubation 
Incubation of cells with ligands to promote binding and measurement 5 – 30 
Washing Application of shear stress deemed to be sufficient to differentiate between 
impure (undifferentiated pluripotent) cells and product (differentiated cells).  
3 
Output  Determination of net amount of cells on surface and subsequent purity 1 
a only required if using Protein –coupled substrates where cell suspension is incubated with IgG prior to addition; b to be 
determined experimentally, depends on ligand choice and binding kinetics.  
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3.5.5.2. Performance criteria  
In spite of the lack of cell-related studies, performance constraints can be inferred from 
some of these basic studies to determine the feasibility of this system for the detection of 
target cells. These performance constraints are detailed below and presented in Table 3-7.  
Limit of Blank (LoB) 
The Limit of Blank (LoB) can be used to determine the Limit of Detection (LoD) and the Limit 
of Quantitation (LoQ). The LoB may be estimated from the mean difference in frequency of 
a blank solution and an IgG-coupled sensor. The mean difference (mean +/- SD) was 
calculated to be 0.77 +/- 0.28 Hz (n = 8), equating to an LoB of 1.23 Hz.  
Limit of Detection (LoD) 
The LoD was estimated from two samples due to the limited amount of data available using 
a low-density sample (5 x 104 cells/mL x 40 µL chamber volume =~ 2,000 cells. The mean 
change following the deposition of cells was estimated to be 1.25 +/- 0.45 Hz (mean +/- SD) 
(n = 2), leading to an LoD of 1.97 Hz, approximating to ~ 2 Hz.  
Limit of Quantitation (LoQ) 
Previously, the change in frequency for a given sample was estimate to be 4 x 10-4 Hz per 
cell (Redepenning et al., 1993), meaning that the LoQ would equate to ~ 5,000 cells on the 
surface.  
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Table 3-7. Performance-related parameters for the QCM biosensor.  
Parameter Equation Value (Hz) Comment 
LoB  𝑳𝑳𝑳𝑳𝑳𝑳 =  𝒎𝒎𝒎𝒎𝒎𝒎𝒎𝒎𝒃𝒃𝒃𝒃𝒎𝒎𝒎𝒎𝒃𝒃 + 𝟏𝟏.𝟔𝟔𝟔𝟔𝟔𝟔(𝑺𝑺𝑺𝑺𝒃𝒃𝒃𝒃𝒎𝒎𝒎𝒎𝒃𝒃) 
 
0.77 +/- 0.28 Based upon unchallenged IgG-coupled 
sensors in buffer solution. 
 
LoD  𝑳𝑳𝑳𝑳𝑺𝑺 = 𝑳𝑳𝑳𝑳𝑳𝑳 + 𝟏𝟏.𝟔𝟔𝟔𝟔𝟔𝟔(𝑺𝑺𝑺𝑺𝒃𝒃𝑳𝑳𝒍𝒍 𝒅𝒅𝒎𝒎𝒎𝒎𝒅𝒅𝒅𝒅𝒅𝒅𝒅𝒅 𝒅𝒅𝒎𝒎𝒎𝒎𝒔𝒔𝒃𝒃𝒎𝒎) 1.97 Two studies from experiments 
involving HLA-A2+ cells loaded at a 
concentration of 5 x 104 cells/mL 
 
LoQ 𝑳𝑳𝑳𝑳𝑺𝑺 = 𝑳𝑳𝑳𝑳𝑳𝑳 + 𝟏𝟏.𝟔𝟔𝟔𝟔𝟔𝟔(𝑺𝑺𝑺𝑺𝒃𝒃𝑳𝑳𝒍𝒍 𝒅𝒅𝒎𝒎𝒎𝒎𝒅𝒅𝒅𝒅𝒅𝒅𝒅𝒅 𝒅𝒅𝒎𝒎𝒎𝒎𝒔𝒔𝒃𝒃𝒎𝒎) 2.00 In excess of the LoD. Would equate to 
5,000 cells deposited on the sensor 
surface.  
LoB = limit of blank; LoD = limit of detection; LoQ = limit of quantitation. 
Minimum measurable purity for 4 % cell density 
For a 4 % cell density prior to shear stress, the minimum measurable purity can be determined by 
first applying Equation 2.14 to determine SPC,n, the surface purity of target cells after shear stress 
exposure, for an NT,n , the total number of cells after shear stress exposure,  of 5,000 cells (the LoQ), 
equating to 26.6 % CD20+ cell purity (SPC,n) after washing at 25 dynes/cm2.  
By then using Equation 2.16 with a 4 % cell surface density (equating to 42,091 cells) and assuming 
that 84 % of the CD20+ cells remain adherent (RTC,n) based on prior experimentation using individual 
cell subpopulations (as illustrated in Chapter 2), Equation 2.17 can then be applied to determine 
SPC,n0, the purity of target cells on the surface prior to shear stress exposure and therefore the 
sample purity. When the LoQ is 5,000 cells, this would yield a 3.8 % CD20+ cell purity as a minimum 
quantifiable purity. As such, the minimum target cell purity for a 5,000 cell limit must be ≥ 4 %.  
These estimates are extracted from the model developed in Chapter 2. In practice, significant 
variation across repeats is expected, which will limit the reliability of the data. The coefficient of 
variance for cells after washing is high, being up to 80 % HLA-A2+ (non-target) cells. In the 
QCM system, this would be reduced since the entire sensor surface would be utilised, 
instead of six-gated regions inside the flow tubes. 
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3.5.5.3. Challenges facing biosensor development 
Whislt generic constraints have been described to account for instrument reliability, several 
limitations which cannot be addressed theoretically are presented in Table 3-8, along with 
potential solutions.  
Table 3-8. Limitations and potential solutions for the QCM biosensor.  
Problem Description Solution  
Cell 
deformation 
The cell will deform as a function of 
incubation time (Cuvelier et al., 2007, Gallant 
et al., 2005) and shear stress (Bose, 2009, 
Nordon et al., 2004), meaning that the signal 
will change irrespective of cell desorption.  
Account for the change in signal strength at 
a given time and shear stress by using a 
converstion factor to measure cell 
deformation as a function of time and shear 
stress. The latter may be more complex.  
Cell density Pluripotent cells have a much higher 
cytoplasm-to-cell content ratio than more 
mature cell types (Thomson et al., 1998), so 
the measured frequency would be higher per 
pluripotent cell than per differentiated cell.  
Account for cell density in models using a 
conversion factor based on the proportion 
of cells retained after washing at a given 
shear stress.  
Non-specific 
cell 
adherence 
The fraction of cells retained without affinity 
interactions was estimated to be ~ 5 % at 25 
dynes/cm2 (it was ~5 % at  5 dynes/cm2 
elsewhere (Nordon et al., 1996, Slowiaczek, 
1998)), meaning that more impure cells would 
be removed, reducing the biosensor 
resolution. 
Since differentiated cells upregulate certain 
extracellular antigens exclusive to their 
state, tagging the antigens of these cells 
with antibodies conjugated to hydrophilic 
PEG could reduce the adhesion of product 
cells, mitigate non-specific adherence 
further. Similar methods have been 
demonstrated for the inhibition of E-
selectin-mediated cell adhesion (DeFrees et 
al., 1996). 
System signal 
strength 
An approximate 5 Hz change in frequency per 
1 % cell coverage (equivalent to 12,500 cells) 
was reported (Redepenning et al., 1993). This 
would equate to 4 x 10-4 Hz per cell. In reality, 
a single cell could not be detected, owing to 
background noise and a lack of precision, but 
larger net changes (>0.5 Hz = ~ 1,250 cells) 
could indicate trends occurring within the 
system over a period of time. However, such 
measurements could not distinguish between 
minor changes in cell purity (e.g. from 99.9 to 
99.9999 % purity) 
Maximise the density of cells per unit 
surface area of sensor surface. According to 
the Sauerbrey equation (Sauerbrey, 1959), 
increasing the resonance frequency will 
magnify the output frequency signal 
(Uttenthaler et al., 2001). However, 
background noise (e.g. cell debris, proteins, 
etc.) would need to be minimised to ensure 
the highest signal-to-noise ratio.  
 
 
 
Debris The models assume that only two 
components exist: the cells and the buffer 
solution. In reality, other contaminent species 
may be present, namely cell debris (e.g. 
membrane segments, DNA, etc.). Such 
components, although smaller, are more 
dense and may generate a signal several 
orders of magnitude per single protein than 
per cell. 
Subject the cell suspension to filtration and 
low-speed centrifugation procedures and 
confirm using a blank solution.  
Antigen 
down-
regulation 
Models assumed that SSEA-4 antigen 
expression was binary. In reality it is transient, 
where cells gradually down-regulate the SSEA-
Identify a threshold based on shear stress 
studies to differentiate between cells with 
low levels of SSEA-4 antigen expression.  
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4 antigen over a period of time during the 
differentiation process. This would lead to a 
change in the number of cells positive for the 
antigen adherent at a given shear stress, 
compromising system accuracy.  
 
Whilst it is possible to detect changes in the density of surface-adherent cells the signal 
strength is very low (4 x 10-4 Hz/cell (Redepenning et al., 1993)) meaning that changes under 
0.3 Hz would be hard to distinguish from background noise, so reliably detecting smaller 
changes in purity (e.g. from 99.9 to 99.99 %) may not be possible.  
Ease of use is also a concern, given that extensive, albeit simple, preparation is required to 
prepare cell samples for measurement versus the flow cytometry benchmark, the procedure 
is similar and feedback is not immediate yet may compromise the reliability of measured 
data, questioning its use as a viable alternative. 
Further, the mode of detachment is inherently reliant on pluripotent cell SSEA-4 antigen 
expression, which is typically representative for only 95 % of cells (Shibata et al., 2006). 
Methods such as RAMAN and FTIR may be more viable alternatives, relying upon the 
measurement of intracellular components  (e.g. nucleic acid, collagen, phsopholipids, etc.) 
that direct cell fate (Chan et al., 2010), rather than antigenic markers which are associated 
with the state of a cell, but not necessarily representative of it (Fong et al., 2009). 
3.6. Conclusion 
This chapter has documented exploratory work into the QCM system as an affinity 
biosensor for impure cell detection. The specific purpose is to detect cells which have 
retained their pluripotent status (based on SSEA-4 antigen expression), through an affinity 
interaction with an SSEA-4 antibody-coated surface. Such information could be used to 
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improve a differentiation process during the development of a cell therapy product, offering 
a cheaper, easier to use alternative to flow cytometry. Preliminary data has been produced 
with cells using affinity-interactive surfaces, partially validated using Protein L and A 
analytes. It is thought that by replicating the same method of cell separation detailed in 
Chapter 2 (shear stress-induced affinity separation) and correlating frequency change with 
cell density, the net change in cells on the surface could be used to deduce the purity of a 
certain population of cells in a sample.  
The results at this stage are far from conclusive. It is not clear what the QCM resolution is or 
how reliable it would be to operate practically for cell detection. Of the two cell types tested 
(B-lymphocytes and red blood cells), large differences were observed in measured 
frequencies and were attributed to (1) concentration differences and (2) cell shape; flatter, 
thinner red blood cells elicited a greater response in frequency than spherical B-
lymphocytes. However, confirmation that cell-surface affinity interactions occurred was not 
possible, since no control studies could be performed.  
The QCM system is not proposed as a universal biosensor, rather, one which is highly 
customised to a pluripotent cell line undergoing extensive testing for differentiation 
towards a specific lineage. Whilst theoretically feasible, it may not possess the resolution, 
ease of use or reliability to be considered a quality control (QC) instrument for a cell therapy 
manufacturing process, but rather, may be considered a routine lab tool. 
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Chapter 4. Affinity membrane development 
4.1. Introduction 
Chapter 2 presented a small-scale model to identify differences in cell adhesion strength 
using shear stress. Cells without affinity interactions proved to be more susceptible to 
detachment than cells with affinity interactions, consistent with theoretical (Bell, 1978, Bell 
et al., 1984) and practical (Kuo and Lauffenburger, 1993, Nordon, 1994) observations.  
To replicate this concept for the separation of cell populations, a suitable device must be 
selected. Several formats derived from bioprocessing permit affinity separations in flow 
through modes (Ghosh, 2002; Moser and Hage, 2010). Beads for instance, have a surface 
area-to-volume ratio as high as 100 m2/g of matrix (Bhattacharyya et al., 1996) and possible 
IgG adsorption densities of 55 – 70 g/L of resin (Coleman et al., 1990, Johansson, 1997, Hahn 
et al., 2005). However, the porous geometry of the beads, which promotes diffusion rather 
than convection-driven transport, is largely inaccessible to cells and would be inefficient for 
separation. Conversely, affinity membranes have lower surface areas (2-20 m2/g) (Ulbricht 
et al., 2009) and lower ligand adsorption capacities (10 – 30 g/L of membrane volume) 
(Colton, 1996, Jia et al., 1999), but are more suited to cell separation because of their ability 
to transport cells via convection processes and apply uniform shear stresses tangentially 
(Slowiaczek, 1998). 
Several membrane formats exhibit favourable geometry for cell separation, centring around 
flat sheet and hollow fibre membranes. Such membranes comprise chemically and 
mechanically stable polymers, such as polyethersulfone, nylon and methacrylate (Ghosh, 
2002).  Chemical functionalities present on these membranes enable covalent ligand 
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adsorption for protein (Hermanson, 1992, Castilho et al., 2000, Hahn et al., 2003) and cell 
separation (Nordon, 1994, Colton, 1996, Slowiaczek, 1998) through affinity interactions. 
Flat-sheet and hollow fibre membranes are particularly desirable because uniform shear 
stresses can be applied  tangentially across the surface enabling similar conditions observed 
in Chapter 2 to be applied.  
Chapter aims and objectives: 
• Construct, chemically modify and characterise hollow fibre membranes. 
• Characterise the hydraulic conditions inside both hollow fibre and flat sheet 
membranes 
• Determine rPrA and IgG antibody adsorption capacities for both hollow fibre and flat 
sheet membranes and their adsorption capacity for IgG molecules 
4.2. Materials and methods 
This section concerns the development and characterisation of hollow fibre membrane 
modules constructed from Nephral ST200 dialysis cartridges (Gambro Lundia AB, Lund, 
Sweden) and a flat sheet microfiltration membrane cassette kindly supplied through Peter 
Levison (Pall Life Sciences, Uk) (Table 4-1). The purpose was to implement the same method 
developed for immunoaffinity cell separation in Chapter 2 using the affinity interaction 
created between immobilised rPrA and IgG-tagged cells, but to separate mixed cell 
populations CD20+ cells and HLA-A2+ cells) in scalable membrane units in Chapter 5.  
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Table 4-1. Comparison of hollow fibre and flat sheet microfiltration membranes 
Membrane 
type 
Physical properties Chemical composition 
Hollow fibre 
dialysis 
Average pore size: < 1 um; 
length: 22 cm; wall thickness 42 
um; outer diameter: 210 um; 
membrane volume per length: 
1.25 mL/cm 
Fibres are comprised of an acrylonitrile and sodium 
methallyl sulfonate copolymer treated with 
polyethyleneimine (PEI) (Figure 4-1 A). Amine terminal 
groups allow aldehyde functionalization with bi-
functional aldehyde molecules via Schiff base 
formation.  
Flat sheet 
microfiltration 
Membrane type: flat sheet 
microfiltration; average pore 
size: 0.45 um 
Sheets are made of polyethersulfone (PES) (Figure 4-1 
B) and have been modified using  proprietary 
techniques to create aldehyde functionality 
Specifications were extracted from commercially available data. 
 
NH
NH2H
n                           
S
O
O
 O 
n
 
Figure 4-1. Basic chemical structures of (A) polyethyleneimine (PEI) (linear chain) and (B) 
polyethersulfone (PES).  
 
4.2.1. Chemical modification 
Since the Pall polyethersulfone (PES) membranes already have aldehyde functionalities, this 
section is devoted to the aldehyde functionalization of polyethylenimine (PEI) hollow fibres.  
4.2.1.1. Hollow fibre aldehyde functionalisation  
Nephral ST200 hollow fibre membrane dialysis cartridges were purchased from Gambro 
Lundia AB (Lund, Sweden). Cartridges were positioned vertically in a fume cabinet using a 
stand and clamp. A 2.5 % (v/v) solution of glutaraldehyde (Fischer Scientific, Loughborough, 
UK) in 0.1 M sodium phosphate buffer with 0.15 M NaCl (PBS) containing 0.075 M sodium 
cyanoborohydride (Sigma-Aldrich, Munich, Germany) (pH 7) was prepared. Each solution 
was then systematically alternated across both the shell and lumen side of the cartridge at 
100 mL/min using Tygon tubing (Cole-Parmer, London, UK) and a peristaltic pump (Watson-
Marlow, Falmouth, UK) for 4 hours. Excess glutaraldehyde solution was drained and 
(A) (B) 
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cartridges were rinsed at 10 minute intervals using de-ionised water, 50 % (v/v) methanol 
(Sigma-Aldrich, Munich, Germany) and de-ionised water for 1 hour. Cartridges were then 
stored at 4 oC in 20 % ethanol. Fibres were then extracted for characterisation or further 
modification by cutting the cartridge open with a saw.  
4.2.2. Chemical assays 
4.2.2.1. TNBS 
The TNBS assay (detailed in Chapter 2 section 2.4.3) was prepared to qualitatively measure 
the change in amine functional groups before and after glutaraldehyde treatment through 
colour changes. Untreated and glutaldehyde-treated fibres were cut into 10 x 5 cm 
segments and soaked in TNBS solution for 15 minutes. Fibres were then rinsed three times 
successively in de-ionised water, 50 % methanol, 100 % methanol and de-ionised water and 
then blotted with absorbent paper. Photographic images of fibres were then recorded 
immediately.  
4.2.2.2. Silver mirror test 
Tollen’s reagent (Fieser, 1987) was used to measure aldehyde functionalities on untreated 
PEI and glutaraldehyde-treated PEI membranes. Prior to conducting the reaction, the same 
procedure for solution preparation from Section 2.4.4. was implemented. Both untreated 
and glutaraldehyde-treated fibres were then soaked in this solution in a water bath at 37 oC 
for 15 minutes. Fibres were then removed with tweezers and rinsed three times in de-
ionised water prior to imaging. 
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4.2.2.3. Fourier Transform Infra-Red (FTIR) spectroscopy 
Dried fibres were mixed with potassium bromide and compressed under a 10-tonne force to 
form a disc. Fourier Transform Infra-Red (FTIR) analysis was performed using a Nicolet 380 
instrument at The University of Birmingham. The discs of both unmodified and modified 
fibres were analysed using Intuitive EZ-OMNICTM software (Thermo Electron Corporation, 
Loughborough, UK).  
4.2.2.4. BCA assay for aldehyde coating efficiency 
Approximately 10 cm of glutaraldehyde-treated and untreated polyethyleneimine hollow 
fibres were soaked in liquid nitrogen then cut into < 1 mm sections using a scalpel. Fibres 
were then incubated in 0.225 mL of working reagent with 0.025 mL of deionised water for 
30 minutes at 37 oC. (No calibration chart was generated since the purpose was to 
determine the net change in absorbance generated by the reaction of primary and 
secondary amines with BCA reagent.) Following incubation, 0.225 mL of supernatant was 
removed and absorbance was quantified in a Falcon black-walled 96 well plate using an 
Omega POLARstar plate reader (BMG Labtech, Bucks, UK) at 562 nm. The baseline 
absorbance was subtracted from recovered data. The net change in absorbance was then 
correlated with fibre length and used to indicate the coating efficiency of glutaraldehyde 
treatment.   
4.2.3. Physical characterisation 
The morphological and structural characterisation of both hollow fibre and flat sheet 
membranes was performed using a range of different techniques.  
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4.2.3.1. Atomic Force Microscopy 
Atomic force microscopy was performed on both flat sheet and hollow fibre membranes. In 
all cases, the average roughness (Ra) and root mean square roughness (Rrms) were measured 
across dimensions of 20 x 20 um from duplicate samples. 
4.2.3.2. Environmental scanning electron microscopy (ESEM) 
Environmental scanning electron microscopy (ESEM) was performed on aldehyde-
functionalised hollow fibre membranes only, owing to their tendency to dehydrate and 
disintegrate rapidly under atmospheric conditions. Fibres were stored in de-ionised water 
prior to use and then studied at 10 kV using an XL30 (FEI-Philips, Oregon, USA) in a 
saturated water vapour environment. 
4.2.3.3. Field emission scanning electron microscopy (FESEM) 
The structural stability of the PES membrane meant that Field Emission Gun Scanning 
Electron Microscopy (FEGSEM) could be performed. Prior to analysis, PES segments (1 x 1 
cm) were sputter coated with gold. PES discs were then observed using a LEO 1530VP field 
emission scanning electron microscope, operating at 5 kV and 30 pA at Nottingham 
University.  
Image analysis 
The available surface area of the PES membrane electron microscope images were 
examined using NIOS-Element AR software (Nikon, Tokyo, Japan). Membrane pores were 
identified and quantified in MCH-mode. Absorbance channels were adjusted to differentiate 
between the top surface (red) and pores (green) as illustrated in Figure 4-2.    
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Figure 4-2. SEM porosity image analysis of (A) raw PES membrane, (B) green-inverted version and (C) 
red-/green-inverted to quantify porosity.  
 
4.2.3.4. BET surface area 
Brunauer-Emmett-Teller (BET) surface area measurements were performed on a 
Micromeritics ASAP2010 device (Hexton, UK) to determine the membrane surface area per 
unit volume of membrane. Weighed samples were degassed initially at 90 oC for 2,000 
minutes and then at 140 oC for 600 minutes under a vacuum of < 10 umHg. The sample was 
cooled to 77 K and nitrogen was administered to the sample in controlled increments. After 
each dose of adsorptive, the pressure was allowed to equilibrate and the quantity of gas 
was used to indicate the available surface area of the membrane.  
This measurement was only performed for the PES membranes as the hollow fibres were 
too fragile. Separate calculations were performed to determine the surface area of the 
hollow fibres.   
4.2.4. Membrane sample preparation 
Different hollow fibre and flat sheet membrane formats were generated for each 
experiment and the details are provided below.  
4.2.4.1. Hollow fibres 
Hollow fibres required preparation for each application, due to instability and difficulties in 
ensuring adequate liquid contact with the fibre lumen. These are detailed systematically for 
chemical modification followed by protein adsorption and cell separation purposes.  
A B C 
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Static protein adsorption  
rPrA and BSA protein adsorption studies required static conditions. Aldehyde-functionalised 
fibres were extracted from the cartridges and the length was measured for each batch 
before soaking in liquid nitrogen (< 10 seconds). Fibres were then immediately shredded 
with a scalpel. To avoid dehydration, shredded fibres were soaked in PBS until further use.  
Fibre module preparation 
Two different types of custom-made hollow fibre modules were created (Figure 4-3) to: (1) 
quantify IgG adsorption capacities and (2) conduct immunoaffinity cell separation (Chapter 
4). 
 
Figure 4-3. Schematic diagrams of constructed hollow fibre modules. Aldehyde-functionalised fibres 
(75 x 10 cm) were glued into tubing using resin. Two types of hollow fibre modules were utilised, 
which included the Type 1 module, where the fibres were sealed at the inlet for IgG adsorption 
capacity studies; and Type 2, fibres, which were sealed at the inlet and outlet and the shell was 
positioned only for cell separation studies. The numbers are represented by: (1) = aldehyde-
functionalised hollow fibres; (2) resin glue; (3) tubing outer-module tubing; (4) inner-module tubing; 
and (5) module shell.  
 
IgG protein adsorption modules (Type 1) 
The fragility of shredded hollow fibres meant that a flow-through model was constructed to 
estimate IgG adsorption capacities. Here, 75 glutaldehyde-treated fibres were inserted into 
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5 cm of tygon tubing at a designated inlet. Fibres were then sealed into place by injecting 
EF80 epoxy resin (Easy Composites Ltd, Stoke-on-Trent, UK) using a plastipipette and the 
mixture was allowed to set for 2 hours.  During this period the fibres, which dehydrate 
rapidly under atmospheric conditions, were sprayed with de-ionised water and kept moist 
by wrapping with foil. Once set, the tygon tubing inlet was cut with a scalpel to 3 cm and 
fibres were trimmed at the outlet to create a total module length of 10 cm. These were 
designated Type 1 modules (Figure 4-3). rPrA and BSA, as well as IgG adsorption procedures 
are detailed in Section 4.2.6. 
Cell separation modules (Type 2) 
For cell separation studies, the same method used to create Type 1 modules was used for 
module construction, except that a tygon tubing outlet port was also included. These were 
designated Type 2 fibre modules (Figure 4-3) and were stored in 20 % ethanol at 4 oC until 
use.  Prior to rPrA adsorption and blocking with BSA (Section 4.2.6.1), modules were 
integrity tested and assessed for variability (section 4.5.2). Further modification involving 
rPrA and BSA adsorption and the positioning of a shell across Type 2 modules for cell 
separation is detailed (Chapter 5, Section 5.2.2.2).  
4.2.4.2. Flat sheet microfiltration membrane 
Static incubation studies 
For rPrA, BSA and IgG adsorption capacities (protocols detailed in Section 4.2.6.2), discs 
(diameter: 0.6 cm2; surface area: 0.283 cm2) were created using a hole punch from 
aldehyde-functionalised flat sheet polyethersulfone (PES) microfiltration membrane 
supplied via Peter Levison at Pall Life Sciences (Portsmouth, UK).  
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4.2.5. Hydraulic studies 
Pressure losses and hydraulic permeabilities were measured for both hollow fibre and flat 
sheet membrane units. A generic process schematic is provided in Figure 4-4. The purpose 
was to study the pressure drop for each unit as a function of the same shear stress (0 – 25 
dynes/cm2) to be used in cell separation studies, as well as the hydraulic permeability of 
each membrane material.  
 
Figure 4-4. Representative schematic of process setup for TFF cassette and the HFM cartridge 
characterisation. Numbers are listed as: 1 = storage vessel with de-ionised water; 2 = pump (syringe 
pump for hollow fibre modules or a peristaltic pump for the microfiltration cassette); 3 = pressure 
sensor; 4 = membrane (hollow fibre or microfiltration); 5 = filtrate outlet (feed-side, microfiltration 
cassette only); 6 = filtrate outlet (outlet side, microfiltration cassette only); 7 = outlet.  
 
For hollow fibres, the pressure drop of both the constructed Type 2 modules and the 
original Nephral ST200 cartridge were used owing to the absence of filtrate ports. The latter 
was only used for hydraulic permeability studies. For flat sheet membranes, a proprietary 
cassette containing the aldehyde-functionalised PES membrane was utilised in both 
pressure drop and hydraulic permeability studies. 
4.2.5.1. Pressure loss 
To determine the pressure loss, de-ionised water was pumped through each unit using an 
Alaris IVAC P7000 syringe pump (CareFusion, St Albans, UK) for fibre modules and a 
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peristaltic pump (Watson Marlow, Falmouth, UK) for the aldehyde-functionalised fibre 
cartridge and flat sheet membrane cassette. In each instance, the filtrate ports were closed, 
such that only the inlet and outlet were open, with the outlet being open to atmosphere. 
Pressure drop was measured using a Druck DPI 705 sensor (Cuthbertson Laird Group, Leeds, 
UK) as a function of shear stress applied sequentially for 3 minute intervals over 1, 5, 10 and 
25 dynes/cm2 for the hollow fibre membrane units and 1, 5 and 10 dynes/cm2 for the flat 
sheet membrane cassette. The latter was restricted to a flowrate equivalent to 5 dynes/cm2 
to avoid damaging the membrane. Each flowrate was maintained for 30 seconds before 
extracting a reading.  
4.2.5.2. Hydraulic permeability  
Hydraulic permeability was determined across a range of 0 – 50 LMH for the aldehyde-
functionalised Nephral ST200 cartridges and the Pall flat sheet membrane cassette. Device 
details were provided in Table 4-1. Prior to use membrane units were equilibrated with de-
ionised water to remove air pockets. The inlet-side filtrate port and the outlet of each unit 
was closed, prior to the addition of de-ionised water.  
4.2.6. Protein adsorption 
The following section details rPrA and BSA adsorption onto both aldehyde-functionalised 
hollow fibre and flat sheet membrane surfaces.  
4.2.6.1. Hollow fibre membrane 
 Static protein adsorption 
rPrA and BSA adsorption capacities of aldehyde-functionalised fibres were performed under 
static conditions using segmented fibres (described in Section 4.2.4.1). Fibres were 
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incubated with recombinant Protein A (rPrA) (Prospec Bio, East Brunswick, USA) at a 
concentration of 1 mg/mL in 0.1 M sodium phosphate with 0.15 M sodium chloride (PBS) at 
pH 7 on an EW-51300 orbital shaker (Cole-Parmer, London, UK) for 4 hours. Fibres were 
then washed in PBS, 1 M NaCl and de-ionised water and then blotted with absorbent paper 
to remove excess moisture. The same procedure was performed using 1 % (v/v) BSA in PBS 
for 2 hours on both uncoupled and rPrA-coupled aldehyde-functionalised fibres to block 
charged sites. Protein densities were then determined according to the BCA assay (Section 
4.2.2.4.), where fibres were incubated with 1.9 mL of working reagent and 0.1 mL of de-
ionised water at 37 oC for 30 minutes. Samples were then centrifuged at 2,000 rpm in an 
Eppendorf 5416 centrifuge (Eppendorf UK, Stevenage, UK) to remove debris from the 
supernatant and transferred to a plastic cuvette (Fischer Scientific, UK). Sample absorbance 
was measured using a Shimadzu UV spectrophotometer (Shimadzu, Tokyo, Japan) at 562 
nm. Protein content was determined using 0.1 mL stock solutions of known concentrations 
mixed with 1.9 mL of working reagent.  
 Flow-through protein adsorption 
rPrA and BSA adsorption 
To determine the IgG adsorption capacity of rPrA-coupled fibres, rPrA and BSA were 
adsorbed inside Type 1 modules. Modules were connected to two 3-way valves and a 1 mL 
micropipette using tygon tubing (Cole-Parmer, London, UK). Modules were then clamped 
into a vertical position suspended above a 2 mL eppendorf using a stand and clamp. A 1 
mg/mL of rPrA solution in PBS was incubated for 4 hours and recycled every 30 minutes. 
During this period, modules were wrapped in foil to prevent dehydration and positioned 
horizontally to minimise fluid loss. Then, a 0.075 M solution of sodium cyanoborohydride in 
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PBS at pH 7 was injected into the column and incubated for 1 hour and recycled every 30 
minutes. Control modules were also prepared for IgG adsorption studies using 1 % (w/v) 
BSA in PBS without rPrA. After incubation, modules were then washed successively in PBS, 1 
M NaCl and de-ionised water. Fibres were then stored at 4 oC in 0.01 % (w/v) sodium azide 
in PBS.  
IgG binding capacity 
The IgG adsorption capacity of hollow fibre membranes was determined using Type 1 
hollow fibre membrane modules. Module inlets of Type 1 hollow fibre modules were 
connected to the aforementioned setup (Figure 4-5). The side-inlet ports for the 3-way 
valves contained a 10 mL syringe containing air and a 10 mL syringe containing an elution 
buffer comprised of 0.1 M sodium citrate (pH 2.5) (Figure 4-5). A CD20  IgG antibody 
solution (0.25 mg/mL) was then injected into the module via a micropipette tip (1 mL) 
attached to the feed inlet and was recirculated through the column 3 times. The column 
was then detached, wrapped in foil and incubated horizontally at room temperature for 2 
hours. The same protein adsorption process was also performed on control modules 
without rPrA, using BSA instead at 1 % (w/v) to determine non-specific adsorption. After 
incubation, modules were rinsed with PBS at 1 mL/min for 10 minutes. Air was injected to 
remove excess fluid, before the modules were rinsed 3 times with 0.5 mL of elution buffer. 
Eluted IgG concentrations from each collected fraction were determined using a Nanodrop 
2000 UV spectrophotometric (ThermoScientific, Loughborough, UK) instrument by placing a 
2 µL on the sensor and recording the absorbance at 280 nm.  
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Figure 4-5. Schematic of a Type 1 hollow fibre module with immobilised rPrA for IgG binding capacity 
evaluation. Numbers represent: (1) = modified 1,000 uL micropipette; (2) = 3-way valve; (3) = 10 ml 
syringe containing 0.1 M PBS; (4) = 10 mL syringe containing air; (5) = Type 1 hollow fibre module; (6) 
= collection vessel; (7) = stand and clamp. 
 
4.2.6.2. Flat sheet membrane 
Protein adsorption 
PES flat sheet membrane discs (Pall Life Sciences, Portsmouth, UK) were incubated in 1 
mg/mL of rPrA for 4 hours under gentle agitation. Excess solution was removed and 0.075 M 
of sodium cyanoborohydride (Sigma-Aldrich, Munich, Germany) in PBS was injected and 
incubated for 1 hour (pH7). Discs were washed three times successively in PBS, 1 M NaCl 
and dH2O for 15 minutes each under mild agitation. Absorbance was quantified using the 
BCA assay (Chapter 2, Section 2.4.4) with an Omega POLARstar plate reader (BMG Labtech, 
Slough, UK) at 562 nm and quantified using known stock solutions of protein concentrations 
in a black-walled 96 well plate. Modified fibres were then incubated in 0.225 mL of working 
reagent and 0.025 mL of de-ionised water at 37 oC for 30 minutes, after which 0.225 mL of 
supernatant was removed and the absorbance measured.  
The IgG adsorption capacity of rPrA-coupled discs was then examined by incubating a range 
of CD20 IgG antibody across 0 – 1.28 mg/mL in 0.15 mL of PBS for 2 hours. Segments were 
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then rinsed three times in 0.2 mL of PBS to remove unbound IgG. Adsorbed IgG protein was 
then eluted in 0.2 mL of 0.1 M sodium citrate (pH 2.5) after 5 minutes of incubation with 
two washes. A control study to measure non-specific IgG binding was not performed. Eluted 
IgG protein was quantified at 280 nm using a Nanodrop 2000 UV-spectrophotometer 
(ThermoScientific, Loughborough, UK).  
4.3. Theoretical considerations 
4.3.1. Hydraulic characterisation 
Pressure drop 
Pressure loss, used to test device integrity and the batch-to-batch variability of constructed 
Type 2 hollow fibre modules was measured as a function of shear stress (0 – 25 dynes/cm2) 
applied for 3 minute intervals. The filtrate lines of both the hollow fibre cartridge and the 
microfiltration cassette were closed. Laminar flow for a Newtonian fluid was confirmed 
using Equation 1.3 (Chapter 1). Shear stress at the wall of each fibre was then estimated 
assuming smooth tubes using (Bird, 2007): 
𝜏𝜏 = 4𝑄𝑄µ
𝛼𝛼𝑎𝑎𝑟𝑟3
 
 
4.1 
 
 
, where Q = flowrate (m3/s); µ = dynamic viscosity (kg/m.s); r = fibre radius (m) and n = the 
number of fibres (-). Shear stress acting on the surface of the flat sheet membrane was then 
calculated assuming that the geometry resembled a parallel plate with laminar flow 
(Bacabac et al., 2005): 
𝜏𝜏 = 3𝑄𝑄µ2𝑤𝑤(ℎ 2⁄ )2 
 
4.2  
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, where Q = flowrate (m3/s); µ = dynamic viscosity (kg/m.s); w = chamber width (m); h = 
chamber height (m).  
Hydraulic permeability 
The hydraulic permeability was determined for both PES flat sheet membranes and 
aldehyde-functionalised hollow fibre membranes. Inlet pressure was measured as a function 
of water flux (Jf) across the membrane and calculated using: 
𝐽𝐽𝑓𝑓 =  𝑄𝑄𝑓𝑓𝐴𝐴𝑚𝑚 
 
4.3 
 
 
, where Jf = permeate flux rate (L/hr/m2); Qf = filtrate flowrate (L/hr); Am = membrane area 
(m2). The transmembrane pressure, TMP (psi), was then calculated from: 
𝑅𝑅𝑀𝑀𝑅𝑅 =  �𝑅𝑅𝑓𝑓𝑓𝑓𝑓𝑓𝑑𝑑 + 𝑅𝑅𝑟𝑟𝑓𝑓𝑡𝑡𝑓𝑓𝑚𝑚𝑡𝑡𝑎𝑎𝑡𝑡𝑓𝑓2 � − 𝑅𝑅𝑓𝑓𝑚𝑚𝑓𝑓𝑡𝑡𝑟𝑟𝑎𝑎𝑡𝑡𝑓𝑓 
 
4.4 
 
 
, where Pfeed = feed inlet pressure (psi); Pretentate = retentate port pressure (psi); Pfiltrate = 
filtrate port pressure (psi). Both values enabled the hydraulic permeability to be calculated 
from: 
𝐻𝐻𝑅𝑅 =  𝐽𝐽𝑓𝑓
𝑅𝑅𝑀𝑀𝑅𝑅
 
 
4.5  
 
 
, where hydraulic permeability = HP (LMH/psi); filtrate flux = Jf (LMH). 
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4.3.2. Protein adsorption capacities 
The binding saturation capacity was estimated using Graphpad software (Prism, California, 
UK), assuming total binding (specific and non-specific): 
𝐵𝐵 = 𝐵𝐵𝑚𝑚𝑎𝑎𝑚𝑚𝑑𝑑
𝐾𝐾𝑑𝑑 + 𝑑𝑑 
 
4.6 
 
 
, where B = the amount of IgG adsorbed per rPrA segment (mg/mL membrane volume); Bmax 
= maximum IgG adsorbed (mg/mL of membrane volume); C = concentration of IgG in free 
solution (mg/mL); Kd = equilibrium binding constant (mg/mL).  
4.3.3. Membrane size calculations 
Hollow fibre membranes 
The total surface area of hollow membrane (internal) available for cell adsorption (SAi) is 
calculated from: 
 
 𝑆𝑆𝐴𝐴𝑚𝑚 = 𝛼𝛼𝑎𝑎𝑚𝑚 . 𝐿𝐿 4.7 
 
, where di = inner fibre diameter (m); L = fibre length (m).  
Total hollow fibre membrane volume including void volume (Vm) can be defined as: 
 𝑉𝑉𝑚𝑚−ℎ = 𝛼𝛼 𝐿𝐿4 �𝑎𝑎𝑜𝑜2 − 𝑎𝑎𝑚𝑚2� 
 
4.8 
, where do = outer fibre diameter (m); di = inner fibre diameter (m). 
Flat sheet membranes 
The total membrane volume including void volume for a circular segment of flat sheet 
membranes may be calculated as: 
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 𝑉𝑉𝑚𝑚−𝐹𝐹 = 𝛼𝛼. 𝑟𝑟2.ℎ. 
 
4.9 
, where r = segment radius (m); h = segment thickness (m). The thickness was taken to be 
0.0152 m, based on personal communication with Pall Life Sciences.  
4.4. Results and discussion 
4.4.1. Physical 
Membrane roughness and morphology were determined from atomic force microscope 
measurements. Data are displayed in Table 4-2 and force micrographs of untreated PEI 
fibres (Figure 4-6), glutaraldehyde-treated fibres (Figure 4-7) and flat sheet microfiltration 
membranes (Figure 4-8).  
Glutaraldehyde treatment of PEI fibres yielded a reduction in surface roughness compared 
to untreated PEI fibres, where micrographs showed a flatter, but more abrasive surface. In 
particular for the glutaraldehyde-treated PEI fibres, the surface roughness (Ra = 32.2 ± 0.5 
nm and Rrms = 45.8 ± 0.4 nm (mean ± SEM)) was comparable to that observed for 
glutaraldehyde-treated glass microslides detailed in Section 2.5.1, where Ra = 25.3 ± 4.8 nm 
and Rrms = 33.9 ± 4.6 nm (mean ± SEM) were observed. 
In contrast, PES flat sheet membranes exhibited much greater morphological variation (Ra = 
102.1 ± 9.9 nm and Rrms = 121.7 ± 10.6 nm (mean ± SEM)). Much larger height ranges were 
observed compared to both fibres, primarily owing to the porous nature of the membranes. 
The PES material surface itself was smooth, but exhibited surface-localised nodules (Figure 
4-8).  
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Table 4-2. Membrane roughness for hollow fibre and flat sheet membrane formats. 
Samples performed in duplicates across two different areas. Ra = roughness average; Rrms = root mean square roughness. 
Data presented as mean ± SEM. n = 2. a untreated PEI (polyethylenmine); b glutaraldehyde-treated PEI; c aldehyde-
functionalised polyethersulfone (PES). 
 
 
Figure 4-6. Atomic force micrographs of polyethylenimine hollow fibres in (A) 2D and (B) 3D formats. 
 
 
Figure 4-7. Atomic force micrographs of glutaraldehyde-treated polyethylenimine hollow fibres in (A) 
2D and (B) 3D formats. 
 
 
Figure 4-8. Atomic force micrographs of polyethersulfone segments in (A) 2D and (B) 3D formats. 
 
Membrane format Surface type Roughness (nm) Height measurements (nm) 
Ra Rrms 
Hollow fibre PEIa 39.9 ± 2.4 53.9 ± 1.9 376.5 – 678.9 
GA-PEIb 32.2 ± 0.5 45.8 ± 0.4 266.0 – 357.4 
TFF PESc 102.1 ± 9.9 121.7 ± 10.6 675.4 – 1,230.0 
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Environmental scanning electron microscopy (ESEM) was performed on hydrated aldehyde-
functionalised fibres only. Data are displayed in Table 4-3 and images in Figure 4-9. ESEM 
geometric measurements (Table 4-3) indicated a reduction in fibre wall thickness versus the 
commercial citations (Table 4-1), equating to ~ 7% increase in shear stress when utilising 
idealised conditions. Beyond possible measurement discrepancies, the primary reason was 
attributed to fibre dehydration prior to or during measurement. ESEM images possessed 
lower resolution than AFM, although demonstrated the absence of visible surface pores and 
an internal porous structure, unlike the PES membrane.  
Table 4-3. Measured properties of aldehyde-functionalised hollow fibres. 
Fibre property Measurement Unit 
Porosity N/A - 
Wall thickness 28.3 ± 1.5 (mean ± SD) Um 
Estimated average inner diameter 157  Um 
Pore size N/A - 
 
 
Figure 4-9. Representative images of hollow fibre membrane surfaces, where (A) the outer region of 
the fibre, (B) a high magnification scan of the fibre surface and (C) an image of the cross-section of 
the fibre.  
 
BET surface area measurements of the aldehyde functionalised PEI fibres were not 
performed, as fibres were too delicate. A literature search failed to provide an estimate of 
the surface area per unit volume of dialysis fibres. However, the molecular weight cut-off of 
such fibres is low: the membranes permit the passage of molecules possessing molecular 
weights of up to 45 kDa in blood and have a molecular weight exclusion limit in water of 
about 200 kDa (Luttropp, 2014). (Protein molecular weights are approximated as: ~45 kDa 
A B C 
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(BSA and rPrA) and 150 kDa (IgG).) Instead, the available surface area inside the tube was 
assumed to be equivalent to that of a smooth tube, since the BET method could not be 
performed on the fibres.  
Data are presented in Table 4-4 and images are displayed in Figure 4-10 for PES 
microfiltration membranes. Membrane surfaces were highly porous (Figure 4-10 (A and B) 
with extensive internal cross-linking (Figure 4-10 (C and D)) and a surface area per unit 
volume characteristic of microfiltration membranes (Table 4-4) (Prasad, 2012, Coleman et 
al., 1990, Liu and Bai, 2006).   
Also worth noting was the PES membrane (pore size: 0.45 µm), which is much smaller than 
most mammalian cells, which have diameters in the range of 10 – 20 µm. Whilst too small to 
allow cell transfer across the membrane surface, the potential for cell deformation into the 
pore, either during static incubation or due to shear stress is possible. Increased membrane 
roughness may also generate minor imbalances in the hydrodynamic forces that the cells 
are subjected to when compared to the idealised conditions assumed in Chapter 2 (Myers, 
2002).  
Table 4-4. Morphological properties of PES membranes  
Membrane property Measurement Unit 
Average pore sizea 0.45 µm 
Porosity 28 % 
Surface area 2.16 m2/mL membrane volume 
a commercially available data. 
       
A B 
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Figure 4-10. SEM Cross-sectional images of raw PES membranes. Top-down images of PES 
membranes, where the scale bar is at 10 µm in image A and 1 µm in image B. Side-view images of 
PES membranes, where the scale bar is 10 µm for both C and D.  
4.4.2. Hydraulic properties 
Pressure losses and hydraulic permeabilities of both membranes were measured and data 
are displayed in Table 4-4. The pressure losses were measured at flowrates equivalent to 25 
dynes/cm2 in Type 2 aldehyde-functionalised modules and up to 5 dynes/cm2 in the 
microfiltration cassette, both used for cell separation in Chapter 4.  
The removal of filtrate ports from the design specifications of hollow fibre modules meant 
that hydraulic permeability could not be determined. Therefore, glutaraldehyde-treated 
fibres in their original Nephral cartridges were examined. Table 4-5 shows that the hydraulic 
permeability of the hollow fibres was much lower than that of the microfiltration 
membranes and was characteristic of both membranes.  
Table 4-5. Pressure drop and hydraulic permeability 
Device Pressure drop/shear stress 
(psi/(dynes/cm2)) 
Hydraulic permeability 
(LMH/psi) 
Type 2 fibre module (n=9) 0.036 ± 0.007 N/A 
Hollow fibre cartridge (n = 3) 0.045 ± 0.004 2.25 ± 0.15 
PES cassette (n = 1) 0.418 99.0 
Note: all hollow fibre systems comprised aldehyde-functionalised membranes. a = at 25 dynes/cm2; b up to 5 dynes/cm2 
only. N/A = not applicable. Data are displayed as the mean ± SD.  
4.4.3. Chemistry 
PEI-fibres were treated with glutaraldehyde to convert primary amine groups into functional 
aldehydes capable of covalent protein adsorption, using the same mechanism as described 
C D 
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in Figures 2.2 – 2.4 in Chapter 2. To confirm chemical bond formation and the extent of 
surface coverage, a range of tests were performed. 
FTIR was used to identify differences in bond formation between PEI (n = 2) and 
glutaraldehyde-treated (n = 2) PEI fibres. Data are presented in Table 4-6 and a 
representative spectrograph is displayed in Figure 4-11. Amine bonds inherent to PEI were 
identified in both fibres, but the –C=N bond, indicative of Schiff base formation, was 
exclusive to glutaraldehyde-treated PEI and was absent in the untreated PEI at 1656 cm-1, 
coinciding with previous studies (Wang et al., 2012a).  
Table 4-6. Selected bands of diagnostic importance from FTIR spectra of PEI and aldehyde-
functionalised PEI. 
Detected wavelength (cm-1) PEI PEI-GA Bond 
3272 N N -N-H stretching 
2940 – 2830 Y Y -C-H stretching 
1576 N N -N-H bending 
1465 Y Y -C-H bending 
1350 – 1000 Y Y -C-N stretching 
1656 N Y -C=N stretching 
Note: Y = present; N = absent.  
 
Figure 4-11. FTIR spectra for unmodified PEI membrane and aldehyde-functionalised PEI membrane. 
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Amine and aldehyde functionalities were assessed using TNBS and silver mirror  stains, 
respectively. Untreated fibres exposed to TNBS solution stained yellow (Figure 4-112 A), 
owing to the formation of a chromogenic derivative resulting from the reaction between the 
nitro functional group of the TNBS molecule and a terminal amine group present on the PEI 
fibre (Hermanson, 1992, Pittner, 2002). (Whilst PEI is comprised of primary, secondary and 
tertiary amine groups, only primary amines possess reactivity with TNBS (Hermanson, 
2008).) Glutaraldehyde-treated fibres exhibited a much paler yellow colour (Figure 4-12 B), 
indicating the reaction of amines with glutaraldehyde.  
To indicate aldehyde functionalities, fibres were exposed to Tollen’s reagent. Untreated PEI 
fibres stained brown (Figure 4-12 C), attributed to the sensitivity of the reagent to 
contaminants (Ahluwalia, 2000). Conversely, glutaraldehyde-treated fibres stained black 
(Figure 4-12 D), consistent with the oxidation of aldehyde functionalities with Tollen’s 
reagent to create silver metal and carboxylic acid (Fieser, 1987).  
 
Figure 4-12. Representative staining images of untreated PEI fibres (A) and (C) and glutaraldehyde-
treated fibres (B) and (D) stained with TNBS and Tollen’s reagent respectively.   
 
Hollow fibre fragility restricted attempts to quantify aldehyde functionality. The BCA assay 
was instead used to estimate the change in absorbance following glutaraldehyde treatment 
relative to untreated PEI fibres. Absorbance was less than 10 % of that for the untreated 
A B 
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fibres following glutaraldehyde treatment (Table 4-7). Incomplete coverage is perhaps 
attributable to the exposure of unreacted amine groups.  
Table 4-7. Net change in absorbance between unmodified and aldehyde-functionalised PEI hollow 
fibre membranes.  
 Net absorbance per 100 cm of fibre 
 Unmodified Aldehyde-modified 
Absorbance (Au) 0.026 ± 0.004a 0.005 ± 0.001b 
Data with the same subscripts are not statistically different at the 5 % significance level based on a T-test. n = 9 runs were 
performed per sample. Data displayed as mean ± SD.  
 
4.4.4. rPrA and BSA protein adsorption densities 
High ligand densities per unit volume of substrate are desirable in protein separation, where 
target molecules can easily enter and exit pores (Bhattacharyya et al., 1996). However, cells 
cannot penetrate such pores (< 1 µm) as they are much larger (10 – 20 µm). Instead, the 
amount of protein accessible to cells on the substrate surface is a more important metric, 
enabling affinity interactions. rPrA and BSA adsorption densities onto aldehyde-
functionalised hollow fibres and flat sheet microfiltration membranes are presented in 
Tables 4-8 and 4-9 below.  
Hollow fibres exhibited comparatively high protein densities per unit volume of membrane, 
in spite of their low porosity. rPrA protein density per unit volume of membrane for the PES 
membranes was below that of other Protein A substrates, which typically ranged from 10 – 
30 mg/mL of membrane volume (Colton, 1996, Dancette et al., 1999, Jia et al., 1999, 
Castilho et al., 2000). This was attributed to a lower Protein A incubation concentration, 
fewer aldehyde functionalities, or perhaps the lower surface area available per unit volume 
of membrane (2.1 m2/mL of membrane). Importantly, both membranes exhibit similar 
(albeit slightly lower) Protein A surface densities to those used previously for cell separation 
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(27,000 – 35,000 per µm2 of substrate) (Colton, 1996) and slightly higher than those 
obtained in Chapter 2.  
Table 4-8. rPrA and BSA adsorption onto aldehyde-functionalised hollow fibre membranes.  
Membrane type Protein Protein density Protein spacing 
(mg/mL mv) #/µm2 (nm) 
Hollow fibre rPrA 0.46 ± 0.30 7,744 ± 5,065 9 – 42 
BSA 0.95 ± 0.71 10,753 ± 8,058 9 – 18 
rPrA-(BSA) 2.28 ± 1.21 25,760 ± 13,626 5 – 17 
rPrA-(BSA) signifies the quantification of BSA on rPrA-coupled membranes. Protein spacing refers to the assumed distance 
between each adsorbed protein molecule, based on an idealised scenario of an assumed monolayer where proteins are 
arranged in a square lattice formation. Values are subtracted from an average baseline generated by uncoupled fibres for 
rPrA and BSA or rPrA-coupled fibres for rPrA-BSA. Protein density is displayed as the mean ± SD and protein spacing is 
displayed as the equivalent range for n = 5 runs. Calibration charts are displayed in Figures 7-4 and 7-5 for rPrA and BSA 
quantification using the BCA assay, respectively. Bead surface area was assumed to be equivalent to that determined from 
the BET surface area and neglected to account for size-restricted regions on the beaded glass surface that would be 
inaccessible to proteins. Calibration charts for rPrA and BSA quantitation are displayed in Figures 7-5 and 7-6.  
 
Table 4-9. rPrA and BSA adsorption onto aldehyde-functionalised PES membranes 
Membrane type Protein Protein density Protein spacing 
(mg/mL mv) #/µm2 (nm) 
Flat sheet PES rPrA 0.80 ± 0.12 5,000 ± 759 13 – 16 
BSA 4.96 ± 0.22 20,750 ± 940 6.8 – 7.2 
rPrA-(BSA) 5.11 ± 0.33 21,394 ± 1,401 6.6 – 7.2 
rPrA-(BSA) signifies the quantification of BSA on rPrA-coupled membranes. Protein spacing refers to the assumed distance 
between each adsorbed protein molecule, based on an idealised scenario of an assumed monolayer where proteins are 
arranged in a square lattice formation. Values are subtracted from an average baseline generated by uncoupled fibres for 
rPrA and BSA or rPrA-coupled fibres for rPrA-BSA. Protein density is displayed as the mean ± SD and Protein spacing is 
displayed as the equivalent range for n = 5 runs. Calibration charts are displayed in Figures 7-6 and 7-7 for rPrA and BSA 
quantification using the BCA assay, respectively. Bead surface area was assumed to be equivalent to that determined from 
the BET surface area and neglected to account for size-restricted regions on the beaded glass surface that would be 
inaccessible to proteins. Calibration charts for rPrA and BSA quantitation are displayed in Figures 7-7 and 7-8. 
4.4.5. IgG binding 
The IgG adsorption capacity is indicative of the number of possible affinity interactive sites 
between the rPrA-coupled membranes and IgG-tagged cells and more importantly the 
ability to differentiate between cells with and without affinity interactions through force-
induced separation (Kuo and Lauffenburger, 1993, Nordon et al., 1996). More explicitly, the 
Fc binding domain of the immobilised rPrA and the Fc region of the IgG antibody.  
However, the accuracy of these IgG adsorption studies is limited. It may be assumed that 
the adsorption capacities acquired indicate the number of affinity interactions taking place 
between the cell and the surface. However, there are very obvious differences in the 
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experimental approaches between each study limiting the accuracy of the measurements. 
IgG adsorption studies involved a 2 hour incubation period, whilst cell adsorption with IgG 
utilises a 30 minute incubation period with Protein A. For instance, static IgG antibody 
adsorption relies on the diffusion of IgG molecules onto the rPrA-coupled support, governed 
by the Stoke-Einstein equation (Young et al., 1980). IgG-tagged cell adsorption relies on cell 
sedimentation onto the surface, the rate of bond formation (Kuo and Lauffenburger, 1993) 
and the extent of cell deformation and therefore cell-substrate contact (Kasza et al., 2007, 
Bose, 2009), as well as the rPrA density and number of IgG-tagged antigens. 
4.4.5.1. Hollow fibre Type 1 modules 
The IgG adsorption capacity of rPrA-coupled hollow fibres was determined under semi-
dynamic conditions. Type 1 hollow fibre modules were exposed to 0.25 mg/mL of IgG 
solution (in excess of that required for rPrA-coupled glass beads in Chapter 2) to saturate 
available binding sites. Data are presented (Table 4-10) based on the net amount of IgG 
affinity interactions with rPrA-coupled hollow fibres. Washing fractions for rPrA-coupled 
fibres blocked with BSA and a control containing only BSA blocked fibres only are both 
displayed in Figure 4-13, where the majority of IgG antibody was eluted during the first 
wash. 
Table 4-10. Net IgG content for rPrA-coupled aldehyde-functionalised fibres 
IgG mg/mL mv #/µm2a IgG : rPrA ratio 
Net IgG 0.069 ± 0.032 1,946 – 9,245 0.25 – 1.19 
Data are displayed as the mean ± SD for specific (n = 5) non-specific (n =5) IgG affinity interactions. a = assumes monolayer 
formation. IgG antibody incubated for 120 minutes. 
 
The estimated IgG density per volume of membrane was comparably lower than more 
porous formats (Klein, 1994, Charcosset et al., 1995, Dancette et al., 1999). More relevant to 
cell separation was the IgG density per unit surface area, which was estimated assuming a 
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smooth, non-porous surface. Even though the calculated capacity may be inaccurate owing 
to the experimental method, the findings resemble densities reported previously for cell 
separation (Colton, 1996) and those reported in Section 2.5.4. 
 
Figure 4-13. The elution of IgG from both rPrA-coupled (blue) and rPrA-free (red) Type 1  
modules over three washes. Data points are displayed as the mean ± SD for n = 5 runs.  
 
4.4.5.2. Flat sheet microfiltration membrane 
The IgG adsorption capacity of rPrA-coupled PES discs was determined under static 
conditions across 0 – 1.28 mg/mL of IgG. Data (n = 4) are presented in Table 4-11 and a 
binding curve is displayed in Figure 4-14. No control study was performed, so the data 
comprises both specific and non-specific binding interactions.  
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Table 4-11. IgG adsorption capacity data for rPrA-coupled PES membranes 
Parameter Value Unit 
Bmax
a 7.17 ± 0.96 mg/mL membrane volume 
 13,320 ± 1,791 #/µm2 
Kd
b 0.15 ± 0.08 mg/mL 
 2.0 ± 0.1 x 106 M-1 
IgG:rPrA 2.6 ± 0.4 - 
Data are displayed as the mean ± standard deviation. a units refer to mg per mL of membrane volume; b units refer to mg 
per mL of challenge solution.  
 
 
Figure 4-14. Binding curve for IgG binding for n = 4 runs comprised of the mean and calculated 
standard of the error mean. The data comprise both specific and non-specific protein adsorption, 
since no control study was performed. 
 
IgG capacities per unit volume of membrane are lower than those reported elsewhere, 
which often cite a range of 10 – 30 mg/mLmv (Klein, 1994, Colton, 1996, Pomianek, 1998, 
Jia et al., 1999). The number of IgG antibody molecules per square micron was higher than 
those observed in Section 2.5.4 for aldehyde-functionalised glass beads and the fibres 
exhibited here. The equilibrium binding constant, Ka, was ~5 x 105 M-1, determined from Kd, 
which was 2.0 ± 0.1 x 10-6 M. The value for Ka is slightly in excess of the recommended 
v v 
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minimum threshold of 105 M-1 to avoid ligand leakage (Ohlson et al., 1997, Castilho et al., 
2000), but this may be attributed to the limitations of the experiment and may not be a true 
reflection.  
Notably, the IgG : rPrA ratio (2.6 ± 0.4) (mean ± SEM) is very high compared to the 
aforementioned formats, suggesting an inaccuracy due to one or both of the following: (1) a 
lower rPrA density than that which was actually obtained (separate rPrA batches were used 
for rPrA and IgG adsorption studies); or (2) non-specific IgG adsorption is high and accounts 
for a large proportion of signal generation.  
4.5. Conclusions 
Aldehyde-functionalised surface chemistry was selected to immobilise proteins via Schiff 
base formation. Unlike flat sheet membranes, PEI hollow fibres did not possess aldehyde 
functionalities, so were chemically treated with glutaraldehyde. Chemical characterisation 
of glutaraldehyde-treated versus untreated fibres revealed: (1) a reduction in amine 
functionality and an increase in aldehyde functionality based on qualitative TNBS and silver 
mirror stains; (2) ~90 % reduction in amine functionality based on BCA assay staining; (3) 
Schiff base formation using FTIR spectra.  
Physical characterisation indicated notable differences in membrane morphology. Hollow 
fibres exhibited no observable pores, with smooth, flat surfaces based on SEM and AFM 
with roughness (Ra) values of (32.2 ± 0.5 nm) (Mean ± SEM). Flat sheet membranes were 
rougher, with AFM revealing (102.1 ± 9.9 nm) and SEM indicating significant porosity (~28 
%).  
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For hollow fibre and flat sheet membranes, rPrA densities were 7,744 ± 5,065  and 5,000 ± 
759 per µm2 (mean ± SEM), whilst IgG : rPrA adsorption ratios were 0.25 – 1.19 and 2.6 ± 
0.4, respectively. Imprecision and possible inaccuracies were attributed to limitations in 
experimental models.  
Protein adsorption densities were limited in accuracy and precision due to the experimental 
approach. These adsorption densities should be compared relative to each other rather than 
being considered absolute. These findings provide a platform for cell separation 
performance to be examined using constructed modules in Chapter 5.  
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Chapter 5. Affinity cell separation 
5.1. Introduction 
A side-effect of pluripotent-derived cell manufacture is anticpated to concern cells which 
have failed to differentiate (Schriebl et al., 2010b, Chen et al., 2014). These cells are 
expected to remain undifferentiated, retaining their pluripotent cell characteristics and 
potential for teratoma formation in vivo, if a pre-determined purity is not achieved 
(Lebkowski, 2011, Schriebl et al., 2012). This is deemed to be more probable at larger scales 
(>1011 cells per batch), where three-dimensional bioreactor heterogeneity is harder to 
control, leading to nutrient and growth factor gradients (Donati, 1997, Lara et al., 2006a). If 
existing purity thresholds (thought to be in excess of 99 % for safe transplantation (Section 
1.7.1.)) cannot be met, downstream purification technologies may be required.  
Affinity-based cell separation is a potential solution, offering the capacity to remove cells 
positive for the SSEA-4 antigen, which is expressed by ~ 95% of undifferentiated cells (Fong 
et al., 2009) and down-regulated on differentiated cells (Shibata et al., 2006, Thomson et al., 
1998). Affinity separation has widespread applications in clinical medicine, from protein 
manufacture (Kelley et al., 2007, Moser and Hage, 2010) to bone marrow and 
haematological transplantation (Menendez et al., 2002, Ringhoffer et al., 2004). Affinity-
based cell separation devices employ a variety of geometric arrangements and techniques 
ranging from magnetic bead- (Miltenyi et al., 1990) and fluorescence-based methods (Basu 
et al., 2010). The use of less commercially successfully polymer-based substrates, such as 
hollow fibres (Colton, 1996, Slowiaczek, 1998) and monoliths (Kumar and Srivastava, 2010) 
have since attracted limited attention owing to no immediate competitive advantage. 
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Magnetic bead separation is the existing benchmark technology for cell separation, with an 
apparent market share of ~70 %. Performance is suitable for clinical applictions, with log 
clearance rates typically ranging from 0.5 – 2.5 (Barfield et al., 2004; Lara et al., 2006b) for 
depletion (negative selection) and from 3 – 5 for enrichment (positive selection) 
(Handgretinger et al., 2002, Martin-Henao et al., 2001). The largest magnetic devices 
(CliniMACS®, which operates up to 1011 cells per unit) are however cumbersome, expensive 
and limited by the reduction in magnetic field strength as the distance from the magnetic 
increases (Ebner et al., 1997).  
Membranes are considered scalable alternatives to magnetic separation devices, 
demonstrating similar separation performance to magnetic ones (Nordon et al., 1996, 
Slowiaczek, 1998). In such devices, shear stress-induced affinity separation is used to enrich 
cells with (Mandrusov et al., 1995, Nordon et al., 1996) or without additional agents 
(Nordon, 1994, Slowiaczek, 1998, Nordon et al., 2004) to enable cell recovery.  
Whilst enrichment strategies yield higher purities useful for CD34+ enrichment (Nordon et 
al., 1996, Slowiaczek, 1998), the dissociation of an affinity interaction for cell separation 
using pH, force or enzymatic digestion used for more mature cell types (Mandrusov et al., 
1995, Nordon et al., 1996, Slowiaczek, 1998) is considered too physiologically stressful for 
pluripotent-derived cells. Therefore, a depletion strategy, whereby impure cells are retained 
through affinity interactions and product cells without affinity interactions are recovered 
using lower shear stresses (≤ 25 dynes/cm2) is deemed a more suitable method.  
Chapter Aims: 
• Investigate the performance of hollow fibre and flat sheet membranes using shear-
stress-induced affinity cell separation to recover product cells and retain impure cells 
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• Investigate the impact of the separation process on cell physiology.  
5.2. Materials and methods 
5.2.1. Cell preparation  
5.2.1.1. Cell culture 
Two B-lymphocyte cell lines were used: (1) Toledo CD20 antigen-positive B-lymphocytes 
cells from ATCC (LGC Standards, Middlesex, UK) and (2) CCRF-HSB-2 HLA-A2 antigen-positive 
B-lymphocytes from Sigma-Aldrich (Dorset, UK). The purpose was for the CD20+ cells to 
mimic undifferentiated pluripotent stem cells expressing the SSEA-4 antigen, whilst HLA-A2+ 
cells were intended to mimic pluripotent-derived cells, such as cardiomyocytes, where the 
SSEA-4 antigen is absent. 
Cells were maintained at 3 x 105 – 1 x 106 cells/mL in 90 % RPMI-1640 with 2 mM glutamine 
and 10 % (v/v) foetal bovine serum (FBS) supplemented with 1 % Pen-Strep (Sigma-Aldrich, 
Munich, Germany). Cell cultures were maintained at 3x105 to 1x106 cells/mL in 5 % CO2 and 
95 % O2 atmospheric content at 37 oC using a Heracell 150i CO2 incubator (Thermo 
Scientific, Loughborough, UK) and cultured every 2-3 days.  
5.2.1.2. Cell harvesting for separation 
Cell viability was measured using a trypan blue membrane exclusion assay prior to 
harvesting. Cells were only harvested if viability was ≥99 %. CD20+ and HLA-A2+ cells were 
centrifuged at 1,200 rpm, re-suspended in cell processing buffer (CPB) comprised of 1 % 
(w/v) BSA in Dulbecco’s phosphate buffered saline (DPBS) (Life Technologies, Paisley, 
Ireland) prior to separation.  
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5.2.2. Separation units 
Membrane-based affinity separation was compared to Miltenyi’s Magnetic Activated Cell 
Separating (MACS) technology. CD20+ cells (impurities) were retained, whilst HLA-A2+ cells 
(product), were recovered as a means to increase purity. All separation was performed 
inside a Class II biological safety cabinet.  
5.2.2.2. Magnetic Activated Cell Separation (MACS) 
Magnetic separation was performed using Miltenyi ® Magnetic Activated Cell Separation 
(MACS) MS columns (Miltenyi Biotec, Surrey, UK) according to the manufacturer’s 
instructions. Briefly, a mixture of HLA-A2+ and CD20+ cells were prepared in a 1:1 ratio 
equating to 2.4 x 107 cells in total. Cells were centrifuged at 1,200 rpm and re-suspended in 
0.16 mL of CPB and 0.04 mL of anti-CD20 MACS microbeads then incubated at 4 oC for 30 
minutes. Cells were then centrifuged and re-suspended twice in 0.6 mL of CPB. A sample of 
the cell suspension was taken for analysis. Miltenyi MS columns were prepared in advance 
and clipped into the magnet prior to the addition of 1.5 mL of CPB in 0.5 mL amounts was 
passed through the column. Thereafter, 0.5 mL of the cell suspension (equivalent to 2 x 107 
cells) was fed into the column and was allowed to run through, followed by an additional 1.5 
mL of CPB to collect remaining cells. Collected cells were then subjected to analysis.  
5.2.2.3. Affinity membrane separation 
Immuno-affinity-based membrane separation was performed inside a Class 2 biological 
cabinet through the sequential application of shear stress across 1, 5, 10 and 25 dynes/cm2 
and 1, 5 and 10 dynes/cm2 for hollow fibre and flat sheet membranes respectively. Prior to 
separation in both formats, combined HLA-A2 and CD20 cells were pooled to create purities  
of approximately 1:1 containing 1.9 x 106  and 2.1 x 107 total cells for hollow fibre and flat 
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sheet membranes respectively. Cells were re-suspended and centrifuged in CPB to 3 x 107 
cells/mL. CD20 IgG antibody purchased from The University of Birmingham Hospital 
(Birmingham, UK) was then added to mixed cell suspensions equivalent to a concentration 
of 10 µg/mL prior to incubation at 4 oC for 30 minutes. Cells suspensions were then diluted 
with CPB, centrifuged at 1,200 rpm and re-suspended twice in CPB to 3 x 106 cells/mL. 
Hollow fibre membrane 
Hollow fibre separation was performed using the modules developed and characterised in 
Chapter 4. The properties of these modules are presented in Table 5-1 below.  
Table 5-1. Hollow fibre module properties 
Property Value / comment 
Fibre internal diameter 168 µm 
Fibre external diameter 210 µm 
Number of fibres 75 
Fibre length 10 cm 
Membrane Aldehyde-functionalised polyethylenimine 
Affinity interaction rPrA – interaction with the Fc domain of IgG-tagged cells 
Supplier Gambro (Nephral ST200) 
a assuming an 8 % coverage of cells 
In advance, Type 2 modules (prepared in Section 4.2.4.1), were removed from a storage 
solution of 0.01 % (w/v) sodium azide in 0.1 M sodium phosphate with 0.15 M sodium 
chloride (PBS) at 4 oC. They were then soaked in de-ionised water for 15 minutes and rinsed 
through with PBS at 30 mL/hr for 10 minutes. A solution of rPrA (1 mg/mL) in PBS (pH 7) was 
then injected into the modules via a connected a 1,000 µL micropipette tip. Modules were 
then wrapped with foil to prevent dehydration during a 4 hour incubation period at room 
temperature. The rPrA solution was recycled every 30 minutes to promote saturation, prior 
to rinsing with PBS using a manual syringe. Then, inside an air-tight glove box, a 0.075 M 
solution of sodium cyanoborohydride in PBS was injected and incubated at room 
temperature for 1 hour. Excess solution was drained and modules were rinsed in PBS, 1 M 
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NaCl and de-ionised water for 10 minutes each using a syringe pump at a flowrate of 60 
mL/hr. 
The tubing shell (tygon tubing) (Cole-Parmer, London, UK) was then positioned across the 
fibres and allowed to set using epoxy resin for 2 hours. Fibres were then manually rinsed 
with CPB containing 0.1 % (w/v) sodium azide using a syringe to test integrity and remove 
air from the shell side. Excess air was removed by inserting the needle of a 10 mL syringe 
into the shell side of the module to draw air out whilst CPB 0.1 % (w/v) sodium azide was 
simultaneously injected, prior to incubation for 4 hours at room temperature. Excess 
solution was then withdrawn and each module was washed with CPB prior to blocking in 1 
% (w/v) BSA for 2 hours at room temperature. Fibres were then connected to the process 
setup (Figure 5-1) and subjected to the separation process detailed below.  
 
Figure 5-1. Hollow fibre membrane cell separation process. The instruments are listed as follows: (1) 
50 mL syringe and syringe pump containing CPB (1 % BSA in 1 x DPBS); (2) 3-way valve; (3) 20 mL 
wash buffer syringe containing 1 % BSA; (4) 1 mL syringe of cell suspension in CPB with needle; (5) 
75-fibre HFM Type 2 module; and (6) cell fraction collection vessel. Note: the dashed line represents 
the manual insertion of a needle into the tubing.  
 
Flat sheet membrane cassette 
A proprietary flat sheet microfiltration membrane cassette was kindly supplied by Peter 
Levison at Pall Life Sciences (Portsmouth, UK). The membrane material and the cassette 
were briefly characterised in Chapter 4 and fundamental characteristics are presented in 
Table 5-2 below.  
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Table 5-2. Flat sheet membrane properties 
Property Value / comment 
Volume 6.4 mL 
Membrane Aldehyde-functionalised polyethersulfone 
Affinity interaction Immobilised rPrA – Fc interaction with IgG-tagged cells 
Supplier Pall Life Sciences 
Membrane porosity (%) 28 % 
 
Prior to modification, the flat sheet membrane cassette, stored in 20 % ethanol at 4 oC was 
drained thoroughly via the manual injection of de-ionised water followed by PBS using a 10 
mL syringe. Inside a class 2 fume cabinet, excess PBS was then drained, and a 1 mg/mL 
solution rPrA was manually injected into the cassette to saturate the surface and promote 
the removal of air pockets. The solution was then incubated overnight at 4 oC on an EW 
51300 orbital platform shaker at 1 rpm (Cole-Parmer, London, UK). Excess rPrA solution was 
then recovered for further use and the cassette was rinsed with PBS solution. Inside an air-
tight glove box, 0.075 M sodium cyanoborohydride in PBS was injected and incubated at 
room temperature for 1 hour. Excess solution was drained and the cassette was sequentially 
rinsed in PBS, 1 M NaCl and de-ionised water for 10 minutes using an Alaris IVAC P7000 
syringe pump (CareFusion, St Albans, UK) at 180 mL/hr. The membrane was then sterilised 
in 0.1 % (w/v) sodium azide in PBS for 4 hours at room temperature, prior to rising in PBS, 1 
M NaCl and de-ionised water, before blocking in 1 % BSA in PBS (pH 7) for 2 hours, prior to 
rinsing again in PBS, 1 M NaCl and de-ionised water. The cassette was then connected 
(Figure 5-2) and separation studies were performed as detailed in Table 3.  
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Figure 5-2. Flat sheet membrane cell separation process schematic. Numbers are represented 
accordingly, where: (1) = storage vessel containing wash buffer; (2) = peristaltic pump; (3) = 50 mL 
syringe and syringe pump containing wash buffer; (4) = 3-way valve; (5) = 20 mL wash buffer syringe 
containing CPB; (6) = 10 mL syringe of cell suspension in CPB with needle; (7) = flat sheet membrane 
cassette; (8) = Filtrate 1 port (closed); (9) = Filtrate 2 port (closed); (10) = outlet port. 
 
5.2.3. Cell separation 
Mixed cell suspensions containing known concentrations of cells were injected into 
respective membrane units at a concentration of 3 x 106 cells/mL in CPB and allowed to 
incubate for 30 minutes. Adherent cells were subjected to shear stresses of 1 – 25 
dynes/cm2 (hollow fibre membrane) and 1 – 10 dynes/cm2 (flat sheet membrane) (Table 5-
3). A process diagram details both magnetic- and membrane-based cell separation 
processes (Figure 5-3).  
Table 5-3. Operating parameters for cell separation 
Stage Mobile 
phase 
Total wash volume (mL)a Shear stress (dynes/cm2) Time (minutes)a 
Cell loading 
    Cell injection CS 0.4 (6.4) 0.5 1.7 (0.45) 
Cell incubation 
 CS - - 30 (3) 
Washing 
     1st fraction 
CPB 
1.4 (86) 1 3 (3) 
     2nd fraction 6.9 (430) 5 3 (3) 
    3rd fraction 13.8 (286) 10 3 (1) 
    4th fractionb 34.5 (0) 25 3 (0) 
a operating parameters are displayed for the hollow fibre membrane with the flat sheet membrane in brackets; b 25 
dynes/cm2 was only applied for the hollow fibre membrane models, since the pressure limit was exceeded for the flat 
sheet membrane cassette.  CPB = cell processing buffer comprised of 1 % BSA in 1 x Dulbecco’s phosphate buffer solution. 
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Figure 5-3. Process diagram for cell separation. Both magnetic and membrane-based separation 
protocols are detailed.  
 
 
5.2.4. Characterisation 
The separation performance of each system was measured based on changes in cell 
recovery, viability and purity. Assays are described below.  
5.2.4.1. Cell membrane integrity and intracellular staining 
Cells were concentrated to provide assay resolution by centrifuging at 1,200 rpm. No doubt, 
this could affect measurement accuracy by removing less dense dead or dying cells, but the 
concentrations of collected fractions were too dilute (<104 cells/mL). 
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Vita Bright-48/Propidium iodide (VB-48/PI) 
A combination of membrane permeable (Vita Bright-48 fluorophore) and impermeable 
(Propidium iodide) compounds were used to measure reduced thiol content and membrane 
integrity. Cells undergoing apoptotic processes exhibit a reduction in cellular free thiol 
concentration detectable upon the formation of a fluorescent compound when reacted with 
VB-48 (Skindersoe et al., 2012). Propidium iodide (PI) is a membrane impermeable dye used 
to indicate losses in membrane integrity (Harrison and Vickers, 1990). Cell samples were 
mixed at a 19:1 ratio with Solution 5 (Chemotec, Gydevang, Denmark) equating to 8 µg/mL 
of VB-48 and 500 µg/mL of PI and content was measured using an A2 chip in an NC3000 
(Chemotec, Gydevang, Denmark). Data were analysed using Nucleoview software 
(Chemotec, Gydevang, Denmark). 
4',6-diamidino-2-phenylindolen  (DAPI) 
4',6-diamidino-2-phenylindolen (DAPI) is used to identify cells exhibiting losses in membrane 
integrity. It fluoresces when bound strongly to A-T rich regions of DNA of cells with 
permeable membranes, but is impermeable to cells with intact membranes (Hamada and 
Fujita, 1983). Cell samples were drawn up into a Via-1 cassette (Chemotec, Gydevang, 
Denmark) yielding a DAPI concentration of 1 µg/mL of cell suspension. The Via-1 cassette 
was immediately inserted into the NC3000 (Chemotec, Gydevang, Denmark) and data was 
analysed using Nucleoview software (Chemotec, Gydevang, Denmark). 
 7-Amino-Actinomycin (7AAD) 
7-Amino-Actinomycin D (7-AAD) is a membrane impermeable dye indicative of losses in 
membrane integrity, by binding cells to DNA of cells with compromised membrane integrity, 
yielding a fluorescent complex detectable at 650 nm (Shapiro, 2003). 7-ADD (BD 
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Biosciences, Oxford, UK) was added to collected fractions (0.15 mL) at a concentration of 2 
µg/mL cell suspension. Samples were gently mixed then incubated in the dark for 10 
minutes. Fluorescence was measured using a Millipore Guava flow cytometer (Millipore, 
Cambridge, UK). Analysis was performed using the accompanying GuavaSoft software. The 
gate region for membrane permeable and impermeable cells was set at log 101.7; cells above 
this threshold were considered to have lost membrane integrity, whilst cells below were 
deemed to have intact membranes. 
Trypan blue 
Trypan blue was used to stain cells with compromised membrane integrity. The 
methodology is described in Section 2.2.6.  
5.2.4.2. Cell recovery 
Acridine orange (AO) is a membrane permeable stain used to quantify cells by fluorescently 
staining DNA. Cell samples were drawn up into a Via-1 cassette, to yield an AO 
concentration of 1 µg/mL and immediately processed on the NC3000. Data were analysed 
using Nucleoview software.  
5.2.4.3. Cell purity 
Cell purity based on antigen expression was determined using flow cytometry. Cells were 
stained using CD20 IgG3 (anti-human/mouse (H147) fluorescent with PE-Texas Red to detect 
CD20+ antigen expression and HLA-A2 IgG2b (anti-human/mouse (BB7.2) IgG 2b fluorescent 
with FITC to detect HLA-A2+ antigen expression. Isotype controls were IgG3 (anti-
human/mouse fluorescent with PE (R&D Systems, Abingdon, UK) and anti-human/mouse 
IgG2b fluorescent with FITC (BD Biosciences, Oxford, UK).  
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Samples were centrifuged at 1,200 rpm for 5 minutes then re-suspended in 0.1 mL of CPB. 
Fluorescent antibody was added to collected fractions separately, agitated on a MaxiMixTM 
vortex (Fischer Scientific, Loughborough, UK) for 5 seconds then incubated for 30 minutes at 
room temperature (~23 oC) in the dark. Samples were then diluted in CPB, centrifuged at 
1,200 rpm for 5 minutes and re-suspended in 0.2 mL of CBP, twice. Re-suspended samples 
were measured using a Millipore Guava flow cytometer. Binding affinities were assessed for 
each cell type versus isotype controls (Figure 5-4). Analysis was performed using GuavaSoft 
software (Millipore, Watford, UK).  
Gain settings were adjusted so that unstained cells resided within the first log decade of 
each detection channel on a four-log decade scale. Initial testing showed CD20+ and HLA-
A2+ cells to be positive for respective antigens (>99 %), whilst the isotype controls and non-
specific binding was estimated to be < 1 % (Figure 5-4).  
 
Figure 5-4. Cell staining histograms. (A) = CD20 cells (red) testing positive for CD20 IgG and negative 
for an isotype control; (B) = CD20 cells testing negative for HLA-A2 IgG control; (C) = HLA-A2 cells 
(blue) testing positive forHLA-A2 IgG and negative for an isotype control; (D) = HLA-A2 cells testing 
negative for CD20 IgG.  
 
A B 
C D 
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5.3. Theoretical considerations 
5.3.1. Hydrodynamic conditions 
Shear stress inside each membrane was determined assuming that fluid flow was 
predominantly laminar (Reynold’s number << 2100) according to Equation 2.1. For hollow 
fibres, the shear stress at the wall of each fibre was calculated using Equation 4.1 and on the 
surface of the flat sheet membrane it was estimated using Equation 4.2.  
Performance analysis 
Output from each assay was evaluated using the following equations to identify changes in 
cell properties. As indicated earlier in Figure 2-12 and Figure 5-4, HLA-A2+ cells, designated 
product cells have no capacity for affinity interactions. Conversely, CD20+ cells, designated 
impurities, have the potential for affinity interactions via the interaction of the Fc region of 
IgG antibody tagged to cells with surface-adsorbed rPrA (Figure 2.4 Section 2.1.). HLA-A2+ 
cell purity (FH,n) (%) for a recovered from a given fraction may be expressed by: 
𝐹𝐹𝐻𝐻,𝑚𝑚 = 𝑁𝑁𝐻𝐻,𝑚𝑚𝑁𝑁𝐶𝐶,𝑚𝑚 + 𝑁𝑁𝐻𝐻,𝑚𝑚 5.3  
 
, where NH,n = the number of HLA-A2+ cells recovered from a given fraction (cells); NC,i =the 
number of CD20+ cells added to the device (cells); NH,i = the number of HLA-A2+ cells added 
to the device (cells). Subscripts ‘i’ and ‘n’ signify input and the collected fraction number, 
respectively. HLA-A2+ cell recovery relative to the original input quantity, RH,n, (%) was 
calculated using: 
𝑅𝑅𝐻𝐻,𝑚𝑚 = 𝑌𝑌𝐻𝐻,𝑚𝑚 𝑌𝑌𝐻𝐻,𝑚𝑚  5.4  
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Limitations meant that changes in membrane integrity for each cell type (CD20+ and HLA-
A2+ lymphocytes) could not be measured. Instead, changes in vital dye uptake for all cells 
recovered at a given shear stress (ΔVT,n) (%) were used to assess the impact of shear-
induced separation on cells from each fraction: 
∆𝑉𝑉𝑇𝑇,𝑚𝑚 = 1 − 𝑉𝑉𝑇𝑇,𝑚𝑚𝑉𝑉𝑇𝑇,𝑚𝑚  
 
5.5  
 
 
, where VT,n =  cell uptake of vital dye at a given shear stress; VT,i = cell uptake of vital dye 
prior to separation device addition. Log10 depletion (LCR) for each collected fraction was 
estimated as: 
𝐿𝐿𝑎𝑎𝑎𝑎10(𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝐴𝐴𝑎𝑎 𝑚𝑚𝑎𝑎𝑀𝑀𝑀𝑀 𝑎𝑎𝑎𝑎𝑒𝑒𝑀𝑀𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎) = log10 �𝑌𝑌𝐶𝐶 ,𝑚𝑚𝑌𝑌𝐶𝐶 ,𝑚𝑚� 5.6  
 
, where Yc,i = CD20+ cell input yield; Yc,n = CD20+ cell output yield.  
Because the starting purity was variable and collected fractions exhibited marginal changes 
in purity, performance trends based on the mean data points could not be deduced. 
Therefore an equation for the Relative Change in Purity (RCP) of product-designated HLA-
A2+ cells was derived to compare the change in purity for each fraction relative to the 
original input.  
𝑅𝑅𝑑𝑑𝑅𝑅 = 𝑅𝑅𝐻𝐻,𝑚𝑚 − 𝑅𝑅𝐻𝐻,𝑚𝑚
𝑅𝑅𝐶𝐶,𝑚𝑚 − 𝑅𝑅𝐶𝐶 ,𝑚𝑚   5.7 
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, where PH,i = HLA-A2+ cell input purity; PH,n = HLA-A2+ cell output purity at a given fraction; 
PC,i = CD20+ cell input purity; PC,n = CD20+ cell output purity at a given fraction. Subscript C = 
CD20 cells; H = HLA-A2 cells; i = input; n = fraction number. All purities are displayed in %. 
5.4. Results 
The following section presents the results for magnetic bead (n = 4) as well as hollow fibre 
(n = 5) and flat sheet membrane (n = 1) affinity separation. Hollow fibre membrane modules 
also included control studies without IgG pre-incubation incubation (n = 2). As stated 
previously, HLA-A2+ cells were designated product cells to be purified and recovered at 
lower shear stresses (≤ 25 dynes/cm2) through the retention of CD20+ target cells using 
affinity interactions.  
5.4.1. Recovery 
HLA-A2+ cell recoveries from the magnetic column, as well as the hollow fibre and flat sheet 
membrane are presented in Figure 5-5. For the magnetic sepration column, approximately 2 
x 107 cells (~ 50 % purity) were introduced. HLA-A2+ cell recovery ranged from 78 – 97 % per 
single column pass. 
In the hollow fibre membrane modules, the application of 1 dynes/cm2 of shear stress 
recovered 23 – 45 % of loaded HLA-A2+ cells. Sequentially increasing shear stress to 5, 10 
and 25 dynes/cm2 recovered 2 – 6 %, 3 – 9 % and 1 – 10 %. Overall HLA-A2+ cell recovery 
ranged from 37 – 55 % across the tested range. A control study for the hollow fibre model 
(excluding IgG incubation) yielded HLA-A2+ cell recoveries of 32 – 37 % at 1 dynes/cm2 and 6 
– 8 %, 3 % and 1 – 2 % at 5, 10 and 25 dynes/cm2 respectively, with a cumulative recovery of 
42 – 50 %.  
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For the flat sheet membrane, 1.92 x 107 cells (~53 % HLA-A2+ purity) were introduced. 
Recoveries of 4, 11 and 1 % of HLA-A2+ cells were achieved across 1, 5 and 10 dynes/cm2, 
equating to a total recovery of around 16 %. 
 
 
Figure 5-5. HLA-A2+ cell recovery across tested units. Separation of HLA-A2+ cell recovery as a % of 
the original input are compared for magnetic separation (MACS) (n = 4), hollow fibre membrane (n = 
5) for IgG-exposed and flat sheet membrane (n = 1) devices. Data are displayed as the average, 
minimum and maximum data points. A control study for the hollow fibre membrane is also displayed 
(n = 2) as the range (minimum (red) and maximum (blue)). The data for CD20 cell recovery is 
displayed in Figure 7-9 and individual cell recoveries are displayed in Figure 7-10.  
 
5.4.2. Purity 
Changes in cell purity were quantified based only on HLA-A2 antibody staining. Isotype 
controls for both HLA-A2+ and CD20+ cells were used to indicate non-specific cell binding. 
Flow cytometry scatter plots and histograms are presented in Figure 5-6. CD20 IgG was not 
used for quantitative indication due to the inability to distinguish between positive and 
negative cells. In hindsight this may be attributed to incomplete antibody washing or 
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excessive incubation, since initial testing (Figure 5-4) showed identifying antigens to be 
exclusive to respective cell types. 
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Figure 5-6. Scatter plots and histograms for separation devices. Graphs show magnetic separation (A), hollow fibre membrane (B) and flat sheet membrane 
(C) separation systems. Cell purity was quantified using HLA-A2-measured purity only. Blue = isotype control staining for HLA-A2+ cells; red = isotype control 
for CD20+ cells. 
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Since the average starting concentration varied across batches, individual data are displayed 
(Tables 5-4 – 5-6). 
Magnetic separation 
The relative change in HLA-A2+ cell purity and changes in purity for each individual run (n = 
4) are presented for MACS (Table 5-4). Data show an increase in HLA-A2+ cell purity for one 
single column pass, ranging from 0.5 to 2.5, whilst the LCR (log10 depletion), ranged from 
0.19 – 0.41. 
Table 5-4. Relative change in purity for each collected fraction 
Run HLA-A2 Purity (%) LCR RCP 
Before After 
1 51.8 69.5 0.34 1.2 
2 71.5 83.4 0.41 2.5 
3 62.4 68.1 0.22 0.5 
4 77.3 80.4 0.19 0.7 
Data displayed for n = 4 individual runs. Green indicates an increase in cell purity; RCP = relative change in purity of HLA-A2 
cells; LCR = log10 depletion of CD20 cells.  
Hollow fibre membrane 
Individual HLA-A2 cell purities, as well as the RCP from hollow fibre membranes  are 
presented in Table 5-5. Shear stress applied across 0 – 25 dynes/cm2 yielded variable 
changes in purity. The RCP was calculated at specific fractions and ranged from 0.2 to 0.5 (1 
dynes/cm2); -0.1 to 0.4 (5 dynes/cm2); -0.4 to -0.1 (10 dynes/cm2) and -0.5 to 0.2 (25 
dynes/cm2). The purity of HLA-A2+ cells collected at lower fractions (≤ 5 dynes/cm2) 
gradually increased, but decreased at higher shear stresses (≥ 5 – 25 dynes/cm2). The 
control study without IgG showed negligible changes in cell purity across the 0 – 25 
dynes/cm2 range, where the RCP was 0.03 – 0.07, -0.01 – 0.1, -0.01 – 0.2 and -0.04 – -0.03 at 
1, 5, 10 and 25 dynes/cm2, respectively.  
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Table 5-5. HLA-A2 cell purification data for each fraction 
Run Shear stress (dynes/cm2) 
Input 1 5 10 25 
1 42.1 51.7 47.1 44.2 36.2 
2 47.7 53.6 49.7 44.4 30.2 
3 40.4 47.9 47.1 38.6 33.0 
4 42.4 51.5 41.6 37.6 35.7 
5 40.0 54.0 51.6 40.6 34.3 
Average RCP (-) - 0.2 – 0.5 -0.1 – 0.4 -0.4 – -0.1 -0.5 – 0.2 
1 (control) 53.7 54.1 54.7 50.4 51.7 
2 (control) 47.6 47.4 47.3 48.1 46.5 
Average RCP (control) (-) - 0.03 – 0.07 -0.01 – 0.1 -0.01 – 0.02 -0.04 – - 0.03 
Individual data points for hollow fibre separation with pre-incubation with IgG (n = 5) and without (n = 2) are displayed. 
Fractions exhibiting an increase in purity relative to the original input are displayed in green; those undergoing a reduction 
in red. 
Flat sheet membrane 
Changes in purity for each collected fraction across 1 – 10 dynes/cm2 (n = 1) are displayed in 
Table 5-6. For an input purity of 53 % the collected purity increased to 65 % and 93 % for 1 
and 5 dynes/cm2, before declining to 79 % for 25 dynes/cm2.  
Table 5-6. Flat sheet membrane purification performance 
 Shear stress (dynes/cm2) 
 Input 1 5 10 
Purity (%) 53.2 65.3 92.8 78.5 
RCP (-) - 0.7 11.8 2.5 
Individual data points for n = 1 runs across a range of 1 – 10 dynes/cm2 
5.4.3. Cell membrane integrity and intracellular staining 
Plasma membrane permeable and impermeable vital stains were used to measure the 
impact of purification in each device on cells. Changes in cell staining relative to the original 
input were assessed using four different assays (three per device) for each separation 
system. Technical problems meant that the membrane permeable VB-48/PI stain was used 
only for magnetic separation and was replaced with 7-AAD for hollow fibre and flat sheet 
membrane systems. 
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Trypan blue  
Trypan blue staining data are displayed in Figure 5-7. For magnetic separation, minor 
fluctuations were observed; percent cell uptake  ranged from -0.2 to 1.5 % post-separation. 
In hollow fibres, an increase in cell staining was observed to 0.8 – 2.3 % at fractions 
collected at 25 dynes/cm2. Flat sheet membranes exhibited much higher levels of cell 
staining, with 3, 14 and 23 % being recorded at 1, 5 and 10 dynes/cm2 respectively.  
 
Figure 5-7. Percent cell uptake of trypan blue as a function of shear stress from collected fractions 
relative to the original input. Average, maximum and minimum data points are displayed for 
magnetic separation (n = 4), hollow fibre membranes (n = 5) and sole data point is displayed for flat 
sheet membranes (n = 1). 
 
 DAPI  
Cells positive for DAPI staining across all three devices are represented in Figure 5-8. Gating 
was set at 2.00; cells above were considered to have lost membrane integrity by staining 
positive for DAPI, whilst cells below were considered to have retained membrane integrity, 
showing no DAPI staining.  
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Figure 5-8. Scatter plots showing DAPI staining. Cells above or below an area intensity of 2.00 are considered positive or negative for DAPI staining, equating 
to cells with and without intact plasma membranes, respectively. Histograms have been used to gate cells into a size range of 7 – 20 µm.  
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The percentage of cells staining positive for DAPI increased following magnetic separation, 
equating to a gain of 2 - 23 % after one column pass. In hollow fibre membranes, staining 
increased gradually to 1 – 8 % at 25 dynes/cm2. For the flat sheet membrane, particularly at 
a higher shear stress (10 dynes/cm2), a 42 % loss was recorded. Data are displayed in Figure 
5-9.  
 
Figure 5-9. Percent cell uptake of DAPI as a function of shear stress from collected fractions relative 
to the original input. Average, maximum and minimum data points are displayed for magnetic 
separation (n = 4), hollow fibre membranes (n = 5) and sole data point is displayed for flat sheet 
membranes (n = 1). 
VB-48/PI 
VB-48/PI staining was performed for magnetic separation only, owing to technical 
constraints. Scatter plots and histograms for cell size gating were applied to plots presented 
in Figure 5-10 and data are in Table 5-7. Scatter plots were interpreted accordingly: cells in 
the lower right (VB-48 high and PI low) were deemed to have intact plasma membrane and 
no intracellular damage; those in the lower left (VB-48 low and PI low) were considered to 
have intracellular changes associated with pre-apoptotic processes in spite of intact 
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membranes; and cells in both regions above the line (PI high and VB-48 low or high) were 
considered necrotic. 
7-AAD 
Since VB-48/PI staining could not be used to assess cells processed in both affinity 
membranes, the 7-AAD assay was used instead. Representative scatter plots are displayed 
in Figure 5-10 and fractions of cell uptake of 7-AAD are displayed in Figure 5-11. The 
percentage of cells staining positive for 7-AAD collected from the hollow fibre membrane 
ranged from 0 – 1.6 % at 25 dynes/cm2. For the flat sheet cassette, cell staining was much 
higher, having increased to 22 and 54 % at 5 and 10 dynes/cm2 respectively (Figure 5-12).  
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Figure 5-10. Scatter plots of B-lymphocyte cells showing VB-48 intensity vs. PI staining intensity before and after magnetic depletion using MACS MS 
columns. Cells staining in these regions is represented accordingly: upper right = VB-48-negative/PI positive; upper left = VB-48-positive/PI-positive; lower 
right = VB-48-positive/PI-negative; lower left = VB-48 negative/PI-positive. 
 
 
Figure 5-11. Scatter plots of gated cells before and after cell separation in hollow fibre and flat sheet membranes over ranges of 1 – 25 and 1 – 10 
dynes/cm2 respectively.  
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Figure 5-12. Percent cell uptake of 7-AAD as a function of shear stress from collected fractions 
relative to the original input. Average, maximum and minimum data points are displayed for hollow 
fibre membranes (n = 5) and a sole data point is displayed for flat sheet membranes (n = 1). 
 
Table 5-7. Cell staining based on VB-48/PI.  
 Upper right Upper left Lower right Lower left 
Change (%) -1.1 – 4.3 4.5 – 8.9 0.1 – 0.2 -8.2 – 2.9 
Cells staining in these regions is represented accordingly: upper right = VB-48-negative/PI positive; upper left = VB-48-
positive/PI-positive; lower right = VB-48-positive/PI-negative; lower left = VB-48 negative/PI-positive. Data are displayed as 
the minimum and maximum data points for n = 5 runs.  
 
In this chapter, the shear stress-induced separation of cells adsorbed with and without 
affinity interactions was performed. The purpose was to retain CD20+ cells (impurities) 
through affinity interactions and recover HLA-A2+ cells (product) free of affinity interactions 
to increase purity. This depletion (negative selection) strategy is in contrast to previous 
studies, committed to recovering cells adsorbed with affinity interactions, using shear 
stresses as high as 200 dynes/cm2 (Colton, 1996, Slowiaczek, 1998) or potentially harmful 
acidic (Mandrusov et al., 1995) or enzymatic agents (Nordon et al., 1996). This work aimed 
to simulate the removal of impure, undifferentiated cells from pluripotent-derived cells 
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using more gentle conditions (shear stresses ≤ 25 dynes/cm2) considered physiologically 
compatible to pluripotent-derived cells (Yamamoto et al., 2005, Wolfe et al., 2012 and 
2013). 
Magnetic separation 
Miltenyi’s magnetic cell separation technology, used as a benchmark, achieved HLA-A2+ cell 
recoveries in excess of 75 %, consistent with other studies (Schriebl et al., 2010b). However, 
both the log10 depletion (LCR) of impure CD20+ cells and the relative change in HLA-A2+ cell 
purity (RCP), were lower versus previous studies (Lara et al., 2006b, Schriebl et al., 2010b, 
Schriebl et al., 2012), perhaps due to lower antibody affinities, inefficient incubation 
protocols or the presence of CD20+ subpopulations with reduced antigen densities. The 
latter was observed in Figure 2.11 (Section 2.5.5); a subpopulation of CD20+ cells exhibited 
little-to-no staining perhaps due to limited antigen expression, a phenomenon which has 
limited the removal of such cells (Nordon et al., 1996, Schriebl et al., 2012). Cell viability was 
measured using membrane permeable and impermeable assays. Surprisingly, an increase in 
dye uptake was observed in collected fractions, owing to a higher propensity to remove 
non-viable cells during centrifugation and aspiration. Cells are less likely to incur process-
induced damage inside the column since cell recovery is gravity-driven and shows no change 
in the biological attributes of magnetically separated cells (Li et al., 2012). 
Membrane separation 
 Recovery 
For hollow fibre and flat sheet membranes, HLA-A2+ cell recovery was highest in lower 
fractions (≤5 dynes/cm2) presumably due to a high proportion of cells with weaker non-
Chapter 5. Affinity cell separation 
 
201 
 
affinity cell-substrate interactions. Cumulative HLA-A2+ cell recovery across 0 – 25 
dynes/cm2 was comparably lower versus previous studies, where ~95 % of cells without 
affinity interactions were recovered at lower shear stresses (≤ 5 dynes/cm2). This is 
attributed to the longer incubation periods used here (30 minutes) and versus other studies 
(5 – 15 minutes) (Colton, 1996, Nordon et al., 2004). Longer incubation times prior to shear 
stress exposure are associated with increased bond formation and therefore greater 
resistance to cell detachment (Gallant et al., 2005, Cuvelier et al., 2007). 
Purity 
The purity of collected fractions, evaluated using the RCP ratio, was highest at lower shear 
stresses (≤ 5 dynes/cm2) and declined when shear stress increased. Differences in the RCP 
ratios in both membrane formats and versus previous studies (Nordon et al., 1996, 
Slowiaczek, 1998) were attributed to different adhesion strengths. Chapter 4 showed that 
for hollow fibres, the number of possible affinity interactions per cell was 5,272 ± 1,102 
(mean ± SEM), assuming a 0.7 µm2 cell-surface contact area. For flat sheet membranes, 
there were 13,320 ± 1,791 possible affinity interactions. Whilst these numbers are rough 
estimates, differences in the number of affinity interactions could account for the different 
selectivities between both membranes, with greater resistance for the flat sheet 
membranes. For instance, theoretical (Bell, 1978, Bell et al., 1984, Kuo and Lauffenburger, 
1993)  as well as practical models (Xia et al., 1994), have shown that cell adhesion strength 
is proportional to the number of affinity interactions for a given dissociation constant and 
contact area. So for the hollow fibre membrane, the lower ligand density could have 
generated weaker adhesion strengths for CD20+ cells – similar to those for HLA-A2+ cells 
compared to the flat sheet cassette. Other possible causes could include: (1) fibres 
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possessing regions with lower rPrA densities, owing to ineffective coupling methods and 
therefore regions with lower affinity-interactive sites and/or (2) blocked fibres, most likely 
via instances where the resin had penetrated fractured or damaged fibres (Figure 5-13). In 
such instances, blocked fibres could inadvertently lead to higher shear stresses being 
applied, creating lower cell recoveries and purities.  
 
Figure 5-13. Dissected hollow fibre membrane modules post-separation: (A) and (B) show images of 
fibres containing adherent cells (x10 magnification) and (C) and (D) indicate microscopic images of 
fibre module cross-sections. Numbers are: 1 = fibres containing adsorbed cells; 2 = fibres without 
cells; 3 = dissected fibre open; and 4 = dissected fibre with possible blockage.  
Membrane integrity 
Changes in cell membrane integrity were radically different between hollow fibre and flat 
sheet membranes. Cells collected from hollow fibres exhibited increased dye uptake (up to 
10 %) after 25 dynes/cm2. Conversely, cells recovered from flat sheet membranes exhibited 
higher losses after 10 dynes/cm2, where up to 50 % stained positive. Assays shared trends, 
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but not sensitivity, mostly likely due to different reagent concentrations and incubation 
times.  
Generally, losses in cell membrane integrity were attributed to: (1) shear stress-induced 
damage where the surface tension acting on the cell membrane exceeded a critical limit 
sufficient to cause a rutpure (4 – 6 dynes/cm was previously deemed sufficient (Vlahakis and 
Hubmayr, 2000)); (2) membrane tearing through force-induced rPrA-IgG or IgG-antigen 
dissociation, as discussed in Chapter 1, or the possible rupture of the antigen out of the cell 
membrane (Pomianek, 1998). Ascertaining the impact on individual cell types (CD20+ or 
HLA-A2+ cells) was not possible since single- rather than multi-parameter flow cytometry 
staining was performed. 
The more extreme reduction in cell membrane integrity in the flat sheet membrane cassette 
could be attributed to: (1) turbulent eddies generated from spacers used to improve mixing 
(Da Costa et al., 1994), leading to forces sufficient for rupture being applied to the 
membrane; (2) increased fluid pressure exerted on cells due to a reduction in internal 
geometry during the transition from the membrane to the outlet ports and tubing; and (3) 
turbulent conditions inside the collection vessel (a plastic beaker), again leading to cell 
membrane rupture. 
Measurements to assess the cell response to shear stress were restricted to membrane 
integrity assays and the true effect on the cell is unknown. Moreover, losses in cell 
membrane integrity apparently indicate cell death (Kroemer et al., 2009), but this is 
contradicted in some instances, such as those caused by pore-forming proteins 
(Bischofberger et al., 2012) or mechanical stress, which is repairable by calcium influx-
dependent mechanisms (McNeil and Steinhardt, 2003). Moreover, cells with apparently 
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intact plasma membranes may have incurred more subtle damage, such as a loss in 
functionality, manifesting much sooner than cell death and independent of membrane 
integrity. For instance, myocardial cells become non-contractile 1 to 2 minutes post-
ischemia, but do not die until 20 to 30 minutes later and visible cell death is not even 
apparent until 6 to 12 hours later (Kumar, 2013). Cardiomyocytes derived from pluripotent 
cells, require a range of different tests to be performed to validate functionality. These 
concern electrophysiology, beating rates, contractility as well as extra- and intracellular-
related characteristics (Blazeski et al., 2012).  
5.5. Conclusion 
This chapter has presented  membrane-based methods for shear stress-induced affinity cell 
separation. Shear stress (0 – 25 dyes/cm2) was applied to surface-adsorbed cells to exploit 
differences in the adhesion strength of those adsorbed with and without affinity 
interactions. Affinity interactions were attributed to substrate-adsorbed rPrA interacting 
with the Fc region of CD20 IgG-antibody-tagged CD20+ cells, increasing adhesion strengths 
relative to HLA-A2+cells without. 
Membrane separation performances versus magnetic bead-based separation was poor. Cell 
recovery was very variable, ranging from 37 – 55 %, further indicating the limitations of the 
particular models used in this study. Cell purity increased (up to 10 % from an input purity of 
50 %) in fractions collected ≤ 5 dynes/cm2 and  it decreased in fractions collected ≥ 5 
dynes/cm2. This lower selectivity was attributed to fewer affinity interactions between 
CD20+ cells and the substrate, perhaps owing to the lower rPrA density, which was variable, 
ranging from 13,320 ± 1,791 per µm2 (mean ± SEM). Vital dye uptake, used to indicate a loss 
of cell plasma membrane integrity, was under 10 % across the 0 – 25 dynes/cm2 range. 
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Conversely, the flat sheet membranes exhibited a larger increase in the purity of collected 
fractions in the single run that was performed (increasing from 53 % at the inlet to 65, 93 
and 79 % at fractions collected at 1, 5 and 10 dynes/cm2. However, cells collected from 
fractions at 5 and 10 dynes/cm2 showed a very high uptake of vital dye, indicating extensive 
damage to cell membrane integrity. However, recovery was also poor, totalling 16 % across 
the collected range.   
Direct comparisons in performance between both membrane formats are of limited use for 
several reasons: (1) the poor quality of the hollow fibre modules and (2) the fact that only a 
single run could be performed using the flat sheet membrane. However, these findings 
show that membranes have the capacity to increase the purity of cells, although compared 
to existing magnetic bead and previous membrane separation devices, aforementioned 
limitations must first be addressed. These primarily centre on membrane design and 
construction, as well as the incubation times used. Further, more detailed assessments 
regarding the impact on cell health and functionality should also be performed.  
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Chapter 6. Thesis summary and future work 
6.1. Thesis output 
6.1.1. Flow tube model 
A small scale model was used to determine differences in the resistance of cells adherent 
with and without affinity interactions using shear stress. The purpose was to exploit these 
differences for cell separation studies for two proposed uses: (1) as an acoustic quartz 
crystal microbalance biosensor to measure cell purity based on net changes in surface-
localised cells and (2) a membrane device capable of scale-up or scale-out to address larger 
batch sizes containing impure cell populations.  
6.1.2. Biosensor 
A quartz crystal microbalance was proposed as a biosensor to measure the purity of cells in 
a given sample. Here, shear stress-induced affinity cell separation is proposed as a means to 
remove cells without affinity interactions (product) and retain cells adherent with affinity 
interactions (impurities), ultimately to detect impure cell populations. A method for 
quantifying cells and converting the change in cell number on the surface with purity was 
proposed. However, the lack of practical output meant that the concept could not be 
investigated and further work is recommended to determine its feasibility.   
6.1.3. Separation devices 
Hollow fibre and flat sheet microfiltration membranes were utilised for cell separation. The 
purpose was to mimic the removal of impure cell populations by exploiting differences in 
the adhesion strength of cells with and without affinity interactions. However, compared to 
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magnetic separation studies, performance (recovery, purity and cell membrane integrity) 
was poor. In short, a possible re-consideration of operating parameters (in particular 
incubation time prior to washing and ligand density) is recommended, along with a re-
design of the system and the use of more advanced methods to study the impact on cells 
are also recommended. 
6.2. Improvements and future work 
Incubation time and ligand density 
The shear stress required to remove 95 % of cells adherent without affinity interactions was 
approximately 25 dynes/cm2 in flow tube models. This is higher than cited papers and is 
primarily attributed to the longer incubation time used (30 minutes versus 5 – 15 minutes 
used elsewhere). This reduced cell selectivity and recovery in both membrane separation 
devices and would translate to a lower resolution in the QCM biosensor. In order to improve 
this, a reduced incubation time is therefore proposed in conjugation with studies that vary 
ligand density, which has also been shown to affect cell selectivity (Pomianek, 1998, Colton, 
1996). 
Studying the physiological effects of shear stress on cells 
Since the flow tube is limited to shear stress-induced cell detachment, which relies upon 
practical models that are difficult to operate for cell collection, the use of a conventional 
rotating plasma separation unit is instead proposed. Here, cells may be exposed to a range 
of shear stresses and collected as a function of rotation rate (Ohashi et al., 1988, Kaplan and 
Halley, 1990). Collected cells may then be assessed for short- and long-term effects of shear 
stress using high-throughput, multiparameter methods.   
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Correlation with cell potency 
Another functionality of this separation device concerns the purification of cells based on 
potency. Recent evidence suggests that non-pluripotent mesenchymal stem cells are in fact 
split into sub-populations during culture that contain cells with and without key potency 
factors (Crigler et al., 2006, Mabuchi, 2013). Increasing the proportion of potent cells in a 
transplant could increase the therapeutic effect of a dose. However, enriching these cells 
may compromise cell functionality, as observed in fluorescent cell sorting methods (Li et al., 
2012). Rather, by identifying extracellular markers exclusive to cells incapable of therapeutic 
action, a depletion separation strategy  targeting inert cells could be implemented without 
compromising cell functionality. 
Backpressure-induced cell separation 
Backpressure-induced cell detachment, demonstrated elsewhere (Colton, 1996, Pomianek, 
1998), may be more appropriate in instances where cells deform and spread across the 
surface (Cuvelier et al., 2007) more quickly than the rate at which new affinity interactions 
could occur. The cells used here are non-adherent lymphocytes and do not deform unless 
subjected to increased external force, irrespective of the incubation time. However, the 
majority of adherent cells do undergo deformation when statically incubated (Itano et al., 
2003, Gallant et al., 2005, Cuvelier et al., 2007), so the use of membranes with larger pores 
would perhaps be more useful in such applications, as demonstrated previously (Colton, 
1996).  
6.3. New system design 
Provides overview of device design and implementation.  
Cartridge design 
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A method of scaling-out the system in order to scale-up is presented. Here, up to 100 
cartridges are stacked 10 x 10 to achieve a system comprised of 100 cartridges. A method to 
process multiple cartridges is highly desirable for large-scale cell separation, since the direct 
scale-up of such systems is limited by the reduction in shear stress as a function of distance 
from the centre of the cartridge at larger scales. The proposed cartridge and system design 
is presented in Figure 6-1 below. 
 
Figure 6-1. Individual cartridge components (not to scale) where (A) = dimensions of an individual 
cartridge; (B) = multiple cartridges stacked in a combined system. 
Cartridge and tube sizes are presented in Tables 6-1 and 6-2. Thinner tube walls, owing to a 
non-porous nature enable tubes to be more closely packed together. Since radial mass 
transfer is not a requirement, the tube may be made non-porous.  
Table 6-1. Cartridge sizing. 
  Actual Compact Units 
# tubes 20,000 20,000 - 
Length 0.22 1 m 
 CS-area 9.8 9.8 cm2 
Width 3.1 3.1 cm 
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Table 6-2. Tube sizing. 
  Actual Compact Units 
Tube length 0.22 1 m 
Outer diameter 250 250 um 
Inner diameter 230 230 um 
Wall thickness 20 20 um 
SA tube total 1.60E-04 7.20E-04 m2 
SA/cm tube 7.20E-06 7.20E-06 m2/cm 
SA/cartridge 3.18 14.45 m2 
 
System design 
The cartridge system for 10 cartridges in a row is presented in Figures 6-2 and 6-3. Up to 90 
additional cartridges may be stacked underneath, also in rows of 10, equating to 100 cartridges in 
total.   
The basic process involves the following: (1) the 3-way valve (2) is adjusted to allow the injection of a 
cell suspension (1) into 10 channel valve (4), which systematically controls the injection of 
suspension into each of the cartridge units (5) (the outlet 3-way valve (9) is adjusted to allow waste 
to be removed from the system (10)); (2) an incubation period occurs whereby cells are allowed to 
form affinity interactions with ligand-coupled surfaces; (3) the feed 3-way valve (2) is adjusted to 
inject wash buffer (3) to recover cells from cartridges, again by selectively adjusting the 10-channel 
valve (4) to permit the systematic recovery of cells from each cartridge in series and the outlet 3-way 
valve (9) is adjusted to allow cell recovery for further downstream processing (8). 
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Figure 6-2. Top-down view of basic setup for 10 cartridges. The potential for adding additional rows 
of 10 cartridges underneath also exists, enabling up to 100 cartridges to be processed in a system. 
Each layer is represented by blue symbols, whereas units used by multiple layers simultaneously are 
represented by red symbols.  
 
Figure 6-3. Side view of 10 layers of 10 cartridges stacked and connected to a single peristaltic pump.  
 
Importantly, the system could also be engineered to comply with the following criteria deemed 
instrumental in a cell therapy manufacturing process (Table 6-3). 
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Table 6-3. Technology requirements recommended for implementation into a cell therapy 
manufacturing process.  
Property Description Justification 
Closed system Functionally closed unit 
permitting operation in non-
GMP settings 
Cell suspension is not exposed to the atmospheric environment 
and can be integrated into a flow-based manufacturing process. 
Utilises closed-system compatible components. 
Single-use Disposable device Critical components are disposable after use 
Cost-effective Exerts minimal costs on the 
process development or 
operation 
Components account for a low cost of the overall process 
Scalable Capacity to increase batch sizes 
whilst maintaining process 
performance 
The technology may purify up to 1.5 x 1012 cells per batcha. 
Capable of 
automated 
operation 
Integration into robotic 
processing steps 
The system may be capable of automation and integration into a 
manufacturing process.  
GMP compliant Consistent with regulatory 
constraints surrounding product 
manufacture 
Maintains cells in a sterile environment. Utilises GMP-compatible 
components.  
ISO9001 
certification 
Demonstration of dependable 
quality 
Ensures that necessary standards have been met and that if the 
system is manufactured in house, that all components received 
from suppliers are validated.  
a based upon a density of 8 % coverage – up to 90 % has been reported elsewhere (Nordon 1996 and patent) 
System operation 
Each cartridge will operate a 1.5 minute injection time, 10 – 15 minute incubation period for cell 
adsorption and the formation of affinity interactions and a 2 minute recovery period (Figure 6-4).  
 
Figure 6-4. Operating regime for an individual cartridge. 
As detailed above, rows of 10 cartridges in each system can be operated in series; the injection of 
cells into one cartridge is immediately followed by the injection of cells into the adjacent cartridge 
until complete. Since the incubation time of the first cartridge in a row of 10 ends prior to cell 
recovery, multiple cartridges may be processed using the same pump. 
The outlet from the 10-cartridge cassette (5) may be connected to a peristaltic pump (7). Since 
peristaltic pumps can process multiple feed lines, additional layers of 10 cartridges may be added 
underneath and operated in parallel with the top layers. As such, Figure 6-5 shows how rows of 10 
may be processed in series. By using the same peristaltic pump for each layer of 10 cartridges, 
multiple feed lines and therefore multiple cassettes containing 10 cartridges may be processed in 
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simultaneously. As such, the processing time will remain the same in spite of additional layers of 
cassettes, meaning that additional cartridges (e.g. 9 cassettes of 10 cartridges each) may be added, 
equating to a system of 100 cartridges. 
 
Figure 6-5. Operating regime for 10 cartridges in series.  
 
Cartridge system performance 
The nature of the design is such that performance may be assumed to be independent of scale. It is 
assumed that performance projections extracted from the scaled-down flow tube models can be 
replicated inside each individual cartridge. Since the cartridge system itself is comprised of several 
individual cartridges, separation performance would be replicated in each of the cartridges.  
Figure 6-6 presents the performance projections for each of the cartridges assuming separation 
performance based upon that of the data gathered in Chapter 2. Here, performance was sub-
optimal versus previous studies: ~91 % of product cells were recovered at 25 dynes/cm2, whilst a 
similar amount were recovered at 5 dynes/cm2 elsewhere (Nordon 1996). This lower recovery would 
mean that higher amounts of impure cells would be recovered, diluting the purity of recovered 
fractions.  
Notably, system performance is independent of scale and has the capacity to recover the majority of 
product cells (~ 75 %) and raising purity above 99 % (up from an original starting purity of 90 % or 
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above). Although not addressing more stringent requirements (Section 1.7), it would satisfy those 
for some clinical standards where ≥99 % is deemed sufficient for therapeutic application (Schwartz 
et al., 2012). 
 
Figure 6-6. System performance projections based on experimental data obtained in Chapter 2.  
Processing capacity 
Idealised estimates (Tables 6-4 and 6-5) using projections from Chapter 2 indicate that the number 
of cells which can be purified in 100 cartridges ranges from 1.6 – 3.2 x 1011 cells for the 0.22 m length 
unit and 0.74 – 1.5 x 1012 cells for the 1 m length unit for densities of 4 and 8 % respectively. 
Ultimately the system size will depend upon the number of cartridges, the length of the cartridges 
and adsorption density of cells on the surface.  
Table 6-4. Cell adsorption capacity per cartridge. 
 Actual (0.22 m) Compact (1 m) 
Cell surface coverage 4 % 8 % 4 % 8 % 
Total cells 1.8 x 109 3.2 x 109 0.75 x 109 1.5 x 1010 
Cartridge dimensions: tube height: 3.1 cm; width: 3.1 cm; number of tubes: 20,000. Assumed cell size = 10 µm diameter.  
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Table 6-5. Large-scale cell adsorption capacity per 100-cartridge system.  
 
Actual (0.22 m) Compact (1 m) 
Cells surface density 4% 8% 4% 8% 
Total cells 1.6 x 1011 3.2E x 1011 7.4E x 1011 1.5E x 1011 
Cartridge quantity: 100; height: 31 cm; width:  31 cm. These values are based upon the assumption that cell adsorption is 
homogeneous across all surfaces. Whilst cells settle under gravity, it is thought that cartridge rotation will encourage cell 
adsorption onto all surfaces. Cell surface adsorption is assumed to be homogeneous, since cells are transported via 
convective processes and would be mixed prior to injection.  
It should be noted that the cell densities assumed here are low compared to those utilised 
previously (Nordon, 1996, Slowiaczek 1998), which were as high as 90 % and independent of 
performance. Such an increase in density would yield a more compact system. The previous design 
where a 90 % starting density was used (Nordon 1996) was 20 cm in length and assuming 20,000 
fibres were compacted together, as calculated in this section, each device could accommodate ~2.5 
x 1010 cells, which would mean that ~60 units would be required to purify 1.5 x 1012 cells. No doubt 
an increase in length would translate to a reduction in the number of cartridges required, but the 
higher densities of cells utilised in such systems could increase the likelihood of aggregation, tubular 
clogging, imbalances in shear stress applied and therefore reduced purification performance. As 
such the precise densities, lengths and number of cartridges utilised could only be determined 
practically but would no doubt benefit from the design presented in Figures 2 and 3 to ensure the 
rapid purification of multiple cartridges.  
Volume generated 
The internal volume of the cartridges must be removed in order to recover the cells from the 
system. Figure 6-7 displays the internal volumes of 100-cartridge systems comprised of 0.22 m-
length cartridges and 1 m-length cartridges. The volumes from each system alone are significant and 
present several technical challenges that would require additional processing in order to overcome.  
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Figure 6-7. Internal volumes inside the 100 cartridge units of length 0.22 m and 1 m with the 
purification capacity of 3.2 x 1011 and 1.5 x 1012 cells respectively, assuming an 8 % density. 
This highlights a significant increase in the volume of cells that would recovered from the system 
versus that for magnetic separation technologies. The final capacity will depend upon the shear 
stress utilised for detachment (applied for ≤ 1 – 2 seconds), as well as the volume of fluid inside the 
system. This means that additional downstream processing to concentrate the cells to a required 
amount (107 – 108 cells/mL) will need to be large-scale – in the order of 100 litres. Such technology 
has been patented previously as either a hollow fibre membrane unit [WO2011091248A1] or a 
continuous centrifugation device.  
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Chapter 7. Appendix 
The following section provides the calibration charts used to quantify various protein and 
chemical contents present on glass and membrane substrates.  
Chapter 2 data 
 
Figure 7-1. Calibration chart for rPrA quantification onto aldehyde-functionalised glass beads using 
the BCA assay. A range of known concentrations (0 – 1 mg/mL) were plotted versus absorbance. The 
R2 value is 0.993. 
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Figure 7-2. Calibration chart for BSA quantification onto aldehyde-functionalised glass beads using 
the BCA assay. A range of known concentrations (0 – 0.75 mg/mL) were plotted versus absorbance. 
The R2 value is 0.989. 
 
 
Figure 7-3. Calibration chart using to convert absorbance at 410 nm into picric acid concentration for 
TNBS data interpretation. The R2 value = 0.9996. 
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Worked example (Section 2.5.13.) 
Assuming a 4 % density of cells on the sensor surface are washed at 25 dynes/cm2, the 
following approach may be applied: 
1. Present equations: 
 𝑁𝑁𝐶𝐶,𝑚𝑚 = 𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚0.𝑅𝑅𝑅𝑅𝐶𝐶,𝑚𝑚.𝑁𝑁𝑇𝑇,𝑚𝑚0 2.16 
 
 𝑁𝑁𝐶𝐶,𝑚𝑚 = 𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚.𝑁𝑁𝑇𝑇,𝑚𝑚 2.15 
 
2. Rearrange equations to determine SPCn,0: 
 
𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚0 = 𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚.𝑁𝑁𝑇𝑇,𝑚𝑚𝑅𝑅𝑅𝑅𝐶𝐶,𝑚𝑚.𝑁𝑁𝑇𝑇,𝑚𝑚0 2.17 
 
3. Present known and unknown parameters from calibration chart: 
Table 7-1. Parameters used to determine cell purity.  
 Data Unit 
SPC,n Unknown  % 
NT,n0 42,091 Cells 
NT,n 32,111 Cells 
RTC,n 84  % 
Note: RTC,n is to be obtained through prior experimental determination – to be customised 
for each cell line.  
4. Determine the unknown parameter (SPC,n): 
Use Equation 2.11 to determine: 
 𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚 = 𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚∗ + �𝑅𝑅𝑀𝑀𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑚𝑚 −  𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚∗�. �1 − exp (−𝐾𝐾.𝑁𝑁𝑇𝑇,𝑚𝑚)� 2.14 
 
, and insert the following data. 
Table 7-2. Constants used in Equation 2.14.  
Constant Data Unit 
SPC,n* -100.9 % 
K 0.0002077 1/cells 
Plateau 96.40 % 
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, such that at 25 dynes/cm2, where NT,n is 32,111 cells , SPC,n would equate to 96.1 % (the 
actual value is 98.8 %). 
5. Insert the data into Equation 2.13 to determine the original starting purity of cells on 
the sensor surface: 
 
𝑆𝑆𝑅𝑅𝐶𝐶,𝑚𝑚0 = 0.96 × 32,1110.84 × 42,091  
 
, such that SPC,n0 = 87.2 % (the actual value would be 90 % based on the projections made in 
Section 2.5.8.). 
A comparison of the calculated versus actual SPC,n0 purities is presented below based on 
shear stress exposure at 25 dynes/cm2. 
 
 
  
Figure 7-4. Comparison of actual purities versus those calculated with Equation 2.13 SPC,n0 
purities. The R2 value is 0.9991 and the equation is y = 0.9822x + 0.0046. The comparison 
shows good agreement, with an R2 value of 0.9991. Note: the actual values are based on the 
original data generated from the model, which considered cell recoveries.  
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Table 7-3. Comparison of actual purities versus calculated purities.  
Actual 90% 75% 50% 25% 10% 5% 1% 
Calculated 87.6% 74.3% 51.4% 25.9% 9.6% 4.6% 1.3% 
Note: CD20+ cell purities below 1 % are not considered measurable due to limitations in the model.  
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Figure 7-5. Calibration chart for rPrA quantification onto aldehyde-functionalised hollow fibre 
membranes using the BCA assay. A range of known concentrations (0 – 1,250 µg/mL) were plotted 
versus absorbance. The R2 value is 0.990. 
6 
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Figure 7-6. Calibration chart for BSA quantification onto aldehyde-functionalised hollow fibre 
membranes using the BCA assay. A range of known concentrations (0 – 1,000 µg/mL) were plotted 
versus absorbance. The R2 value is 0.981. 
 
Figure 7-7. Calibration chart for rPrA quantification onto aldehyde-functionalised PES membranes 
using the BCA assay. A range of known concentrations (0 – 1,000 µg/mL) were plotted versus 
absorbance. The R2 value is 0.994. 
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Figure 7-8. Calibration chart for rPrA quantification onto aldehyde-functionalised PES membranes 
using the BCA assay. A range of known concentrations (0 – 1,000 µg/mL) were plotted versus 
absorbance. The R2 value is 0.996.  
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Chapter 5 data 
 
 
Figure 7-9. CD20+ cell recovery across tested units. Separation of CD20+ cell recovery as a % of the 
original input are compared for magnetic separation (MACS) (n = 4), hollow fibre membrane (n = 5) 
for IgG-exposed and flat sheet membrane (n = 1) devices. Data are displayed as the average, 
minimum and maximum data points. A control study for the hollow fibre membrane is also displayed 
(n = 2) as the range (minimum (red) and maximum (blue)).  
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Figure 7-10. Individual cell recoveries from hollow fibre membranes across 1, 5, 10 and 25 dynes/cm2 
for CD20+ and HLA-A2+ cells with affinity interactions (A-E) and without (F-G). Total cell recovery 
across 0 – 25 dynes/cm2 (H), where undashed lines = main runs and dashed lines control runs 
(without IgG antibody incubation).  
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